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Beyond maternal death: improving the quality of maternal
care through national studies of ‘near-miss’
maternal morbidity
Marian Knight,1* Colleen Acosta,1 Peter Brocklehurst,2
Anna Cheshire,3 Kathryn Fitzpatrick,1 Lisa Hinton,4 Mervi Jokinen,5
Bryn Kemp,1 Jennifer J Kurinczuk,1 Gwyneth Lewis,2
Anthea Lindquist,1 Louise Locock,4 Manisha Nair,1 Nishma Patel,6
Maria Quigley,1 Damien Ridge,3 Oliver Rivero-Arias,1 Susan Sellers7
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1National Perinatal Epidemiology Unit, Nuffield Department of Population Health,
University of Oxford, Oxford, UK
2Institute for Women’s Health, University College London, London, UK
3Faculty of Science and Technology, University of Westminster, London, UK
4Health Experiences Research Group, Nuffield Department of Primary Care Health Sciences,
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7Department of Obstetrics and Gynaecology, University Hospitals Bristol NHS Trust, Bristol, UK
*Corresponding author marian.knight@npeu.ox.ac.uk
Background: Studies of maternal mortality have been shown to result in important improvements to
women’s health. It is now recognised that in countries such as the UK, where maternal deaths are rare,
the study of near-miss severe maternal morbidity provides additional information to aid disease prevention,
treatment and service provision.
Objectives: To (1) estimate the incidence of specific near-miss morbidities; (2) assess the contribution
of existing risk factors to incidence; (3) describe different interventions and their impact on outcomes and
costs; (4) identify any groups in which outcomes differ; (5) investigate factors associated with maternal
death; (6) compare an external confidential enquiry or a local review approach for investigating quality of
care for affected women; and (7) assess the longer-term impacts.
Methods: Mixed quantitative and qualitative methods including primary national observational studies,
database analyses, surveys and case studies overseen by a user advisory group.
Setting: Maternity units in all four countries of the UK.
Participants: Women with near-miss maternal morbidities, their partners and comparison women without
severe morbidity.
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Main outcome measures: The incidence, risk factors, management and outcomes of uterine rupture,
placenta accreta, haemolysis, elevated liver enzymes and low platelets (HELLP) syndrome, severe sepsis,
amniotic fluid embolism and pregnancy at advanced maternal age (≥ 48 years at completion of
pregnancy); factors associated with progression from severe morbidity to death; associations between
severe maternal morbidity and ethnicity and socioeconomic status; lessons for care identified by local
and external review; economic evaluation of interventions for management of postpartum haemorrhage
(PPH); women’s experiences of near-miss maternal morbidity; long-term outcomes; and models of
maternity care commissioned through experience-led and standard approaches.
Results: Women and their partners reported long-term impacts of near-miss maternal morbidities on their
physical and mental health. Older maternal age and caesarean delivery are associated with severe maternal
morbidity in both current and future pregnancies. Antibiotic prescription for pregnant or postpartum
women with suspected infection does not necessarily prevent progression to severe sepsis, which may be
rapidly progressive. Delay in delivery, of up to 48 hours, may be safely undertaken in women with HELLP
syndrome in whom there is no fetal compromise. Uterine compression sutures are a cost-effective
second-line therapy for PPH. Medical comorbidities are associated with a fivefold increase in the odds of
maternal death from direct pregnancy complications. External reviews identified more specific clinical
messages for care than local reviews. Experience-led commissioning may be used as a way to commission
maternity services.
Limitations: This programme used observational studies, some with limited sample size, and the possibility
of uncontrolled confounding cannot be excluded.
Conclusions: Implementation of the findings of this research could prevent both future severe pregnancy
complications as well as improving the outcome of pregnancy for women. One of the clearest findings
relates to the population of women with other medical and mental health problems in pregnancy and their
risk of severe morbidity. Further research into models of pre-pregnancy, pregnancy and postnatal care is
clearly needed.
Funding: The National Institute for Health Research Programme Grants for Applied Research programme.
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Plain English summary
S tudies of maternal mortality have been shown to result in important improvements to women’s health.It is now recognised that in countries such as the UK, where maternal deaths are rare, the study of
severe complications of pregnancy, so called ‘near-misses’, provides additional information to help disease
prevention and treatment. The objectives of this programme were to investigate risk factors, management
and associated outcomes of ‘near-misses’ and explore methods for reviewing the quality of care. We
conducted an interview study of women and their partners and identified that having a ‘near-miss’ can
have long-lasting effects on the health, particularly the mental health, of both women and their partners.
We investigated reviewing women’s care using two different approaches: external review (‘confidential
enquiry’) and local hospital internal reviews. We found that the local reviews were less likely to report
detailed clinical messages for care and less likely to involve a range of different specialist doctors and
midwives. We collected anonymous information nationally on all women who had specific severe
pregnancy complications, from which we were able to determine that older women and women with
previous caesarean deliveries, particularly those that underwent induction of labour, were at a 1.5- to
14-fold higher risk of complications. When we investigated further, women who had a medical or mental
health problem before they became pregnant were at higher risk of dying from a severe pregnancy
complication. Further research is needed into care for women who have pre-existing medical and mental
health problems before, during and after pregnancy.
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Scientific summary
Background
Studies of maternal mortality have been shown to result in important improvements to women’s health and
maternal death rates are an important national indicator of the quality of maternity care. A comprehensive
programme of study of maternal deaths has been undertaken in the UK for > 50 years, including
confidential expert review. This has contributed to major improvements in the quality of maternity care and
a dramatic reduction in the maternal mortality rate, such that maternal deaths are now very rare. This does
not mean that pregnancy can be regarded as ‘safe’. It is now increasingly being recognised that in countries
such as the UK, where maternal deaths are rare, study of near-miss severe maternal morbidity provides
additional important information to aid disease prevention, treatment and service provision.
This programme used mixed methodologies to provide a national picture of the near-miss maternal
morbidities underlying the leading direct causes of maternal death with the specific aim of generating
evidence-based recommendations for practice and service provision, and to improve the quality of care
and, hence, outcomes of these conditions for women, their babies and families.
Objectives
1. To determine the incidence of the specific morbidities most commonly leading to maternal death in
the UK.
2. To assess the contribution of existing risk factors to disease incidence and identify steps which may be
taken in clinical practice to address these factors to reduce incidence.
3. To describe how the conditions are managed and describe any variations in management, exploring the
impact that different management strategies or interventions have on outcomes and costs, in order to
make recommendations for best practice to improve outcomes for all women.
4. To describe the outcomes of the conditions for mother and infant and identify any groups in which
outcomes differ.
5. To investigate which factors influence the risk of death and how these might be addressed to
prevent death.
6. To explore whether an external confidential enquiry or a local review approach can be used to
investigate and improve the quality of care for affected women.
7. To assess the longer-term impacts of near-miss maternal morbidity for women, their babies
and families.
Methods
The programme comprised six interrelated workstreams:
Workstream 1: this workstream used the national collaboration of clinicians contributing to the UK
Obstetric Surveillance System (UKOSS) and employed primary data collection to conduct descriptive and
case–control studies to establish the incidence; risk factors; management and outcomes of uterine rupture;
placenta accreta; haemolysis, elevated liver enzymes and low platelets (HELLP) syndrome; severe sepsis;
and amniotic fluid embolism (AFE).
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Workstream 2: over two separate time periods (2003–8 and 2009–12) this workstream compared data
from the national Confidential Enquiries into Maternal Deaths with data on women who survived
near-miss morbidity collected through UKOSS. The analyses used logistic regression techniques in order
to identify factors associated with progression from severe morbidity to death.
Workstream 3: inequalities in rates of near-miss maternal morbidity were explored in different population
groups. Secondary analyses of UKOSS data were used to explore associations between severe maternal
morbidity and ethnicity and socioeconomic status. Primary data collection was used to investigate the
outcomes of pregnancy at advanced maternal age (≥ 48 years at completion of pregnancy).
Workstream 4: this workstream explored methods to improve local learning from adverse events.
The project identified the approaches currently in use locally to examine the care of women with severe
maternal morbidity, through a detailed examination of the guidelines for local incident review using
the Appraisal of Guidelines for Research and Evaluation tool. In addition, ‘trigger checklists’ were examined
to determine which conditions are currently being reviewed. A comparison between local peer review and
external case review (confidential enquiry) was then undertaken in six centres selected by stratified random
sampling. Lessons for care identified by local and external review were identified and compared.
Workstream 5: an economic evaluation of four different secondary managements for postpartum
haemorrhage (PPH) was undertaken using national observational data from UKOSS as well as a literature
review and primary cost data collection. The use of uterine compression sutures, interventional radiology,
pelvic vessel ligation and factor VIIa were compared.
Workstream 6: this workstream comprised three component projects to explore women’s experiences of
near-miss maternal morbidity and long-term outcomes.
Study 6A: women who had experienced a near-miss maternal morbidity were invited with their partners to
undertake a qualitative interview study to describe their experiences. This study used the well-established
methodology of the Health Experiences Research Group. Women were purposively sampled to represent a
range of groups, conditions and time periods since their illness. Semistructured interviews were conducted
by a single researcher and all interviews were video- or audio-recorded for analysis. Analysis used the
thematic approach and was used to develop a patient and clinician education site.
Study 6B: this surveyed the experiences of women who had a peripartum hysterectomy to control severe
peripartum haemorrhage and their matched controls through a postal questionnaire. The questionnaire
sought information about the women’s general health, using the Short Form questionnaire-12 items,
information about health-care usage, questions on fertility wishes prior to their hysterectomy and issues
raised by the qualitative interview study.
Study 6C: this investigated the use of the ‘experience-led commissioning’ (ELC) model, informed by data
from study 6A to commission maternity services. The ‘intervention’ group was a health economy receiving
a facilitated ELC programme. The ‘control’ was a health community who redesigned services without the
ELC process. The evaluation used a case study approach, using predominantly qualitative methods, to
investigate in what ways the addition of ELC programme facilitation affected the commissioning process
and how commissioned models of maternity care differed with and without the ELC approach.
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Findings and recommendations
The incidence of the specific morbidities most commonly leading to
maternal death in the UK
The incidences of these conditions ranged from 2 to 47 per 100,000 maternities. Clinicians should be
aware of the frequency of these rare but severe complications and ensure that facilities and training are in
place to manage women with these conditions when they occur. Uterine rupture in women with a
previous caesarean section planning vaginal delivery is less common than previously estimated and women
should be advised of this when discussing their planned mode of delivery; increased risk associated with
induction or augmentation of labour should also be considered. Women who have placenta praevia and
have had a previous caesarean delivery are at a high risk of placenta accreta/increta/percreta and delivery
should be managed in accordance with this risk.
The contribution of existing risk factors to disease incidence and steps that
may be taken in clinical practice to address these factors to reduce incidence
Older maternal age is associated with severe maternal morbidities and women should be aware of this if
they are planning to delay childbearing. Caesarean section delivery is associated with severe maternal
morbidity in both current and future pregnancies. These risks, together with planned family size, need to
be taken into account when planning mode of delivery.
Primary and secondary care practitioners should remain aware that pregnant or recently pregnant women
with suspected infection need closer attention than women who are not pregnant; antibiotic prescription
does not necessarily prevent progression to severe sepsis and women should be followed up to ensure
recovery. The rapid progression to severe sepsis highlights the importance of early administration of
high-dose intravenous antibiotics for anyone with suspected sepsis. Signs of severe sepsis, particularly
with confirmed or suspected group A streptococcal infection, should be regarded as an obstetric
emergency and should be routinely included in obstetric emergency training courses. Vigilant infection
control at vaginal delivery should be maintained.
The impact of different management strategies or interventions on
outcomes and costs, and recommendations for best practice to
improve outcomes
Delay in delivery, of up to 48 hours, may be safely undertaken in women with HELLP syndrome in whom
there is no fetal compromise and may assist in the delivery of antenatal steroids where these are indicated.
The number of previous caesarean sections and the time interval between the last delivery and conception
should be taken into account when counselling women with previous caesarean deliveries about their
mode of delivery in this pregnancy and risk of uterine rupture. Uterine compression sutures are a more
cost-effective second-line therapy for PPH than interventional radiology and guidelines should reflect this.
Earlier treatments, including correction of coagulopathy, may reverse the cascade of deterioration that
seems to be present with AFE, and so improve survival in the most serious cases.
Experience-led commissioning may be used as a way to commission maternity services. The commissioned
strategy appears more patient-focused and the process led to beneficial engagement of both user and
health professional groups in commissioning services.
Variation in outcomes between groups
Maternity services need to be responsive to women of different ethnic and social groups, to ensure
optimal utilisation of care. ELC may provide a route to fully engaging different social and ethnic groups in
the commissioning of appropriate maternity services. Older women are at a considerably higher risk of
pregnancy complications and this should be considered when counselling and managing women of very
advanced maternal age, particularly in the context of assisted reproduction. There may be a place for
considering early fetal reduction in women of very advanced age with multiple pregnancies. Recommendations
regarding assisted conception including egg donation in older mothers, as well as single embryo transfer,
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should take into account the high risks of adverse pregnancy outcomes in older women with multiple
pregnancies and who have undergone assisted reproduction.
Factors that influence the risk of maternal death and how these might
be addressed
Health professionals should be aware of the associated risk of dying from severe obstetric morbidity in
women with medical and mental health comorbidities, hence women with medical and mental health
comorbidities need to be identified and fully assessed for their risks in pregnancy. Inadequate uptake of
antenatal care, substance misuse, hypertensive disorders of pregnancy, previous pregnancy problems and
minority ethnicity are also associated with maternal death from direct pregnancy complications. The
adverse consequences of these conditions can potentially be minimised through access to appropriate
services, extra vigilance and proactive multidisciplinary management.
Comparison of an external confidential enquiry or local review approach to
investigate and improve the quality of care for affected women
Substantial variation exists in the local review of severe maternal morbidities in terms of the definition and
scope of incidents that trigger a review, the guidelines for conducting a review and the outputs and
conclusions of reviews. Maternal sepsis was omitted in one-third of trigger checklists; maternal sepsis
should be added to both Royal College of Obstetricians and Gynaecologists and local checklists of cases,
which should stimulate a local review. Trigger checklists need to be responsive at both a local and national
level to emerging conditions of public health and/or patient safety concern; processes should exist for
ongoing review and revision to respond to such concerns. The implementation of recommendations from
local reviews of the care of women with severe maternal morbidity should be audited to ensure that
change has led to the desired improvement in outcomes.
Local reviews should be multidisciplinary, including – as a minimum – obstetricians, midwives and
anaesthetists, together with other professional groups such as physicians, general practitioners (GPs)
and health visitors, as appropriate. At a local level, individual disciplinary procedures/recommendations
should be separated from the incident review processes.
Longer-term impacts of near-miss maternal morbidity for women, their
babies and families
When a woman has had a severe maternal morbidity, community midwives as well as her GP need to be
made aware of this when she is discharged from hospital. Follow-up appointments with hospital obstetric
and/or midwifery staff are helpful for women with severe maternal morbidities. However, women reported
that they felt they needed these at varying times after the event; flexibility beyond the standard timing of
6 weeks post delivery would be helpful. There should be a clear pathway for access to counselling services
for women with severe maternal morbidities. GPs should remain alert to the possibility of ongoing mental
health problems in women who have had a severe pregnancy complication, as well as being aware that
the experience may impact on the mental health of the woman’s partner.
Implications for future research
Pre-pregnancy
It is unclear how and by whom pre-pregnancy care is best delivered to access women with the wide
spectrum of medical and mental health disorders that are associated with morbidity. Allied to this, further
research is needed to fully identify the pathways through which minority ethnicity is associated with severe
maternal morbidity. This may include pre-pregnancy educational, cultural and social factors that provide a
focus for further research into possible pathways of prevention of severe maternal morbidity.
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During pregnancy
Obstetric interventions, such as induction of labour and caesarean delivery, are associated with a number
of severe morbidities and research investigating methods to reduce intervention rates without increasing
other adverse outcomes is important as a route to prevention of near-miss morbidity. Further investigation
is needed to establish the role of prophylactic antibiotics for the prevention of infection following operative
vaginal delivery. Some women found intensive care outreach services helpful and further studies are
needed as to how this can be optimally provided to the maternity population to improve outcomes.
This programme demonstrated that robust observational data can be used to conduct a cost–utility analysis
and further studies of interventions for severe maternal morbidities could include similar approaches.
Following pregnancy
There has been little research on the long-term impact of traumatic birth and how best to help women.
There is inconclusive evidence on the impact of debriefing programmes and this needs to be robustly
evaluated. Many of the women we interviewed reported symptoms associated with post-traumatic stress
disorder (PTSD). Further investigation of the role severe pregnancy complications play as precipitating
factors for PTSD is needed, alongside investigation of possible therapies to prevent traumatic flashbacks.
Serious incident reviews
Further evaluation is needed to establish whether or not there is added value to including an external
perspective to local reviews once high-quality multidisciplinary local review processes are fully
implemented. The balance of cost/complexity versus benefit of local versus external reviews of the
care of women with severe pregnancy morbidity needs to be fully established in a prospective study
including audit of change in practice and outcomes.
Funding
Funding for this study was provided by the Programme Grants for Applied Research programme of the
National Institute for Health Research.
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Chapter 1 Introduction
Background
A comprehensive programme of study of maternal deaths has been undertaken in the UK for > 50 years,1,2
including confidential external review. This has contributed to major improvements in the quality of
maternity care and a dramatic reduction in the maternal mortality rate,2,3 such that maternal deaths are now
very rare. The latest figures from the confidential enquiry into maternal deaths show that only three women
died from causes directly related to pregnancy for every 100,000 women giving birth,2 equating to fewer
than 30 deaths per year. This rate has not changed significantly for more than 20 years, but this does not
mean that pregnancy can be regarded as ‘safe’. Waterstone et al.4 demonstrated in 1997–8 that 1200
cases of near-miss severe maternal morbidity occurred per 100,000 births in the South East Thames region,
with a ratio of near-miss morbidity to death of more than 100 : 1.4 It is now increasingly being recognised
that in countries such as the UK, where maternal deaths are rare, the study of near-miss severe maternal
morbidity (defined as a ‘severe life-threatening obstetric complication necessitating urgent medical
intervention in order to prevent likely death of the mother’5) provides additional important information to
aid disease prevention, treatment and service provision.6,7
The advantages of an additional study of near-miss morbidity are several. Near-miss morbidity occurs more
frequently, allowing for more rapid study completion and reporting of results owing to the larger number
of cases identified.6 The higher case numbers give studies of near-miss morbidity greater power to identify
factors associated with disease incidence and hence generate recommendations to impact on disease
prevention.8 In addition, morbidity studies allow for the investigation of factors associated with poor
disease outcomes. When information about fatal and non-fatal cases is compared, factors associated with
progression from severe disease to death can be identified and management guidelines produced
to help improve outcomes.9 A further advantage of a national programme of study of near-miss morbidity
is the ability to examine the quality of care of specific rare diseases10 and hence impact on patient safety.11
The national collaboration of clinicians contributing to the UK Obstetric Surveillance System (UKOSS)10
provided a unique opportunity to undertake such a programme of study of near-miss severe
maternal morbidity.
The only population-based study of near-miss maternal morbidity previously undertaken in England4
suggested that 1% of births are complicated by near-miss maternal morbidity. This illustrates the high
burden of disease underlying maternal deaths in the UK, with an estimated 8000 women in the UK
experiencing near-miss maternal morbidity each year compared with only approximately 80 who die from
direct or indirect causes during pregnancy or in the first 6 weeks after the end of pregnancy.2 Changes to the
characteristics of women giving birth in the UK, including older age at childbirth,12 rising levels of obesity,13
more births to ethnic minority women14 and greater numbers of women with multiple pregnancies,15 each a
reported risk factor for near-miss maternal morbidity, suggest that this rate is likely to rise.
At the time of commencement of this programme, the aim of health reform in England was ‘to develop a
patient-led NHS that uses available resources as effectively and fairly as possible to promote health, reduce
health inequalities and deliver the best and safest healthcare’.16 Guidance for commissioners of maternity
services stated that ‘this means providing high quality, safe and accessible services’.17 Reducing the gap in
infant mortality between socioeconomic groups was one of the key measures of the national Public Service
Agreement health inequalities target18 and, as part of interventions to address this, the Department of
Health also called for specific action to improve the quality of antenatal care.19 Maternity care, safety and
quality of maternity services remains a priority area in the NHS as recognised by the recent report on
maternity services in a group of hospitals in the north of England20 and a recently announced review of
maternity services by NHS England.21
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The aim of this programme of research into near-miss maternal morbidity was to address these priorities by
providing evidence to underpin the development of preventative and management strategies for near-miss
maternal morbidity, hence leading to improved quality of maternity care. Basic information, such as
method and timing of diagnosis, use of specific interventions at the right time and in the right order,
appropriate transfer to secondary care, seniority and discipline of carer and the impact of these factors on
the outcomes for women and their babies, is largely lacking in this field. Exploring the role of these
modifiable events yields important information to improve the quality and safety of maternity care.
Rationale
Although individually rare, when considered together, near-miss maternal morbidities represent a
considerable burden to women, their families and health-care systems. Studies of rare disorders, such as
specific near-miss maternal morbidities, require large collaborations to identify even a small number of
cases. High-quality research is thus rarely undertaken, with studies frequently limited to retrospective
hospital-based case series. Hence, clinical practice is rarely based on robust evidence and evidence-based
guidelines for management are frequently lacking. We established the UKOSS in 2005 to enable the study
of rare disorders of pregnancy, including near-miss maternal morbidity,10 and have shown that national
data collection is feasible with the participation of all UK consultant-led maternity units in the UKOSS
programme and clear identification of messages to improve patient outcomes.11 However, in order to
conduct a comprehensive programme of study to improve the care of women with near-miss maternal
morbidity, this work needed to be expanded to address additional research questions through
different methodologies.
Studies in other developed countries have investigated near-miss maternal morbidity through routine
sources of data,22–25 but these studies are limited in their scope to identify risk factors by incomplete
information on potential confounders.26 In addition, the use of routine data means that these studies are
unable to investigate diagnosis and management and hence provide evidence to improve clinical care.
Only one population-based study has been conducted in England,4 although the small number of cases
meant that the authors were unable to address research questions specific to individual morbidities and
the impact of maternal characteristics, diagnosis and management on outcomes. This study only
conducted follow-up to a maximum of 1 year following the event27 and did not explore women’s
experiences. Surveillance studies of specific near-miss morbidities in the UK have been conducted through
UKOSS,8,28–32 but further expanded work was required to conduct a comprehensive programme covering all
the main causes of direct maternal death.
Studies of near-miss maternal morbidity using other methodologies, beyond hospital-based case series and
surveillance using routine hospital data, are even more limited. The impact of basic factors on outcomes,
such as pregnancy-related factors (e.g. multiple pregnancy following assisted reproduction), maternal
characteristics (such as obesity), method of diagnosis (e.g. antenatal ultrasound or magnetic resonance
imaging diagnosis of placenta accreta), timing of diagnosis [e.g. of acute fatty liver of pregnancy (AFLP) or
haemolysis, elevated liver enzymes and low platelets (HELLP) syndrome], interventions (such as induction
or augmentation of labour in women with uterine rupture) or other management techniques (e.g. brace
sutures or arterial embolisation in severe peripartum haemorrhage), have not been systematically assessed
for any of these conditions in national studies. All these factors are potentially modifiable and, hence, this
programme sought to provide important information, currently lacking, to guide clinical practice and
service provision and improve outcomes for women and their babies.
INTRODUCTION
NIHR Journals Library www.journalslibrary.nihr.ac.uk
2
Aims and objectives
Aims
1. To implement a national programme of study of near-miss maternal morbidity to complement
confidential enquiries into maternal deaths.
2. To use mixed methodologies to improve the evidence base for disease prevention and treatment and to
inform commissioning of maternity services.
3. To use the data to develop recommendations for best practice to prevent and manage near-miss
maternal morbidities.
Objectives
1. To determine the incidence of the specific morbidities most commonly leading to maternal death in
the UK.
2. To assess the contribution of existing risk factors to disease incidence and identify steps that may be
taken in clinical practice to address these factors to reduce incidence.
3. To describe how the conditions are managed and describe any variations in management, exploring the
impact that different management strategies or interventions have on outcomes and costs, in order to
make recommendations for best practice to improve outcomes for all women.
4. To describe the outcomes of the conditions for mother and infant and identify any groups in which
outcomes differ.
5. To investigate which factors influence the risk of death and how these might be addressed to
prevent death.
6. To explore whether an external confidential enquiry or a local review approach can be used to
investigate and improve the quality of care for affected women.
7. To assess the longer-term impacts of near-miss maternal morbidity for women, their babies
and families.
Workstreams
The aims and objectives were addressed in six workstreams.
Workstream 1: incidence, risk factors, management and outcomes of near-miss maternal morbidity,
described in Chapters 3 and 4.
Workstream 2: factors contributing to case fatality, described in Chapter 6.
Workstream 3: addressing inequalities – focusing services for near-miss maternal morbidity, described in
Chapter 7.
Workstream 4: working with hospitals to maximise the benefits of studies of near-miss maternal morbidity,
described in Chapter 8.
Workstream 5: exploring the use of UKOSS data to conduct economic evaluation of treatments for
near-miss morbidities, described in Chapter 5.
Workstream 6: long-term follow-up of women and their infants affected by near-miss morbidity, described
in Chapters 2, 9 and 10.
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Patient and public involvement
We set up an Advisory Group, consisting of women who had experienced severe morbidities in pregnancy,
their partners and representatives of voluntary groups working in the maternity area. We held an annual
face-to-face meeting, with e-mail discussion in the intervening periods. The first meeting took place in
September 2010. The group, chaired by a public member, advised on developing the different component
studies in a manner appropriate for women and so that they would provide most benefit in terms of
improving maternity care. Members also helped recruit participants for the studies and publicised them
through their networks when appropriate. Study progress and interim results of all studies were discussed
with the group, who advised on additional analyses, interpretation and presentation prior to publication.
The Advisory Group also suggested future research priorities based on their experiences and priorities and
the findings of the programme. The activities of this group thus contributed throughout the component
workstreams and their contribution was invaluable to the success of the programme.
INTRODUCTION
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Chapter 2 Unheard voices: women’s and their
partners’ experiences of severe pregnancy
complications
Background
Facts and figures are essential, but insufficient, to translate the data and promote the acceptance of
evidence-based practices and policies . . . narratives, when compared with reporting statistical evidence
alone, can have uniquely persuasive effects in overcoming preconceived beliefs and cognitive biases.
Meisel and Karlawish33
Up to 8000 women and their families each year have to cope with a life-threatening pregnancy
complication and its aftermath. The causes of these ‘near-miss’ maternal morbidities are varied but
include pre-eclampsia, haemorrhage, thrombosis and sepsis, and may in some cases require an emergency
hysterectomy and/or result in pre-term delivery.4 Mother and newborn are often separated, as women
may have to spend time in intensive care or a high-dependency unit (HDU). Their babies may be born
prematurely and require the neonatal intensive care unit (NICU).
Recent studies draw attention to the potential for long-term psychological and emotional impact on
women of maternal morbidities.34–38 In addition to their physical recovery, women can experience anxiety,
isolation and flashbacks in the aftermath. Birth trauma can have lasting consequences that impact
negatively on maternal, infant and family well-being.39 Medically complicated pregnancies can also impact
negatively on breastfeeding rates.35,40
Women may be discharged from hospital having had major surgery and emergency treatment or time in
intensive care, and follow-up is variable. Some may have lost their baby as a result of their illness. Babies
delivered pre-term may need to spend long periods in NICU. These experiences are a long way away from
normal birth.
Qualitative research allows a detailed exploration of the range of different reactions, emotions and
experiences of care women encounter and the significance of the ‘near-miss’ in their life and their
wider family. It may suggest avenues for service improvement that are not apparent from quantitative
survey findings. The aim of this workstream was to explore the impacts of experiencing a near-miss
obstetric emergency, in order to inform development of subsequent workstreams, provide a resource
for women who have had a severe maternal morbidity and develop teaching and learning materials for
NHS staff in order to help improve future care.
Research questions
l What are the experiences of women who have near-miss maternal morbidity in the UK?
l How does this experience impact on their social and family relationships and future childbearing plans?
l Are there any aspects of the care experience that were particularly good or bad or could be improved?
Methods
The study was conducted using the standard methodology developed by the Health Experiences Research
Group at the University of Oxford.41 Interviews were conducted by a professional qualitative researcher.
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Women who experienced a life-threatening complication in pregnancy (defined as ‘severe maternal
illnesses which, without urgent medical attention, would lead to a mother’s death’5) were invited to take
part in an interview study. We also invited the women’s partners to participate.
The sample
We aimed for a maximum variation sample of women living in the UK42,43 covering a wide range of
conditions, based on the principal causes of direct maternal deaths identified in recent maternal death
enquiry reports.2 We sought to include women with a range of ethnic and socioeconomic backgrounds
and at varying times after their ‘near-miss’ event. Interviews continued until thematic saturation was
reached. Our overall sample included 36 women, 10 male partners and one lesbian partner (Table 1).
The majority of partners were interviewed together.
TABLE 1 Sociodemographic characteristics of the 47 participants
Characteristic Number of participants
Age at the time of interview (years)
21–30 3
31–40 31
41+ 13
Age at time of near miss event (years)
21–30 11
31–40 31
41+ 5
Sex
Women/mothers 36
Fathers/partners 11 (10 men, one lesbian partner)
Occupation
Professional 21
Other non-manual 13
Skilled manual 4
Unskilled manual 2
Other (such as housewife or student) 7
Ethnic group
White British 42
British Pakistani 1
White other 3
British Somali 1
Time since near miss
< 1 year 9
> 1 to < 2 years 16
2–4 years 16
5–9 years 4
10+ years 2
UNHEARD VOICES: WOMEN’S AND THEIR PARTNERS’ EXPERIENCES OF SEVERE PREGNANCY COMPLICATIONS
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Recruitment packs were distributed through a number of routes to ensure a wide, varied sample.
Routes included support groups, the National Childbirth Trust, social network forums [Mumsnet
(www.mumsnet.com) and Netmums (www.netmums.com)], newspaper advertisement, intensive care
clinicians contacted through the Intensive Care National Audit & Research Centre (ICNARC), an
advertisement in the UKOSS newsletter and word of mouth. To try and reach a wider ethnic minority
population, we had the recruitment packs translated into Bengali and distributed through a consultant in
an east London hospital. Note, however, that the final sample had limited ethnic diversity (see Table 1).
We sought to include as broad a range of conditions and time distance from the event as possible as we
were keen to understand the longer-term effects of a near-miss maternal morbidity. All women had
experienced a severe life-threatening complication in pregnancy [thrombosis or thromboembolism,
hypertensive disorders of pregnancy, haemorrhage, amniotic fluid embolism (AFE) or sepsis]. Our sample
included broad socioeconomic diversity. Interviews took place between 2010 and 2014.
After obtaining informed consent, one of the authors (LH) interviewed participants in the setting of their
choice (usually their home). Participants were asked about their or their partner’s experiences of pregnancy
and life-threatening illness. The interview started with an open ended narrative section during which
respondents described what had happened, followed by a semistructured section with prompts to explore
any relevant issues that had not already emerged, including their recovery and family life since their
near-miss. The interviews were all audio- or video-taped and transcribed verbatim.
The analysis reported here focuses on the implications that emerged from the data for quality
improvement, commissioning and clinical practice across the care pathway for women and their families.
Verbatim quotations are used to illustrate themes that emerged from the data.
Analysis
The transcripts were read and reread, a coding frame was constructed and the data coded. Anticipated
and emergent themes were then examined across the whole data set as well as in the context of each
person’s interview. A qualitative interpretive approach was taken, combining thematic analysis with
constant comparison.44,45 NVivo 9 (QSR International, Warrington, UK) was used to facilitate the analysis.
Results
Implications for quality improvement, commissioning and clinical practice
This section pulls together all the implications for quality improvement, commissioning and clinical practice
that have been identified from analysis of the data. Implications were identified across the care pathway:
l the emergency
l experiences of intensive care
l transfer from intensive care
l contact with the baby
l communication
l the aftermath
l follow-up
l support in the community
l emotional recovery
l counselling
l impact on the family – partners
l impact on the family – family and family life
l information and support
l good practice.
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The emergency
l Symptoms that lead to an unexpected or traumatic event in childbirth are varied; some have early
warning signs but others are an emergency (to the mother or baby) that develops rapidly, out of the
blue. However, both groups of women may find it difficult to adjust emotionally to their unexpected
childbirth experience.
l Some women may be hospitalised during their pregnancy for monitoring, which can be challenging
but provides an opportunity for good communication and understanding of their condition.
l If the baby suddenly arrives early, mothers may be especially emotionally unprepared for the arrival of
their newborn:
You know, I wasn’t ready. I wasn’t mentally prepared. I certainly wasn’t emotionally prepared.
[Um] Luckily I’d had some time to sort out a Moses basket and [um] some clothes and nappies,
but that was what the last 4 weeks were for. For reading the books. For doing some research.
For decorating the nursery, you know, getting it all set up. That was going to be the joyous
moment of preparing. And that was all taken away from me, I suppose. Well from us.
Kirsty, first baby
l Women are reassured by calm professionalism from staff during their emergency.
Experiences of intensive care
l Some mothers (or babies) may need to be in intensive care for a while. For a mother, waking up in
intensive care can be very shocking. As new mothers they are often distressed at being separated from
their baby. It would be helpful to develop protocols for women who require high dependency or
intensive care to facilitate the baby being taken to visit their mother or vice versa.
You’re not as I would thought, in a place where may be there’s other people who have been
through pregnancy related or birth related issues. I was in this, some old man ranting, there was
a man ranting and pulling out his drips on one side. There was a man who’d had an accident
opposite me. They brought in somebody who they discovered had E. coli [Escherichia coli] next
to me and then she died next to me, and they were busy cleaning up.
Rachel, third baby
l Separation from their newborn baby can be very hard as mothers feel they are missing vital first steps.
If it is not possible for women to see or be with their baby, they appreciate being kept in touch with
the baby’s progress through photos, updates or contact with the paediatrician.
l Many find it helpful to piece together what has happened to them, filling in the blanks, with the help
of discussion with both staff and family and friends.
l Being in an intensive therapy unit (ITU) can be very distressing; women often experience fear,
humiliation and difficulties communicating.
Experiences of transfer from intensive care
l Women who have suffered an unexpected event feel different from other new mothers. They feel
more supported when information about what has happened has been handed over between staff and
the team in the new setting shows that they are fully aware of what they have experienced.
l Transfer from intensive care, although a positive step, can be difficult. Although there appears no ideal
solution to step-down care:
¢ Women who go to a high-dependency area alongside a labour ward find this helpful.
¢ If women are in high-dependency care for an extended period, policies that allow visits from the
wider family (e.g. grandparents) are appreciated.
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l Similarly, women can find transfer to the postnatal ward challenging:
¢ If possible, a side room is the most comfortable place for women who have experienced a
near-miss to be cared for.
¢ If side rooms are not available or not appropriate in view of a woman’s clinical condition and
potential safety concerns, a clear explanation of the reason for this is helpful.
¢ Some women will experience significant problems with caring for themselves and their new baby in
a side-room and will need extra help.
And then through the night, I actually had what I kind of look back on, I felt like I was in
a survival mode through that first night because I was left on my own with the baby.
Now bearing in mind the baby had been looked after by the nurses at night. This is my first
night out of intensive care. And my first night with the baby, all on my own, with no
support whatsoever.
Clara, first baby
¢ Personal support and empathy from individual staff members makes a real difference to how
women cope with transfer and recovery.
Contact with the baby
l Even when very ill, women want to be a mother to their new baby.
l Sometimes babies will be in intensive care for days or weeks.
l Many women face challenges in seeing their new baby and it would be helpful to develop protocols
ahead of time for women who require high dependency or intensive care to facilitate the baby being
taken to visit their mother or vice versa.
You have this idealistic picture in your head, what it’s like when you’ve got a baby, that you’ll
spend all the time cuddling them, and I didn’t feel I could do that, because just holding him to
start with was just exhausting. So that was a really difficult sort of emotional battle really.
Amy, first baby
And obviously I didn’t see my son for 4 days. Such an odd feeling. I mean [not] expecting to
have the baby so early and then I wasn’t a mother. I was just some useless person lying there.
Kirsty, first baby
l When it is not possible for women to see or be with their baby, they appreciate being kept in touch
with the baby’s progress through:
¢ photos
¢ regular verbal or written updates such as a diary of the baby’s day
¢ direct contact with the paediatrician when the baby is ill.
l Missing a baby’s ‘firsts’ is something women particularly notice; if at all possible they want to be there
for important milestones such as the first feed.
l Breastfeeding is very important for some women, particularly in the context where they may feel they
have failed at normal childbirth.
l Having a baby in a neonatal unit, after a severe obstetric emergency, is often challenging for women as
they recover from their own illness. Sometimes they need to focus on getting well themselves, as well
as being with their baby.
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Communication
l Women and their partners appreciate staff giving clear explanations in non-medical language at all
stages before, during and after the emergency (Box 1):
¢ When conditions are diagnosed in the non-emergency situation antenatally, being aware of what
might happen helps women and their partners prepare and cope better afterwards.
¢ During the emergency, repeated reassurance is appreciated.
¢ Being listened to and being able to ask questions after the emergency is important for women to
come to terms with what has happened.
I do vaguely recall someone sitting next to me holding my hand, and just saying, ‘It’s all right,
you know, it’s going to fine. Just they need to get some blood into you’. And I don’t actually
remember all of what she said. It’s more a memory present of there being somebody next to
me, kind of trying to reassure me. So there was after that initial flurry of activity, I’m fairly
certain that there was someone with me, trying to keep me calm. Which I greatly appreciated.
Naomi, first baby
l Partners/fathers can feel forgotten during and after the emergency:
¢ Frequent updates from any member of staff can help them to feel less anxious and isolated.
¢ Having another family member with them for support can help.
l Knowing that staff have learned from a woman’s near-miss is reassuring for her.
BOX 1 Communication example: placenta praevia
Kerry and Sarah were both diagnosed with placenta praevia and didn’t feel doctors explained to them the
severity of their condition. In contrast, Alex, who had the same condition, described excellent communication
with her doctors who explained to her clearly why she needed to stay in hospital until her baby was born.
Kerry felt that doctors did not fully explain to her the risks of her placenta praevia. She wished they had sat her
down and explained to her what a haemorrhage was and what to expect.
I would rather they had sat down and said are you aware of what haemorrhage is? What it means.
Expect, this is how much … I just thought I haemorrhage was when you was bleeding and it just trickled
slowly out of you, but didn’t stop. That to me was what a haemorrhage was. I didn’t expect it to be the
biggest gush. I felt like, to look at the blood, I can see it now, I felt like every pint of blood in my body was
on the floor it was that bad.
Kerry, second baby
Alex was told she was a walking time bomb. Doctors explained very well how serious her situation was in a
way that allowed her to process little things at a time.
They did it very well. They explained the gravity of the situation but not in a way that would have
complete…. I mean every time, it was almost like a drip feeding process. And I mean, it might not work
for everyone, but it worked well for me, because it enabled me to process little things at a time.
Alex, second baby
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The aftermath
l What physical shape women are in when they get home will vary greatly; some will be recovering from
major abdominal surgery, others from severe blood loss. Women find general practitioner (GP) support
once they are discharged, and recognition of their particular childbirth experience, valuable to help
them return to normal life.
l Many women experience longer postnatal recovery periods than normal, although, on the whole,
women did make a good recovery.
l Women felt frustration at not being able to look after their new baby properly on their own.
l Scars left over from the surgery caused distress for some women.
l Women may face difficulties settling back into their previous social relationships with family, friends
and their local community.
But it is hard you know, when I left hospital people, people just stopped bothering and . . . I felt
I really struggled with friends. I really struggled with people that made false promises, and I’ve
still got a lot of upset towards them people that were all round and all there, when I was in
hospital. But as soon as I came out they didn’t care. That’s when I really needed my friends.
That’s when I really needed people to be there for me.
Emma, second baby
l Women often feel isolated (physically and emotionally) when they first come out of hospital, unable to
relate to others who have not experienced their trauma.
l They feel that it is a taboo subject to raise at postnatal support groups, an experience which can be
particularly isolating for first-time mothers.
l Given the rarity of the conditions that lead to a near miss, or unexpected event, women can struggle to
find anyone to talk to about it. Online support groups can be particularly valuable in providing access
to other patient experiences.
Follow-up
l Women who had a follow-up review at the hospital found this a positive experience to help their
understanding of their emergency and their recovery.
l When follow-up was not offered, women felt abandoned and were left with questions.
l Women noted a number of things that were particularly helpful elements of the follow-up review:
¢ Seeing and talking through their notes.
¢ Answering questions about future pregnancies.
¢ Sensitivity about the place where the review was conducted – returning to the antenatal clinic or
labour ward or even hospital could be upsetting.
¢ Flexible timing of the follow-up review – some women were not ready for this until several months
or even years after the event.
¢ An offer of counselling was helpful to some.
l The follow-up programme with intensive care unit (ICU) staff that some women were involved with
was considered a good model.
Huge, hugely helpful, because it made you feel, because after about 6 weeks I felt that
everybody had kind of not forgotten about it, but moved on. You know, you’re alive you made
it through it, you know, it’s time to put it behind you and everybody has moved on with their
life and you’re just left with this yuk you know. And so to be able to be actually go into hospital
and talk to people who knew, because even if you talk to some people who weren’t related to
ICU, they still couldn’t really understand the trauma of what your body had gone through,
having lost so much blood and what an impact that had on you.
Catherine, second baby
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Support in the community
l Support from their GP and health visitors was highly valued by women who received it. It helped their
physical and mental recovery.
He’s seen me every 4 weeks. He put me in touch with support groups and things like that.
And he was really patient, because I did keep going back. I thought I had illness after illness.
Kathryn, second baby
l Those who did not receive support felt they could have done with:
¢ practical help coping with their physical recovery and new babies or young children
¢ emotional support as they came to terms with their emergency experience and its implications
¢ help overcoming isolation from peers
¢ early discussions around fears about future pregnancies/fertility
¢ an awareness of how their emergency experience could impact on other family members.
Emotional recovery
l Finding out what happened to them, and coming to terms with the seriousness of their illness and
what a narrow escape they had had, was often very emotionally difficult for women.
l Realising the severity of what they have been through can take time.
l Understanding what had happened was very important; it helped mothers fill in the gaps in their
memories and start to come to terms with their illness.
I know from hearing through the grape vine that there was some kind of debrief that
happened. That my case was kind of obviously looked into and sort of, they kind of had a look
at what had went wrong. And I would have liked to have been involved in that. I would have
liked to have had, not even a say I would have just liked to have known what had happened,
because I still don’t know to this, to this day, quite what happened. I just kind of know just kind
of bits and pieces.
Sally, third baby
l Talking through events with clinicians at follow-up meetings, or going through their notes, can be
valuable in helping women understand what has happened to them.
l Coming to terms with their emergency experience can be difficult and take time. Anniversaries could
stir up strong emotions.
Before the [year] anniversary, that’s when I really panicked, because I just thought, well what
am I going to do? I don’t know what I’m . . . It’s weird, it’s like I was in, in prison in my head . . .
It was like I put on a front every day, and I don’t think many people saw past it, but my
boyfriend did. And I know he worried for me, and he would just say to me, ‘You know, we
need to get over this’. But not because he was like, oh get over it. It was because he could see
how much underneath everything it was sort of eating me up and that was really hard.
Emma, second baby
Counselling
l Women felt the need for counselling at different times after their emergency and there was great
variation in when women felt ready to talk.
The aftermath was so kind of overwhelming really, that at the time you just work through it,
and its only afterwards you kind of think, you know, you stamp your foot a bit and say that was
really unfair, that happened to me. You know, and so I was able to do all of that with, with the
counsellor then, just at the time I needed it.
Penny, first baby
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l Many found counselling very helpful, in particular cognitive–behavioural therapy.
l Others who had not received counselling said they wish they had received it as it would have helped
them make sense of what they had been through.
l Help may not be sought for long-term mental health issues; therefore, actively offering help may
be beneficial.
Impact on the family
Partners
l All of the partners/fathers we spoke to have been deeply affected by their partner’s life-threatening
experiences; for some it has had a profound impact on their long-term mental health.
l In situations for which an emergency delivery might be anticipated, such as when a woman has
placenta praevia, explanation of what might happen helps partners prepare and cope subsequently.
l Frequent updates during the emergency help partners/fathers feel less isolated and anxious.
So there was this massive rush, alarms going everywhere, rush, shooting off and everything
and they said, ‘Well you stay there’. And I’m thinking, what’s going on, you know, no one was
telling me. And this is the bit I don’t like telling [my partner], is I was left there with blood
everywhere, all over me, all over the floor, and they left me there for about 3 to 4 hours.
Joe, first baby
l Personal touches of support from individual staff make a real difference to how partners cope.
l Partners remember more about events than the woman who is ill, but still appreciate repeated explanations.
l Partners/fathers can find seeing their partner in high dependency or intensive care very traumatic and
may need support from staff and family members to:
¢ enable them to visit their partner
¢ understand that the situation is not hopeless – their partner may recover
¢ come to terms with what has happened.
l Long-term mental health problems in partners/fathers after a near-miss experience may have a big
impact financially, practically and emotionally, and families may need additional support in this event.
l Partners/fathers who experience mental health symptoms do not necessarily seek help, although they
do feel that counselling, if offered, could be beneficial.
Family and family life
l Women’s relationships with their partners are often put under severe strain and additional support may
be required in this context.
l Parenting advice can be important because:
¢ Existing children can be severely affected by nearly losing a parent.
¢ Building a relationship with the new baby following a near-miss event can be challenging even
when the baby does not require neonatal unit care.
l Issues around future fertility and family size can be complex:
¢ Some women require support to come to terms with a loss of future fertility.
¢ For others, the worry about the possibility of a near-miss event in a future pregnancy leads to a
decision not to have further children and robust contraceptive advice can be important in
these circumstances.
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l Mental health impacts for both mothers and fathers may require long-term management.
And so, yes, it’s not nice. I get flashbacks every now and again. They used to be really bad,
really, really bad, because visions are, meant to be a happy time picking your baby up. I get . . .
it is visions of her being whizzed passed me, my wife. Doctors and nurses running and all of a
sudden me baby is whizzed straight past and she’s going to special care baby unit, you know, in
an incubator. It’s not nice. And that’s what visions come back all the time and haunt me.
Justin, third baby
l Mental health and other impacts can lead to significant changes in career or life paths, which places an
additional burden on parents.
l Many women reported that they would have welcomed more support in the community, in particular
access to mother and toddler or other parent’s groups where other women had similarly ‘abnormal’
birth experiences.
Information and support
l Women and their families often needed a great deal of practical support as they recovered from
their emergency.
l Because of the rarity of these conditions, women often felt isolated when they came home and found
it hard to access information.
l Women wanted further information for various reasons and at various stages:
¢ if possible, before the baby was born – to understand more about the condition they had been
diagnosed with, and the risks to them and their baby
¢ while in hospital – clear, jargon-free explanations of what has happened to them
¢ after the emergency – practical information about what to expect during recovery.
l Information tailored to new mothers, particularly in the case of hysterectomy, was highly valued.
l Specialist online support was described as invaluable.
An oasis of somewhere that I could talk to women who’d been through exactly what I’d been
through and to be able to pour out your grief feelings without being judged. It was like having
a huge family of sisters . . . It is just a place to go that you can absolutely unload.
Catherine, second baby
Good practice
l Personal touches from individual staff can make a real difference to how women and their partners
cope with the emergency and recovery.
l Transfers within the hospital can be difficult and are made easier for women by:
¢ considering both their critical care needs and their needs as a new mother
¢ use of a single room if possible.
l Reviewing their notes and/or a discussion with their consultant after an event can help women make
sense of what happened.
l Women find GP support once they are discharged valuable to help them return to normal life.
l Explanations, often repeated, of what is happening are helpful to women and their partners at all
stages of the emergency and recovery.
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Teaching and learning points
The themes identified in the interviews were summarised as a series of teaching and learning resources.
They are intended as a resource for clinicians across the care pathways of these women and their families,
including midwives, obstetricians, nurses, anaesthetists, intensive care specialists, health visitors and GPs.
Below are the key learning points from each of the summaries. A fuller description and clips are available
on www.healthtalk.org.46 Note that themes relevant to both analyses are repeated.
Good practice that makes a big difference
l Personal touches from individual staff can make a real difference to how women and their partners
cope with the emergency and recovery.
l Transfers within the hospital can be difficult and are made easier for women by:
¢ considering both their critical care needs and their needs as a new parent
¢ use of a single room if possible.
l Reviewing their notes and/or a discussion with their consultant after an event can help women make
sense of what happened.
l Women find GP support once they are discharged valuable to help them return to normal life.
l Explanations, often repeated, of what is happening are helpful to women and their partners at all
stages of the emergency and recovery.
Access to the baby after the emergency
l Even when very ill, women want to be a mother to their new baby.
l Many women face challenges in seeing their new baby and it would be helpful to develop protocols
ahead of time for women who require high dependency or intensive care to facilitate the baby being
taken to visit their mother or vice versa.
l If it is not possible for women to see or be with their baby, they appreciate being kept in touch with
the baby’s progress through:
¢ photos
¢ regular verbal or written updates such as a diary of the baby’s day
¢ direct contact with the paediatrician when the baby is ill.
l Missing a baby’s ‘firsts’ is something women particularly notice; if at all possible they want to be there
for important milestones such as the first feed.
Transfer from critical care
l Women who have suffered a near-miss feel different from other new mothers. They feel more
supported when information about their condition has been handed over between staff and the team
in the new setting show that they are fully aware of what they have experienced.
l Transfer from intensive care, while a positive step, can be difficult. Although there appears no ideal
solution to step-down care:
¢ Women who go to a high-dependency area alongside a labour ward find this helpful.
¢ If women are in high-dependency care for an extended period, policies that allow visits from the
wider family (e.g. grandparents) are appreciated.
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l Similarly, women can find transfer to the postnatal ward challenging:
¢ If possible, a side room is the most comfortable place for women who have experienced a
near-miss to be cared for.
¢ If side rooms are not available, a clear explanation of the reason for this is helpful.
¢ Some women will experience significant problems with caring for themselves and their new baby in
a side room and will need extra help.
l Personal support and empathy from individual staff members makes a real difference to how women
cope with transfer and recovery.
Information and understanding
l Women and their partners appreciate staff giving clear explanations in non-medical language at all
stages before, during and after the emergency:
¢ When conditions are diagnosed in the non-emergency situation antenatally, being aware of what
might happen helps women and their partners prepare and cope better afterwards.
¢ During the emergency, repeated reassurance is appreciated.
¢ Being listened to and being able to ask questions after the emergency is important for women to
come to terms with what has happened.
l Partners/fathers can feel forgotten during and after the emergency:
¢ Frequent updates from any member of staff can help them to feel less anxious and isolated.
¢ Having another family member with them for support can help.
l Knowing that staff have learned from a woman’s near-miss is reassuring for her.
Support for partners/fathers
l All the partners/fathers we spoke to have been deeply affected by their partner’s life-threatening
experiences, for some it has had a profound impact on their long-term mental health.
l In situations for which an emergency delivery might be anticipated, such as when a women has
placenta praevia, explanation of what might happen helps partners prepare and cope subsequently.
l Frequent updates during the emergency help partners/fathers feel less isolated and anxious.
l Personal touches of support from individual staff make a real difference to how partners cope.
l Partners remember more about events than the woman who is ill, but still appreciate
repeated explanations.
l Partners/fathers can find seeing their partner in high dependency or intensive care very traumatic and
may need support from staff and family members to:
¢ enable them to visit their partner
¢ understand that the situation is not hopeless – their partner may recover
¢ come to terms with what has happened.
l Long-term mental health problems in partners/fathers after a near-miss experience may have a big
impact financially, practically and emotionally, and families may need additional support in this event.
l Partners/fathers who experience mental health symptoms do not necessarily seek help, although they
do feel that counselling, if offered, could be beneficial.
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Follow-up and counselling
l Women who had a follow-up review at the hospital found this a positive experience to help their
understanding and recovery.
l When follow-up was not offered, women felt abandoned and were left with questions.
l Women noted a number of things that were particularly helpful elements of the follow-up review:
¢ Seeing and talking through their notes.
¢ Answering questions about future pregnancies.
¢ Sensitivity about the place where the review was conducted – returning to the antenatal clinic or
labour ward or even hospital could be upsetting.
¢ Flexible timing of the follow-up review – some women were not ready for this until several months
or even years after the event.
¢ An offer of counselling was helpful to some.
l The follow-up programme with ICU staff that some women were involved with was considered a
good model.
Long-term effects
l Women’s relationships with their partners are often put under severe strain and additional support may
be required in this context.
l Parenting advice can be important because:
¢ Existing children can be severely affected by nearly losing a parent.
¢ Building a relationship with the new baby following a near-miss event can be challenging even
when the baby does not require neonatal unit care.
l Issues around future fertility and family size can be complex:
¢ Some women require support to come to terms with a loss of future fertility.
¢ For others, the worry about the possibility of a near-miss event in a future pregnancy leads to a
decision not to have further children and robust contraceptive advice can be important in
these circumstances.
l Mental health impacts for both mothers and fathers may require long-term management.
l Help may not be sought for long-term mental health issues; therefore, actively offering counselling may
be beneficial.
l Mental health and other impacts can lead to significant changes in career or life paths, which place an
additional burden on parents.
l Many women reported that they would have welcomed more support in the community. In particular:
¢ access to mother and toddler or other parent’s groups where other women had similarly
‘abnormal’ birth experiences
¢ GP and health visitor support for first-time mothers to help with feelings of isolation.
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Conclusions
There has been little research about the long-term impact of traumatic birth and how best to help women.
There is inconclusive evidence on the impact of debriefing programmes. However, we know that those who
are most likely to be well after childbirth are women who had no complications, no worries about their
labour and birth and information about their choices for care.47 Women who experience a near-miss
maternal morbidity have had none of these. For them, there is often no follow-up from hospital obstetric or
midwifery staff. Primary care teams should routinely be made aware if a woman has had a near-miss event
so they can offer the support these women may need and be aware these new mothers may be isolated
from their peers. Therefore, potential support networks, GPs and health visitors need to be alert for mental
health problems developing and mindful of the impact that the near-miss experience can have on the whole
family (including partner and other children) and be prepared to offer advice about future pregnancies.
Although critical illness may be uncommon, it is a potentially devastating complication in pregnancy.48
The obstetric population is changing, increasingly presenting clinicians with older mothers with pre-existing
disorders and advanced chronic medical conditions. The 2011 report by the Maternal Critical Care Working
Group49 acknowledged the many challenges of caring for critically ill obstetric patients. Multidisciplinary
approaches are essential for these women and require urgent attention.50 However, there is minimal
guidance for nursing management of critically ill obstetric patients in the ITU. Critical care nurses report
concerns about their competence and confidence in managing obstetric patients in the ICU, finding it hard
to meet their needs. Special issues arise in terms of lactation support, emotional impact and communication
with family members.51,52 Midwives express anxiety about caring for critically ill pregnant women53 and further
research is still needed into how to provide optimum care for critically ill pregnant and postpartum women.
All the partners/fathers we spoke to had been deeply affected by their partner’s life-threatening
experiences. For some, it had a profound impact on their long-term mental health. In situations for which
an emergency delivery might be anticipated, such as when a woman has placenta praevia, an explanation
of what might happen helped partners prepare and cope subsequently. Staff might consider that frequent
updates during the emergency help partners/fathers feel less isolated and anxious. Our study demonstrates
that (often small) personal touches of support from individual staff can make a real difference to how
partners cope. Although partners may remember more about events than the woman who is ill, they still
appreciate repeated explanations. Partners/fathers can find seeing their partner in high dependency or
intensive care very traumatic and may need support from staff and family members to enable them to visit
their partner, understand that the situation is not hopeless and that their partner may recover, and to
come to terms with what has happened.
Long-term mental health problems in partners/fathers after a near-miss experience may have a big impact
financially, practically and emotionally, and families may need additional support in this event. They often
felt that counselling could have been beneficial, if it had been offered. However, clinicians should take into
account that partners/fathers who experience mental health symptoms do not necessarily seek help.
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Chapter 3 Incidence, risk factors, management
and outcomes of severe maternal morbidities
This chapter includes excerpts from Fitzpatrick KE, Hinshaw K, Kurunczuk JJ, Knight M, Risk factors,management, and outcomes of hemolysis, elevated liver enzymes, and low platelets syndrome and
elevated liver ezymes, low platelets syndrome, Obstetrics and Gynecology, 123, 3, 618–27, reproduced
with permission.54
Background
Rare obstetric events are, by virtue of their rarity, difficult to study. Each clinician will see less than one
affected woman per year, and perhaps only one in a clinical lifetime. As noted in Chapter 1, any study
beyond a small case-series requires a large collaboration and thus management is rarely evidence based,
and information for women and their families about the likely outcome and long-term prognosis of their
condition is lacking. Hospital-based studies of these conditions require retrospective review of many years
of data and are not necessarily representative of the condition in the current population as a whole
because of changes over time and social and demographic differences in the populations served by
individual hospital units as well as local differences in clinical practice. Fundamental questions, therefore,
remain unanswered and the potential remains for significant improvements in the outcomes of these
conditions for women and their babies by the collection of detailed national information. This workstream
included a rolling programme of studies, thus enabling the study of risk factors, diagnosis and
management, and relating these to outcomes of a range of near-miss maternal morbidities on a national
basis. This co-ordinated programme of parallel studies had the additional advantage of preventing
clinicians being burdened with multiple requests for information from different researchers. National
studies of the following near-miss morbidities were conducted: AFE, placenta accreta/increta/percreta,
HELLP/elevated liver enzymes and low platelets (ELLP) syndrome, and uterine rupture.
Amniotic fluid embolism
Amniotic fluid embolism although rare, remains one of the leading causes of direct maternal mortality in
high-income countries,2,55,56 characterised by sudden unexplained cardiovascular collapse, respiratory distress
and disseminated intravascular coagulation. The rarity of AFE together with the fact that clinical diagnosis of
the condition is one of exclusion makes it difficult to obtain reliable information concerning incidence, risk
factors, management and outcomes. Previous reviews56,57 suggest that the reported total incidence of AFE
varies from 1.9 per 100,000 to 7.7 per 100,000 maternities; the reported incidence of fatal AFE cases varies
from 0.4 per 100,000 to 1.7 per 100,000 while the case fatality rate owing to AFE ranges from 11% to 43%.
There is little consistency in the factors reported to be associated with the occurrence of AFE and very limited
data available regarding factors associated with serious maternal outcomes.
Placenta accreta/increta/percreta
Three variants of abnormally invasive placentation are recognised: placenta accreta, in which placental
villi invade the surface of the myometrium; placenta increta, in which placental villi extend into the
myometrium; and placenta percreta, in which the villi penetrate through the myometrium to the uterine
serosa and may invade adjacent organs, such as the bladder. Placenta accreta, increta or percreta are
associated with major pregnancy complications58 and are thought to be becoming more common59 owing
to a number of factors including rising maternal age at delivery and an increasing proportion of deliveries
by caesarean.60,61 This finding is of particular concern in the context of increasing rates of caesarean
delivery and older maternal age at childbirth.62,63 However, the risk associated with these factors has not
been quantified on a population basis in studies using robust clinical and pathological definitions. There is
also limited information to guide the optimal management of this condition.
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HELLP/ELLP syndrome
Haemolysis, elevated liver enzymes and low platelets syndrome is a serious complication of pregnancy that
usually occurs in women who have signs of pre-eclampsia.64 In the absence of haemolysis, the condition
has been called ELLP syndrome.65,66 Incidence estimates vary widely and there has been no comprehensive
study of the risk factors for this complication. There is also debate over the optimal management of the
syndrome, particularly with regard to women who develop the condition remote from term.66,67
Uterine rupture
Uterine rupture is a complication of pregnancy associated with severe maternal and fetal morbidity and
mortality. In high-income countries it most commonly occurs in women who have previously delivered by
caesarean section.68 This observation has led to debate about the optimal management of labour and
delivery in women who have delivered by caesarean section in previous pregnancies. Women with a
previous caesarean delivery have generally been encouraged to attempt a trial of labour in subsequent
pregnancies,69 but recent reports of an increased risk of morbidity, particularly owing to uterine rupture,
are thought to have contributed to a marked decrease in some countries in the number of women
attempting vaginal birth after caesarean section.70
Research questions
The following questions were addressed in all studies:
l What is the incidence of the condition?
l Are any factors (e.g. age, parity, obesity, ethnicity, socioeconomic status, multiple pregnancy, late or
poor attendance for antenatal care) associated with an increased risk of developing the condition?
l How is the condition managed in the UK?
l What are the outcomes of the condition for women and their babies?
In addition, the following condition-specific questions were addressed.
Amniotic fluid embolism
l What are the presenting features of the condition?
l Are there any temporal trends in the incidence of the condition?
l Are there specific factors, including timing of involvement of medical personnel and management
strategies used, that are associated with adverse maternal outcomes?
Placenta accreta/increta/percreta
l What are the risks associated with previous caesarean delivery and older maternal age?
l What proportion of cases are diagnosed antenatally by ultrasound or MRI? Is antenatal diagnosis
related to outcomes?
l What proportion of cases have no attempt to remove their placenta, in an attempt to conserve their
uterus or prior to hysterectomy? Do cases managed in this way have different outcomes?
HELLP/ELLP syndrome
l What are the presenting features of the condition?
l What proportion of antenatally diagnosed cases have a planned management of immediate delivery,
delivery within 48 hours or expectant/conservative management? Are there any differences in
outcomes according to planned management?
l How are corticosteroids used to manage the syndrome in the UK?
l Are there any differences in the characteristics, diagnostic features, presenting symptoms/signs,
management and outcomes of women diagnosed with HELLP syndrome compared with women
diagnosed with ELLP syndrome?
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Uterine rupture
l What are the common symptoms and signs noted prior to diagnosis of uterine rupture?
l What proportion of ruptures occur in women who have previously delivered by caesarean section?
l What are the risks associated with planned mode of delivery and labour induction and/or
augmentation among women with a prior delivery by caesarean section?
l What are the characteristics of the women who experience uterine rupture in the absence of a previous
caesarean delivery?
UK Obstetric Surveillance System methodology
Case and control definitions
The case and control definitions used for each of the studies were as follows:
Amniotic fluid embolism
Cases were all women in the UK identified as having AFE defined as follows:
In the absence of any other clear cause:
EITHER
acute maternal collapse with one or more of the following features: acute fetal compromise, cardiac arrest,
cardiac rhythm problems, coagulopathy, hypotension, maternal haemorrhage, premonitory symptoms
(e.g. restlessness, numbness, agitation, tingling), seizure and shortness of breath, excluding women with
maternal haemorrhage as the first presenting feature in whom there was no evidence of early
coagulopathy or cardiorespiratory compromise
OR
women in whom the diagnosis was made at postmortem examination with the finding of fetal squames or
hair in the lungs.
Controls were defined as the two women who did not have AFE and delivered immediately before other
UKOSS study cases.8,28,29,71–74
Placenta accreta/increta/percreta
Cases were all women in the UK identified as having placenta accreta/increta/percreta defined as either
placenta accreta/increta/percreta diagnosed histologically following hysterectomy or postmortem, or an
abnormally adherent placenta, requiring active management, including conservative approaches where the
placenta is left in situ.
Controls were defined as the two women who did not have placenta accreta/increta/percreta and
delivered immediately before each case in the same hospital.
HELLP/ELLP syndrome
Cases were any pregnant women in the UK identified as having new onset of the following:
elevated liver enzymes (serum aspartate aminotransferase ≥ 70 IU/l or gamma-glutamyl transferase ≥ 70 IU/l
or alanine aminotransferase ≥ 70 IU/l)
AND
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low platelets (platelet count < 100 × 109/l)
AND EITHER
haemolysis [abnormal (fragmented or contracted red cells) peripheral blood smear or serum lactate
dehydrogenase levels ≥ 600 IU/l or total bilirubin ≥ 20.5 µmol/l)
OR
hypertension (systolic blood pressure ≥ 140mmHg or a diastolic blood pressure ≥ 90mmHg) OR
proteinuria [1+ (0.3 g/l) or more on dipstick testing, a protein : creatinine ratio of ≥ 30mg/mmol on a
random sample, or a urine protein excretion of ≥ 300mg per 24 hours].
Cases with haemolysis were classified as HELLP syndrome and those without haemolysis were classified as
ELLP syndrome.
Controls were defined as the two women who did not have HELLP or ELLP syndrome and delivered
immediately before each case in the same hospital.
Uterine rupture
Cases were all women in the UK identified as having a uterine rupture defined as a complete separation of
the wall of the pregnant uterus, with or without expulsion of the fetus, involving rupture of membranes at
the site of the uterine rupture or extension of the complete separation of the wall of the uterus into uterine
muscle separate from any previous scar and endangering the life of the mother or fetus. Any asymptomatic
palpable or visualised defect, noted incidentally at caesarean delivery for example, was excluded.
Controls were defined as any woman delivering a fetus or infant who had not had a uterine rupture and
who had delivered by caesarean section in any previous pregnancy regardless of the mode of delivery of
the current pregnancy.
Data collection
Cases of the specific near-miss morbidities were notified through the monthly card mailing of UKOSS from
all hospitals with obstetrician-led maternity units in the UK. On reporting a case, clinicians were sent a data
collection form requesting further details to confirm the case definition and ascertain information regarding
potential risk factors, diagnosis, management and outcomes. AFE cases were identified between 1 February
2005 and 31 January 2014; placenta accreta/increta/percreta cases were identified between 1 May 2010
and 30 April 2011; HELLP/ELLP syndrome cases were identified between 1 June 2011 and 31 May 2012;
and uterine rupture cases were identified between 1 April 2009 and 30 April 2010.
For the uterine rupture study, controls were obtained from a random sample of obstetrician-led maternity
units in the UK in month 4 and month 12 of the study, weighted by the total number of births. The time
and day on which reporting clinicians were asked to select controls were randomly identified using data on
birth date and time from one county of England (Leicestershire) to try and provide a representative sample
of women delivering during each 24-hour period and on different days of the week. Clinicians were then
asked to complete a data collection form for these controls. For the placenta accreta/increta/percreta and
HELLP/ELLP syndrome studies, clinicians who reported a case were asked to select and complete a data
collection form for two controls, identified as the two women meeting the control definition.
All data requested were anonymous and obtained from the woman’s medical records. If complete forms
were not returned, up to five reminders were sent. The data were double entered into a customised
database. Duplicate reports were identified using information on the woman’s year of birth and expected
date of delivery. Cases were checked to ensure that they met the case definition and controls were
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checked to confirm they had been selected correctly. When data were missing or a data validity check
highlighted a problem, the reporting clinicians were contacted to provide or check the information.
Study power
Amniotic fluid embolism: the analysis had 80% power at the 5% level of statistical significance to detect
odds ratios (ORs) of ≥ 1.7 and ≥ 2.6, assuming putative risk factors have a prevalence of 40% and
5%, respectively.
Placenta accreta/increta/percreta: the actual number of cases and controls identified during the study gave
an estimated power of 80% at the 5% level of significance to detect ORs between 1.9 and 3.3, assuming
a prevalence range for potential risk factors of between 5% and 40% in the control women.
HELLP/ELLP syndrome: the actual number of HELLP cases and controls identified gave an estimated power
of 80% at the 5% level of significance to detect ORs between 1.8 and 2.9, assuming a prevalence range
for potential risk factors of between 5% and 40% in the control women.
Uterine rupture: over the 13-month study period, we anticipated identifying 200 cases (based on an
estimated incidence of 1 in 4000 maternities4) and 600 controls. A ratio of three controls per case was
planned in the study proposal to maximise the power of the study given that uterine rupture is a rare
condition and the number of cases would be limited by disease incidence. Assuming that 10% of women
with a previous caesarean section delivering in the UK are induced with prostaglandin and/or receive
oxytocin in their labour, and with a 3 : 1 ratio of controls to cases, 106 cases and 316 controls would give
an estimated power of 80% at the 5% level of statistical significance to detect a 2.5-fold increase in the
odds of uterine rupture in women with a previous caesarean section who have prostaglandin labour
induction and/or oxytocin used in labour.
Analysis
The overall incidence with 95% confidence intervals (CIs) of each condition was calculated using the most
recently available national birth data that corresponded most closely with the particular study period, as a
proxy denominator for the number of maternities during the study period. Denominator data to calculate
the incidence and 95% CIs of placenta accreta/increta/percreta in women with and without a previous
caesarean delivery and in women with and without placenta praevia diagnosed prior to delivery were
estimated using the proportions of women in these various categories observed in the control women
together with the most recently available birth data. To calculate the incidence and 95% CIs of placenta
accreta/increta/percreta in women with a previous caesarean with and without placenta praevia diagnosed
prior to delivery, we used an estimate of the incidence of placenta praevia in women with a previous
caesarean delivery (1.2%), derived from a 2010 systematic review.75 To calculate the incidence with
95% CIs of uterine rupture in women with and without a previous caesarean section, the most recently
available birth data were used together with an estimate of the proportion of women in the UK who had
previously delivered by caesarean section (15%), derived from the rate in a group of population-based
controls comprising women giving birth in the UK in 2005–6.8 Information on the proportion of women
with a previous caesarean delivery planning a vaginal or caesarean section delivery in their current
pregnancy, estimated from that observed in the control women, was used to estimate the denominator for
calculation of the incidence and 95% CI of uterine rupture according to planned mode of delivery in
women with a previous caesarean section. Denominator data to allow calculation of the incidence and
95% CI of uterine rupture in women with a prior caesarean delivery planning a vaginal delivery according
to whether labour was induced with or without prostaglandin and/or oxytocin were also estimated using
the proportions observed in the control women.
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Potential risk factors for each condition were investigated using unconditional logistic regression to
estimate ORs and 95% CIs. A full regression model was developed by including both explanatory and
potential confounding factors in a core model if there was a pre-existing hypothesis or evidence to suggest
they were related to the condition in question; the findings are reported as adjusted odds ratios (aORs) and
95% CIs. Continuous variables were tested for departure from linearity by the addition of first-order
fractional polynomials to the model and subsequent likelihood ratio testing. When there was evidence for
non-linearity, continuous variables were presented and treated as categorical in the analysis. When there
was no evidence of departure from linearity, continuous variables were presented as categorical for ease of
interpretation, but have been treated as continuous linear terms when adjusting for them in the analysis.
Plausible interactions were tested in the full regression model by the addition of interaction terms and
subsequent likelihood ratio testing on removal, with a p-value of 0.01 considered evidence of significant
interaction to account for multiple testing. The chi-squared test, Fisher’s exact test or Wilcoxon rank-sum
test, as appropriate, were used to compare groups. Logistic regression using robust standard errors (SEs)
to allow for the non-independence of infants from multiple births was used when comparing infant
outcomes. All analyses were carried out using Stata statistical software version 11 (StataCorp LP,
College Station, TX, USA).
Results
Amniotic fluid embolism
Incidence
There was a total of 120 confirmed cases of AFE, 23 of which were fatal (case fatality rate 19%,
95% CI 12% to 29%), in an estimated 7,001,438 maternities.76–89 This represents a total incidence
of 1.7 per 100,000 maternities (95% CI 1.4 to 2.1) and a fatal incidence of 0.3 per 100,000 maternities
(95% CI 0.2 to 0.5).
Presentation
Amniotic fluid embolism presented at or before delivery in 53% (62/117) of women, at a median gestation
of 39 weeks (range 28–42 weeks); the remaining women (n= 55) presented with AFE a median of
19 minutes after delivery (range 1 minute to 6 hours and 27 minutes) having delivered at a median
gestation of 39 weeks (range 28–42 weeks). Diagnosis of AFE, including both antenatal and postnatal
cases, was first considered a median of 33 minutes (range 0 minutes to 2 days) after presentation. Women
with AFE who died were also significantly more likely than those who survived to present with cardiac
arrest (87% vs. 36%; p< 0.001) and exhibit this feature as the first recognised symptom or sign of AFE
(26% vs. 5%; p= 0.006); no other significant differences in presentation were found between these
groups. The majority of women (91%, 108/119) had ruptured membranes at or before AFE presentation.
Risk factors
The characteristics of the women with AFE compared with the control women are shown in Table 2.
Women aged ≥ 35 years had significantly raised odds of having AFE. The odds of having AFE were also
significantly increased in women who had a multiple pregnancy, placenta praevia and induction of labour
using any method.
Of the 55 women who presented with AFE postnatally, 11 (20%) had an instrumental vaginal delivery
(ventouse or forceps) and 39 (71%) delivered by caesarean. Both instrumental vaginal delivery and
caesarean delivery were associated with significantly raised odds of having AFE postnatally (aOR 9.51,
95% CI 3.17 to 28.51, and aOR 16.15, 95% CI 6.20 to 42.05, respectively).
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TABLE 2 Characteristics of women with AFE and their controls
Risk factor
Number (%)
of cases
(N= 120)
Number (%)
of controls
(N= 3834) uOR (95% CI) p-value aOR (95% CI)a p-value
Sociodemographic factors
Age (years)
<35 74 (62) 3062 (80) 1 1
≥ 35 46 (38) 766 (20) 2.48
(1.71 to 3.62)
< 0.0001 2.15
(1.43 to 3.23)
0.0002
Missing 0 (0) 6 (0)
Ethnic group
White 92 (77) 3064 (80) 1 1
Black or other
minority ethnic
group
25 (21) 699 (18) 1.19
(0.76 to 1.87)
0.4458 1.17
(0.72 to 1.91)
0.5183
Missing 3 (3) 71 (2)
Socioeconomic group
Managerial and
professional
occupations
42 (35) 977 (25) 1 1
Other 60 (50) 2075 (54) 0.67
(0.45 to 1.01)
0.0529 0.81
(0.52 to 1.24)
0.3306
Missing 18 (15) 782 (20)
BMI at booking (kg/m2)
< 30 90 (75) 2797 (73) 1 1
≥ 30 22 (18) 674 (18) 1.01
(0.63 to 1.63)
0.9528 0.99
(0.60 to 1.62)
0.9559
Missing 8 (7) 363 (9)
Smoking status
Never/ex-smoker 99 (83) 3045 (79) 1 1
Smoked during
pregnancy
20 (17) 732 (19) 0.84
(0.52 to 1.37)
0.4842 1.12
(0.66 to 1.89)
0.6829
Missing 1 (1) 57 (1)
Previous obstetric factors
Parity
0 48 (40) 1669 (44) 1 1
≥ 1 72 (60) 2160 (56) 1.16
(0.80 to 1.68)
0.4353 1.07
(0.72 to 1.60)
0.7336
Missing 0 (0) 5 (0)
continued
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TABLE 2 Characteristics of women with AFE and their controls (continued )
Risk factor
Number (%)
of cases
(N= 120)
Number (%)
of controls
(N= 3834) uOR (95% CI) p-value aOR (95% CI)a p-value
Current pregnancy factors
Multiple pregnancy
No 106 (88) 3786 (99) 1 1
Yes 14 (12) 48 (1) 10.42
(5.57 to 19.48)
< 0.0001 7.75
(3.60 to 16.69)
< 0.0001
Induction of labour using any method
No 71 (59) 2921 (76) 1 1
Yes 49 (41) 908 (24) 2.22
(1.53 to 3.22)
< 0.0001 2.53
(1.70 to 3.75)
< 0.0001
Missing 0 (0) 5 (0)
Gestation age at delivery (weeks)b
Pre-term (< 37) 99 (83) 3414 (89) 2.12
(1.25 to 3.60)
0.0053 1.34
(0.71 to 2.55)
0.3653
Term (37–41) 17 (14) 276 (7) 1 1
Post term (≥ 42) 3 (3) 125 (3) 3.45
(0.44 to 27.20)
0.2401 0.51
(0.15 to 1.71)
0.2742
Missing 1 (1) 10 (0)
Macrosomia (birthweight ≥ 4500 g)b
No 109 (91) 3742 (98) 1 1
Yes 5 (4) 77 (2) 2.23
(0.88 to 5.62)
0.0892 2.28
(0.88 to 5.92)
0.0892
Missing 6 (5) 6 (0)
Placenta praevia
No 116 (97) 3797 (99) 1 1
Yes 3 (3) 22 (1) 4.46
(1.32 to 15.12)
0.0163 5.75
(1.64 to 20.19)
0.0064
Missing 1 (1) 15 (0)
Placental abruption
No 119 (99) 3806 (99) 1
Yes 0 (0) 6 (0) 3.93
(0 to 27.44)
Missing 1 (1) 22 (1)
BMI, body mass index; uOR, unadjusted OR.
a Adjusted for all factors in the table apart from placental abruption.
b Data do not necessarily add up to total number of cases/controls as this information is not applicable to miscarriages and
terminations of pregnancy.
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Management and outcomes
Table 3 shows the factors used to manage coagulation following AFE presentation. Forty-four women
(37%) did not receive any coagulopathy management. The variety of other management strategies used
following AFE presentation is illustrated in Table 4. Thirty-one women (26%) had one and 21 women
(18%) had more than one of these other management strategies.
Twenty-three women (19%) died and seven (6%) of the women who survived had permanent
neurological injury. Women with AFE who died or had permanent neurological injury were less likely than
those who survived and did not have permanent neurological injury to have cryoprecipitate given, were
more likely to have had a hysterectomy, had a shorter time interval between the AFE event and when
the hysterectomy was performed (median interval 77 minutes, range 0–360 minutes vs. median interval
248 minutes, range 23 minutes to 12 days; p= 0.0315) and were more likely to be from black or other
minority ethnic groups (aOR 2.85, 95% CI 1.02 to 8.00).
TABLE 3 Coagulation management of women with AFE according to severity of outcome
Number (%) of cases
that had severe
outcomea (N= 30)
Number (%) of cases
that did not have severe
outcomea (N= 90) uOR (95% CI) p-value
Cryoprecipitate
No 24 (80) 49 (54) 1
Yes 6 (20) 41 (46) 0.3 (0.11 to 0.80) 0.0163
Fresh-frozen plasma
No 13 (43) 38 (42) 1
Yes 17 (57) 52 (58) 0.96 (0.41 to 2.20) 0.9151
Platelets
No 22 (73) 54 (60) 1
Yes 8 (27) 36 (40) 0.55 (0.22 to 1.36) 0.1929
Factor VIIa
No 24 (80) 70 (78) 1
Yes 6 (20) 20 (22) 0.88 (0.31 to 2.43) 0.7981
Fibrinogen
No 29 (97) 89 (99) 1
Yes 1 (3) 1 (1) 3.07 (0.19 to 50.64) 0.433
uOR, unadjusted OR.
a Died or had permanent neurological injury.
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TABLE 4 Other management of women with AFE according to severity of outcome
Number (%) of cases
that had severe
outcomea (N= 30)
Number (%) of cases
that did not have severe
outcomea (N= 90) uOR (95% CI) p-value
Hysterectomy
No 18 (60) 71 (79) 1
Yes 12 (40) 19 (21) 2.49 (1.02 to 6.06) 0.0441
Other surgery for haemorrhageb
No 25 (83) 81 (90) 1
Yes 5 (17) 9 (10) 1.8 (0.55 to 5.87) 0.3296
Exchange transfusion
No 30 (100) 87 (97) 1
Yes 0 (0) 3 (3) 0.77 (0 to 7.33) 0.8366
Plasma exchange
No 30 (100) 86 (96) 1
Yes 0 (0) 4 (4) 0.55 (0 to 4.58) 0.6221
Misoprostol
No 28 (93) 86 (96) 1
Yes 2 (7) 4 (4) 1.54 (0.27 to 8.84) 0.6309
Hemabate
No 28 (93) 84 (93) 1
Yes 2 (7) 6 (7) 1 (0.19 to 5.24) 1
Intrauterine balloons
No 29 (97) 84 (93) 1
Yes 1 (3) 6 (7) 0.48 (0.06 to 4.18) 0.5085
Embolisation
No 30 (100) 88 (98) 1
Yes 0 (0) 2 (2) 1.24 (0 to 16.10) 1
Tranexamic acid
No 29 (97) 85 (94) 1
Yes 1 (3) 5 (6) 0.59 (0.07 to 5.23) 0.6324
Obstetrician present at time of event or arrived within 5 minutes
No 10 (33) 28 (31) 1
Yes 17 (57) 55 (61) 0.87 (0.35 to 2.14) 0.7541
Missing 3 (10) 7 (8)
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Women with AFE gave birth to a total of 134 infants (106 singletons and 14 twin pregnancies). There
were four stillbirths (one antepartum and three intrapartum) and five early neonatal deaths among these
infants, equating to a perinatal mortality rate of 67 per 1000 (95% CI 31 to 124), which is significantly
higher than the national rate of 7.5 per 1000 [risk ratio (RR) 8.91, 95% CI 4.74 to 16.75]. Both mother
and infant did not survive in four cases. Major complications were reported in 17 of the surviving infants,
including 10 diagnosed with neonatal encephalopathy and three requiring phototherapy for
severe jaundice.
HELLP syndrome
Incidence
There were 210 women who met the case definition in an estimated 799,003 maternities.80,90,91 Of these,
129 had haemolysis and were considered to have HELLP syndrome, giving an incidence of 1.6 per
10,000 maternities (95% CI 1.3 to 1.9); a further 81 of the women met the case definition, but either they
did not have haemolysis (n= 79) or it is unknown whether or not they had haemolysis (n= 2). These women
were considered to have ELLP syndrome, giving an incidence of 1 per 10,000 maternities (95% CI 0.8 to 1.3).
Risk factors
The odds of having both HELLP and ELLP syndrome were significantly raised in nulliparous women and
women who had a gestational hypertensive disorder in a previous pregnancy (HELLP aOR 3.47, 95% CI
1.49 to 8.09; ELLP aOR 4.66, 95% CI 1.37 to 15.9). Older women and women who had a multiple
pregnancy also had significantly raised odds of having HELLP (aOR in women aged ≥ 35 years was 1.85,
95% CI 1.12 to 3.06; aOR in women with multiple pregnancy was 4.51, 95% CI 1.45 to 14.1) but not
ELLP syndrome, noting the limited power of the analysis. There was also evidence that women of black or
other minority ethnic groups and women who smoked during pregnancy had significantly reduced odds of
ELLP (aOR in women of black or other minority ethnic groups was 0.42, 95% CI 0.19 to 0.95; aOR in
women who smoked was 0.15, 95% CI 0.03 to 0.63), although no such association was apparent for
HELLP, again noting the limited power of the analysis. The only significant interaction found was between
essential hypertension and parity for HELLP syndrome; women who had essential hypertension had a
raised odds of having HELLP syndrome if they were nulliparous but not if they were multiparous (aOR 6.46,
95% CI 1.62 to 25.83 in nulliparous women; aOR 0.23, 95% CI 0.01 to 1.95 in multiparous women).
TABLE 4 Other management of women with AFE according to severity of outcome (continued )
Number (%) of cases
that had severe
outcomea (N= 30)
Number (%) of cases
that did not have severe
outcomea (N= 90) uOR (95% CI) p-value
Anaesthetist present at time of event or arrived within 5 minutes
No 9 (30) 26 (29) 1
Yes 18 (60) 57 (63) 0.91 (0.36 to 2.30) 0.8457
Missing 3 (10) 7 (8)
Obstetrician and/or anaesthetist present at time of event
No 11 (37) 35 (39) 1
Yes 16 (53) 47 (52) 1.08 (0.45 to 2.62) 0.8593
Missing 3 (10) 8 (9)
uOR, unadjusted OR.
a Died or had permanent neurological injury.
b Includes B-Lynch suture, artery ligation.
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Management and outcomes
Women with HELLP syndrome were significantly more likely than those with ELLP syndrome to have
received magnesium sulphate [76% (98/129) vs. 62% (50/81); p= 0.028]. No other significant differences
in management were seen between the women with either HELLP or ELLP syndrome (data not shown)
and, therefore, the management of these women has been presented together. Of the women diagnosed
antenatally with HELLP or ELLP syndrome, 51% (71/138) had a planned management of immediate
delivery and 43% (60/138) had a planned management of delivery within 48 hours; only 7/138 (5%) had a
planned attempt at expectant (conservative) management. Women who had a planned management of
delivery within 48 hours were more likely than those who had planned immediate delivery to be
nulliparous [83% (50/60) vs. 68% (48/71); p= 0.039], but no other differences in characteristics were
found between these women. A total of 80% (166/208) were given antihypertensive medication.
Although there were no maternal deaths among the women diagnosed with ELLP syndrome, one woman
with HELLP syndrome died (case fatality 0.8%, 95% CI 0.02% to 4.2%). No significant differences were
found between the women who had a planned management of delivery within 48 hours of diagnosis and
those who had a planned management of immediate delivery. There were no significant differences in the
outcomes of HELLP according to whether women were managed with blood products or admitted to ITU.
There were two stillbirths among the 135 infants born to women with HELLP syndrome, equating to a
perinatal mortality rate of 15 per 1000 total births (95% CI 2 to 53). Of the 87 infants born to women
with ELLP syndrome, one died in the early neonatal period, equating to a perinatal mortality rate of
12 per 1000 total births (95% CI 0.3 to 62). There were no significant differences between the infants
born to women who had a planned management of delivery within 48 hours of diagnosis and those born
to women who had a planned management of immediate delivery. Of the seven infants born to the
women who had a planned attempt at expectant management, none died but two had major
complications relating to pre-term birth and three were small for gestational age.
Placenta accreta/increta/percreta
Incidence
There was a total of 134 confirmed cases of placenta accreta/increta/percreta in an estimated 798,634
maternities,81,92,93 representing an estimated incidence of 1.7 per 10,000 maternities (95% CI 1.4 to 2.0).
Table 5 shows the estimated incidence of accreta/increta/percreta for various categories of women;
incidence estimates range from 1 in 33,000 for women without a previous caesarean delivery to 1 in 20
for women with at least one previous caesarean delivery and placenta praevia diagnosed prior to delivery.
Risk factors
The odds of having placenta accreta/increta/percreta rose with increasing maternal age (aOR 1.15, 95% CI
1.06 to 1.24) for every 1-year increase in age. The odds of having placenta accreta/increta/percreta were
also raised in women who had a previous caesarean delivery (aOR 14.41, 95% CI 5.63 to 36.85). There
was evidence of an interaction between age and previous caesarean delivery. The raised odds associated
with older maternal age were apparent only in women without a previous caesarean delivery (aOR 1.30,
95% CI 1.13 to 1.50 for every 1-year increase in age in women without a previous caesarean delivery
compared with aOR 1.03, 95% CI 0.92 to 1.15 for every 1-year increase in age in women with a previous
caesarean). Women who had other previous uterine surgery, such as myomectomy, also had an increased
odds of having placenta accreta/increta/percreta (aOR 3.40, 95% CI 1.30 to 8.91), as did women who
had an in vitro fertilisation (IVF) pregnancy (aOR 32.13, 95% CI 2.03 to 509.23). The odds of placenta
accreta/increta/percreta were also raised in women who had placenta praevia diagnosed antenatally
(aOR 65.02, 95% CI 16.58 to 254.96).
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Diagnosis
Placenta accreta/increta/percreta was suspected prior to delivery in half of the women (66/133, 50%). The
majority of the women who did not have placenta accreta/increta/percreta suspected antenatally presented
with difficult or unsuccessful delivery of the placenta either at vaginal or caesarean delivery (52/65, 80%).
Women who had placenta accreta/increta/percreta suspected antenatally were more likely than those who
did not to be multiparous [98% (65/66) vs. 84% (56/67); p= 0.003], were more likely to have had a
previous caesarean delivery [98% (65/66) vs. 72% (48/67); p< 0.001] and were more likely to have had
placenta praevia diagnosed prior to delivery [97% (64/66) vs. 33% (22/67); p< 0.001]. Sixty-three (95%)
suspected cases had both placenta praevia diagnosed antenatally and a previous caesarean delivery
compared with 20 (30%) of the unsuspected cases (p< 0.001). There was a suggestion that the women
who had placenta accreta/increta/percreta suspected antenatally had a greater severity of placental
invasion as they were more likely to have a final diagnosis after delivery of placenta increta or percreta
rather than accreta [43% (28/65) of suspected cases vs. 27% (18/67) of unsuspected cases; p= 0.051].
In total, 65% (87/133) of the women had a final diagnosis after delivery of placenta accreta, 5% (7/133)
had a final diagnosis of placenta increta and 29% (39/133) had a final diagnosis of placenta percreta.
Management and outcomes
Women who had placenta accreta/increta/percreta suspected antenatally were more likely than those who
did not to deliver by planned caesarean, have no attempt to remove any of their placenta around the time
of delivery, have other therapy or therapies to prevent haemorrhage and be admitted to ITU/HDU (Table 6).
Although they were less likely to have other therapy or therapies to treat haemorrhage, there was
no significant difference in their median estimated total blood loss, the proportion who received a blood
transfusion or who subsequently had a hysterectomy. However, subgroup analysis suggests that while
antenatal diagnosis is not associated with a lower median estimated total blood loss or need for blood
transfusion in women with a final diagnosis of placenta accreta [median estimated blood loss 3000ml,
range 300–14,435ml in suspected cases vs. 3100ml, range 200–15,000ml in unsuspected cases
(p= 0.9131); 84%, 31/37 of suspected cases had blood transfusion vs. 81%, 39/48 of unsuspected cases
(p= 0.761)], there is such an association in those who had a final diagnosis of placenta increta or percreta
TABLE 5 Estimated incidence of placenta accreta/increta/percreta for different categories of women
Categorya
Number of women
with placenta accreta/
increta/percreta
Estimated number
of maternities
Estimated incidence of placenta
accreta/increta/percreta
(95% CI) per 10,000 maternities
Women without a previous
caesarean delivery
21 678,839 0.3 (0.2 to 0.5)
Women with at least one previous
caesarean delivery
113 119,795 9 (8 to 11)
Women without placenta praevia
diagnosed prior to delivery
47 790,648 0.6 (0.4 to 0.8)
Women with placenta praevia
diagnosed prior to delivery
86 7986 108 (86 to 133)
Women with at least one
previous caesarean delivery but
without placenta praevia
diagnosed prior to delivery
30 118,357 3 (2 to 4)
Women with at least one
previous caesarean delivery and
placenta praevia diagnosed prior
to delivery
83 1438 577 (462 to 711)
a Categories are not mutually exclusive.
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TABLE 6 Management and outcomes of placenta accreta/increta/percreta according to whether or not diagnosis
was suspected antenatally
Peripartum management/
maternal outcome
n (%)a unless otherwise
stated of cases suspected
antenatally (N= 66)
n (%)a unless otherwise stated
of cases not suspected
antenatally (N= 67) p-value
Planned mode of delivery
Vaginal 2 (3) 20 (30)
Caesarean 64 (97) 46 (70) < 0.001
Attempt made to remove any of placenta around time of delivery
No 27 (41) 5 (7)
Yes 39 (59) 62 (93) < 0.001
Hysterectomy performed
No 23 (35) 31 (46)
Yes 43 (65) 36 (54) 0.18
Hysterectomy type
Total 25 (58) 18 (50)
Subtotal 18 (42) 18 (50) 0.469
Other therapy(ies) to prevent haemorrhage
No 17 (26) 32 (48)
Yes 49 (74) 34 (52) 0.007
Other therapy(ies) to treat haemorrhage
No 33 (50) 17 (25)
Yes 33 (50) 50 (75) 0.003
Median estimated total blood
loss in ml (range)
3000 (250–14,435) 3500 (200–24,000) 0.126
Estimated total blood loss (ml)
< 2500 30 (45) 20 (30)
≥ 2500 36 (55) 47 (70) 0.063
Blood products given
No 17 (27) 10 (15)
Yes 47 (73) 56 (85) 0.109
Median units of whole or packed
red cells transfused (range)b
7 (0–24) 7 (2–29) 0.783
Median units of fresh-frozen
plasma transfused (range)b
3.5 (0–13) 4 (0–12) 0.685
Median units of platelets
transfused (range)b
0 (0–6) 0 (0–4) 0.813
Median units of cryoprecipitate
transfused (range)b
0 (0–10) 0 (0–10) 0.848
Median millilitres of cell salvaged
blood transfused (range)b
75 (0–8000) 0 (0–1700) < 0.001
Admission to ITU/HDU
No 13 (20) 29 (43)
Yes 53 (80) 38 (57) 0.003
Median duration of stay in ITU/HDU
in days (range)
2 (1–26) 1.5 (1–19) 0.617
a Percentage of individuals with complete data.
b In women who received some type of blood product.
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[median estimated blood loss 2750ml, range 250–10,514ml in suspected cases vs. 6100ml, range
1500–24,000ml in unsuspected cases (p= 0.008); 59%, 16/27 of suspected cases had blood transfusion vs.
94%, 17/18 of unsuspected cases (p= 0.014)].
A total of 102 (76%) women had an attempt made to remove their placenta around the time of delivery.
The hysterectomy rate did not vary according to whether or not an attempt was made to remove any of
the placenta (Table 7). As well as being more likely to have been diagnosed antenatally, in terms of
characteristics, women who had no attempt to remove any of their placenta were more likely than those
who did to have had a previous caesarean delivery [97% (31/32) vs. 80% (82/102); p= 0.025], were more
likely to have had placenta praevia diagnosed prior to delivery [88% (28/32) vs. 57% (58/101); p= 0.002]
and were more likely to have a final diagnosis of placenta increta or percreta rather than accreta [71%
(22/31) vs. 24% (24/102); p< 0.001]; no other significant differences were found in other current
pregnancy, previous obstetric or sociodemographic characteristics (data not shown). Despite being more
likely to have a greater severity of placental invasion, the women who had no attempt to remove any of
their placenta were less likely to have other therapy or therapies to treat haemorrhage, had a lower
estimated total blood loss and were less likely to have a blood transfusion (see Table 7).
TABLE 7 Peripartum management and outcomes of women with placenta accreta/increta/percreta according to
whether or not any attempt was made to remove the placenta around the time of delivery
Peripartum management/
maternal outcome
n (%)a unless otherwise stated
of cases who had no attempt
to remove placenta around
time of delivery (N= 32)
n (%)a unless otherwise stated
of cases who did have an
attempt to remove placenta
around time of delivery (N= 102) p-value
Caesarean delivery
No 2 (6) 14 (14)
Yes 30 (94) 88 (86) 0.356
Hysterectomy performed
No 11 (34) 44 (43)
Yes 21 (66) 58 (57) 0.379
Hysterectomy type
Total 12 (57) 31 (53)
Subtotal 9 (43) 27 (47) 0.771
Other therapy(ies) to prevent haemorrhage
No 7 (23) 42 (42)
Yes 24 (77) 59 (58) 0.055
Other therapy(ies) to treat haemorrhage
No 24 (75) 26 (26)
Yes 8 (25) 75 (74) < 0.001
Median estimated total blood loss
in ml (range)
1750 (200–15,000) 3700 (500–24,000) 0.001
Estimated total blood loss (ml)
< 2500 18 (56) 32 (31)
≥ 2500 14 (44) 70 (69) 0.011
continued
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None of the women with placenta accreta/increta/percreta died. Four of the women lost or had their
pregnancy terminated before 24 weeks’ gestation. The remaining 130 women gave birth to a total of
134 infants (126 singletons and four pairs of twins). There were no stillbirths and two early neonatal
deaths among the 134 infants, equating to a perinatal mortality rate of 14.9 per 1000 (95% CI
1.8 to 52.8).
Uterine rupture
Incidence
There were 159 confirmed cases of uterine rupture in an estimated 852,206 maternities,82,92,94 representing
an estimated incidence of 1.9 per 10,000 maternities (95% CI 1.6 to 2.2). Table 8 shows the estimated
incidence of uterine rupture in different categories of women. Data collection forms were received for
448 controls (75% of those requested).
TABLE 7 Peripartum management and outcomes of women with placenta accreta/increta/percreta according to
whether or not any attempt was made to remove the placenta around the time of delivery (continued )
Peripartum management/
maternal outcome
n (%)a unless otherwise stated
of cases who had no attempt
to remove placenta around
time of delivery (N= 32)
n (%)a unless otherwise stated
of cases who did have an
attempt to remove placenta
around time of delivery (N= 102) p-value
Blood products given
No 13 (43) 14 (14)
Yes 17 (57) 87 (86) < 0.001
Median units of whole or packed
red cells transfused (range)b
7 (3–24) 7 (0–29) 0.597
Median units of fresh-frozen
plasma transfused (range)b
4 (0–13) 4 (0–12) 0.763
Median units of platelets
transfused (range)b
0 (0–4) 0 (0–6) 0.583
Median units of cryoprecipitate
transfused (range)b
0 (0–4) 0 (0–10) 0.402
Median ml of cell salvaged blood
transfused (range)b
0 (0–8000) 0 (0–5500) 0.067
Admission to ITU/HDU
No 10 (31) 32 (31)
Yes 22 (69) 70 (69) 0.99
Median duration of stay in ITU/HDU
in days (range)
1.5 (1–26) 2 (1–19) 0.894
a Percentage of individuals with complete data.
b In women who received some type of blood product.
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Risk factors for uterine rupture after prior delivery by caesarean section
A total of 139 (87%) of the uterine ruptures occurred in women who had previously delivered by
caesarean section. Table 9 shows the characteristics of these women compared with control women.
Women who had two or more previous caesarean deliveries had a higher odds of having a uterine rupture
than women with only one previous caesarean delivery (aOR 3.02, 95% CI 1.16 to 7.85), as did women
who had an interval of < 12 months compared with ≥ 24 months between their last caesarean section
and their last menstrual period in their current pregnancy (aOR 3.12, 95% CI 1.62 to 6.02). There was no
evidence to suggest a departure from linearity in the relationship between odds of rupture and number of
caesarean deliveries, with the odds of rupture increasing by 3.02 (95% CI 1.62 to 5.63) for every one
additional caesarean delivery. However, there was evidence of a non-linear relationship in the association
between uterine rupture and caesarean section pregnancy interval, with the odds of rupture appearing to
plateau for intervals beyond 12 months (Figure 1).
The presence of placenta praevia increased the odds of rupture (aOR 28.19, 95% CI 4.03 to 197.39),
although note that this finding is based on a very small number of women and should be interpreted with
caution. The odds of rupture was also raised in women who planned to have a vaginal delivery in their
current pregnancy compared with women who planned to deliver by elective caesarean section (aOR
19.37, 95% CI 8.53 to 43.98). This finding was irrespective of whether or not the women who planned to
have a vaginal delivery had their labour induced and/or received oxytocin in labour (Table 10). However,
the women who had prostaglandin labour induction and/or oxytocin used in labour appeared to have
raised odds of rupture compared with the women who laboured without prostaglandin induction or
oxytocin in labour (see Table 10). No significant interactions were found.
TABLE 8 Estimated incidence of uterine rupture in different categories of women
Category
Number of women
with a uterine rupture
Estimated number
of maternities
Estimated incidence of
uterine rupture (95% CI)
per 10,000 maternities
Women without a previous
caesarean delivery
20 724,375 0.3 (0.2 to 0.4)
Women with a previous
caesarean delivery
139 127,831 11 (9 to 13)
Women with a previous caesarean delivery planning
Elective caesarean delivery in
current pregnancy
20 71,585 3 (2 to 4)
Vaginal delivery in current
pregnancy
116 56,246 21 (17 to 25)
Women with a previous caesarean delivery planning a vaginal delivery in current pregnancy and
laboured without prostaglandin
inductiona or oxytocin used
in labour
52 41,622 13 (9 to 16)
labour induced with prostaglandins
and/or oxytocin used in labour
44 14,624 30 (22 to 40)
labour induced with prostaglandin
and oxytocin not used in labour
10 2812 36 (17 to 65)
laboured without prostaglandin
inductiona but oxytocin used
in labour
28 10,124 28 (18 to 40)
labour induced with prostaglandin
and oxytocin used in labour
6 1687 36 (13 to 77)
a Labour either not induced or induced without prostaglandin.
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TABLE 9 Risk factors for uterine rupture in women with prior delivery by caesarean section
Risk factor
n (%)a of cases
with a previous
caesarean (N= 139)
n (%)a of controls
(N= 448)
Unadjusted
OR (95% CI)
Adjustedb
OR (95% CI)
Sociodemographic factors
Age (years)
< 35 94 (68) 313 (70) 1 1
≥ 35 45 (32) 134 (30) 1.12 (0.74 to 1.68) 1.47 (0.89 to 2.45)
Ethnic group
White 94 (69) 325 (75) 1 1
Non-white 42 (31) 111 (25) 1.31 (0.86 to 2.00) 1.12 (0.68 to 1.84)
Socioeconomic group
Managerial and
professional occupations
33 (30) 108 (32) 1
Other 77 (70) 226 (68) 1.12 (0.70 to 1.78)
BMI at booking (kg/m2)
< 25 56 (42) 173 (40) 1 1
25–29.9 43 (33) 132 (31) 1.01 (0.64 to 1.59) 1.12 (0.65 to 1.91)
≥ 30 33 (25) 127 (29) 0.8 (0.49 to 1.31) 0.73 (0.41 to 1.30)
Previous obstetric and medical history
Parity
1–2 116 (83) 385 (86) 1 1
≥ 3 23 (17) 62 (14) 1.23 (0.73 to 2.07) 1.1 (0.57 to 2.14)
Number of previous caesarean deliveries
1 121 (87) 368 (82) 1 1
≥ 2 18 (13) 79 (18) 0.69 (0.40 to 1.20) 3.02 (1.16 to 7.85)
Previous caesarean uterine incision type(s)
All low transverse
incisions
120 (99) 390 (98) 1
Any non-low transverse
incisions
1 (1) 8 (2) 0.41 (0.05 to 3.28)
Previous caesarean uterine closure type(s)
All double 75 (90) 241 (91) 1
All single 5 (6) 17 (6) 0.95 (0.34 to 2.65)
Mixture of double and
single or other closure
type
3 (4) 7 (3) 1.38 (0.35 to 5.46)
Previous uterine surgery
No 124 (90) 394 (88) 1 1
Yes 14 (10) 52 (12) 0.86 (0.46 to 1.60) 0.92 (0.43 to 1.96)
Previous uterine performation
No 137 (100) 446 (100)
Yes 0 (0) 1 (0)
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TABLE 9 Risk factors for uterine rupture in women with prior delivery by caesarean section (continued )
Risk factor
n (%)a of cases
with a previous
caesarean (N= 139)
n (%)a of controls
(N= 448)
Unadjusted
OR (95% CI)
Adjustedb
OR (95% CI)
Current pregnancy
Twin pregnancy
No 139 (100) 444 (99)
Yes 0 (0) 4 (1)
Interval between last
caesarean section and last
menstrual period (months)
≥ 24 71 (52) 294 (67) 1 1
12–23 35 (26) 99 (22) 1.46 (0.92 to 2.33) 1.38 (0.80 to 2.38)
< 12 31 (23) 48 (11) 2.67 (1.59 to 4.50) 3.12 (1.62 to 6.02)
Placenta praevia
No 136 (98) 445 (99) 1 1
Yes 3 (2) 3 (1) 3.27 (0.65 to 16.40) 28.19 (4.03 to 197.39)
Macrosomia (birthweight ≥ 4000 g)
No 117 (89) 382 (86) 1 1
Yes 14 (11) 62 (14) 0.74 (0.40 to 1.36) 0.85 (0.42 to 1.73)
Planned mode of delivery
Elective caesarean section 20 (15) 250 (56) 1 1
Vaginal 116 (85) 198 (44) 7.32 (4.40 to 12.19) 19.37 (8.53 to 43.98)
BMI, body mass index.
a Percentage of those with complete data.
b Adjusted for all factors in the table apart from socioeconomic group, previous uterine incision type(s), previous caesarean
uterine closure type(s) and twin pregnancy. When adjusting for age, BMI, parity and number of previous caesarean
deliveries, these variables have been treated as a continuous linear term in the analysis.
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FIGURE 1 Risk of uterine rupture according to the interval between the last caesarean section and start of current
pregnancy. a, Adjusted for women’s age as a continuous variable, ethnicity, body mass index as a continuous linear
term, parity as a continuous linear term, number of previous caesarean deliveries as a continuous linear term,
previous uterine surgery, placenta praevia, macrosomia and planned mode of delivery.
TABLE 10 Risk factors for uterine rupture in women with prior delivery by caesarean section
Risk factor
n (%)a of cases
with a previous
caesarean (N=139)
n (%)a of controls
(N=448)
Unadjusted
OR (95% CI)
Adjustedb
OR (95% CI)
Planned elective caesarean
section delivery
20 (17) 250 (58) 1 1
Planned vaginal delivery and
laboured without
prostaglandin inductionc
or oxytocin in labour
52 (45) 132 (31) 4.92 (2.82 to 8.60) 12.74 (5.44 to 29.87)
labour induced with
prostaglandin and
oxytocin not used
in labour
10 (9) 9 (2) 13.89 (5.06 to 38.10) 35.91 (10.38 to 124.28)
laboured without
prostaglandin inductionc
but oxytocin in labour
28 (24) 33 (8) 10.61 (5.38 to 20.91) 35.36 (13.38 to 93.41)
labour induced with
prostaglandin and
oxytocin used in labour
6 (5) 5 (1) 15.00 (4.21 to 53.48) 52.05 (11.30 to 239.84)
a Percentage of those with complete data.
b Adjusted for woman’s age as a continuous linear term, ethnicity, body mass index as a continuous linear term, parity as a
continuous linear term, number of previous caesarean deliveries as a continuous linear term, previous uterine surgery,
interval between last caesarean section and last menstrual period as a categorical term, placenta praevia and macrosomia.
c Labour either not induced or induced without prostaglandin.
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While dinoprostone (prostin, propess, prostaglandin E) was the agent used for all the control women
induced with prostaglandin, dinoprostone was used in 82% and misoprostol in 18% of the women induced
with prostaglandin who had a uterine rupture. Intrauterine death was the indication for induction for all of
the women who received misoprostol.
A further exploratory analysis found that among women with a previous caesarean delivery, uterine
rupture was no more likely to occur in women who had not had a previous vaginal delivery compared with
those who had (79%, 110/139 of women with uterine rupture had not had a previous vaginal delivery
compared with 74%, 331/446 of control women, aOR 1.43, 95% CI 0.65 to 3.13).
Outcomes
Two of the 159 women with a uterine rupture died, a case fatality of 1.3% (95% CI 0.2% to 4.5%).
Fifteen (9%) women had a hysterectomy following uterine rupture, 10 (6%) women had one or more
other organs damaged at rupture or removed during surgery and 69 (43%) women had other or
additional morbidity following their uterine rupture.
Outcomes were known for 152 of the infants born to women with a uterine rupture. There were
15 stillbirths (12 antepartum, seven of which occurred prior to uterine rupture in women who were
induced following intrauterine death, and three intrapartum) and 10 early neonatal deaths. Excluding the
stillbirths that occurred prior to uterine rupture, the perinatal mortality rate was 124 per 1000 (95% CI
75 to 189 per 1000), significantly higher than the national rate of 7.5 per 1000 (RR 16.46, 95% CI 10.68
to 25.39 per 1000).95 Major complications were reported in an additional 19 infants, including nine
infants diagnosed with neonatal encephalopathy and six diagnosed with respiratory distress syndrome.
Conclusions and implications for practice
These studies identified several important messages for care and future research.
AFE: for every one woman with AFE who dies, four survive. Of the women with AFE who survive, 7% have
permanent neurological injury. Outcome appears largely related to the severity of the clinical presentation.
Women who die or have permanent neurological disability are more likely to have cardiac arrest at
presentation and death most commonly occurs on the same day as the event. Women who die or have
permanent neurological disability are more likely to have a hysterectomy, suggesting more intractable
haemorrhage. Further investigation is needed to establish whether or not better and more rapid correction
of coagulopathy, through the use of cryoprecipitate, fresh-frozen plasma, platelets and fibrinogen is
associated with improved outcomes. Consideration needs to be given to whether or not earlier treatments,
including correction of coagulopathy, can reverse the cascade of deterioration that seems to be present
with AFE, and so improve survival in the most serious cases.
HELLP/ELLP syndrome: where there are sound reasons that a delay in delivery of women with HELLP or
ELLP syndrome may be beneficial, for example to allow administration of corticosteroids for fetal lung
maturation, this study suggests that a short delay, of up to 48 hours, may be considered. Current UK
guidelines recommend corticosteroids when there is a risk of delivery prior to 35 completed weeks96 or
planned caesarean delivery at < 39 completed weeks. Although we cannot comment on whether ELLP
cases proceed to HELLP or whether they are different entities, it is clear that women with ELLP as well as
HELLP have severe additional complications and, thus, ELLP should not be managed as a less severe form
of HELLP. In particular, there is a high rate of eclampsia among both women with ELLP and HELLP, thus
obstetricians should consider magnesium sulphate prophylaxis alongside delivery planning.
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Placenta accreta/increta/percreta: women with both a prior caesarean delivery and placenta praevia have a
high incidence of placenta accreta/increta/percreta (1 in every 20 women). In the absence of a completely
sensitive and specific antenatal diagnostic technique,97 this highlights the importance of having a high
index of suspicion of abnormal placental invasion and making preparations for delivery accordingly in this
group of women. It also highlights the importance of preventing the first caesarean section in order to
reduce the risk of subsequent placenta accreta/increta/percreta. Women with placenta accreta/increta/
percreta who have no attempt to remove any of their placenta with the aim of conserving their uterus or
prior to hysterectomy, have reduced levels of haemorrhage and reduced need for blood transfusion,
supporting recommendation of this practice.
Uterine rupture: although uterine rupture is associated with significant maternal and perinatal mortality
and morbidity, even among women with a previous caesarean section planning a vaginal delivery in their
current pregnancy, it is rare, occurring in only one of every 500 women. For women with a previous
caesarean section, the risk of uterine rupture increases not only with trial of labour but also with the
number of previous caesarean deliveries, a short interval since the last caesarean section and labour
induction and/or augmentation. These factors should be considered when counselling and managing the
labour of women with a previous caesarean section.
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Chapter 4 Severe maternal sepsis: identifying
actions to address morbidity and mortality
This chapter includes excerpts from Acosta CD, Bhattacharya S, Tuffnell D, Kurinczuk JJ, Knight M.Maternal sepsis: a Scottish population-based case–control study. BJOG 2012;119:474–83.98
© The Authors. BJOG An International Journal of Obstetrics and Gynaecology © 2012 RCOG,
reproduced with permission.
Background
Maternal death from sepsis appears to be increasing in countries with advanced health-care systems.2,99–101
Sepsis is estimated to cause 9.7% of maternal deaths in Africa, 11.6% in Asia and 7.7% in Latin America
and the Caribbean combined.102 In 2006–8, the UK maternal mortality rate from genital tract sepsis was
1.13/100,000 maternities, a rate not seen since the early 1970s,100,103 and in 2009–12, one-quarter of all
maternal deaths were due to infectious causes.2 Although the absolute risk of maternal death from sepsis
is low, an increase in maternal mortality implies a greater number of women with severe, life-threatening
illness. Recent work has suggested an approximate doubling of the incidence of maternal sepsis in the
USA since 2003.99
Key information gaps in the understanding of this pressing problem are the number of women affected,
causative organisms, sources of infection and risk factors for severe sepsis and poor outcomes such as
septic shock. Sepsis progresses along a spectrum of severity, so clarity about these factors has urgent
implications for clinical management and infection control strategies to avoid preventable maternal deaths.
The objectives of this workstream were to estimate the incidence, investigate any temporal trends, describe the
causative organisms and sources of infection, and identify the risk factors for severe maternal sepsis with the
aim of informing strategies to improve outcomes for mothers and their babies through further development of
guidelines for prevention and management of sepsis in pregnancy in the UK. The objectives were addressed
using three complementary data sources: data from the Aberdeen Maternity and Neonatal Databank (AMND),
ICNARC Case Mix Programme (CMP) database, and primary data collected using the UKOSS.
Methods
Data sources
Aberdeen Maternity and Neonatal Databank
All pregnancy-related events from the University of Aberdeen, Aberdeen Maternity Hospital, a tertiary-care
maternity hospital for the NHS North of Scotland region, have been recorded in the AMND since 1950.
The hospital is the only tertiary referral hospital in the region; it serves a large and well-defined geographical
region and has approximately 5000 births per year. Data entry, coding protocols and consistency rates for
internal validation and valid ranges of measurable variables are described in previous studies.104–106
Intensive Care National Audit & Research Centre Case Mix Programme
database
The ICNARC CMP is the national clinical audit for adult critical care units (including intensive care and
combined intensive care and HDUs) in England, Wales and Northern Ireland. The CMP database contains
pooled case mix data, collected from the first 24 hours following admission to the critical care unit and
outcome data on consecutive admissions to units participating in the CMP.107 The CMP database has been
independently assessed to be of high quality.108 All data used in this study were validated and from units
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that had been reporting to the CMP for at least 6 months. Support for the collection and use of patient-
identifiable data without consent was obtained under Section 251 of the NHS Act 2006109 (approval number
PIAG 2–10(f)/2005). Data were extracted on women who were reported to be pregnant or recently pregnant.
National birth statistics were used for comparison with CMP data in this study. Aggregate published data
on maternal age, Index of Multiple Deprivation, multiple births and stillbirths were obtained from the
Office for National Statistics (ONS) for England and Wales,110 and the Northern Ireland Statistics and
Research Agency.111 Data on ethnic groups were obtained from ONS and extrapolated for Northern Ireland
based on the reported ethnic population distribution in the region.112 Data on mode of delivery were
obtained from Hospital Episode Statistics,113 StatWales114 and extrapolated for Northern Ireland based on
published rates of mode of delivery in the region.115
UK Obstetric Surveillance System
Primary data on severe maternal sepsis were collected using UKOSS. Data were collected as described in
Chapter 3.
Analyses
Stata 11 statistical software was used for all analyses. Frequencies of demographic and clinical variables
were tabulated for all studies and compared across groups using chi-squared tests for categorical variables
and a Student’s t-test or Wilcoxon rank-sum test as appropriate for continuous variables.
Aberdeen Maternity and Neonatal Databank
An anonymised case–control study was conducted including all cases of maternal sepsis recorded in the
AMND between 1986 and 2009. All cases were identified as those with an International Classification of
Diseases, Ninth Edition (ICD-9) sepsis code: 038.0–038.9 (septicaemia), 634.0–639.0 (sepsis following
abortion), 670.2 (puerperal sepsis) and 785.5 (septic shock). Severe (‘near-miss’) sepsis cases were identified
as those with an ICD-9 code of septic shock or according to previously validated criteria defined by Martin
et al.,116 which were those with an additional ICD-9 code for acute organ dysfunction associated with sepsis.
All other cases of sepsis are referred to as ‘uncomplicated’. All cases with an ICD-9 code for sepsis had a
clinical diagnosis for systemic inflammatory response syndrome (SIRS) in addition to a culture-confirmed
diagnosis of infection. Four controls per case selected from the AMND who did not have an ICD-9 code for
sepsis were frequency matched to the cases on year of delivery.
The sample size of this study was limited by the population incidence of maternal sepsis and prevalence of
exposures. As an illustration, with 103 cases (all cases occurring in the population over the study period)
and four controls per case, the study had 90% power at p< 0.05 (two-sided) to detect a statistically
significant OR of ≥ 2.3 associated with obesity, with a prevalence of exposure of 19%.
Univariable logistic regression analyses were carried out to initially identify demographic and clinical risk
factors for uncomplicated maternal sepsis and severe sepsis; all p-values were unadjusted and two-sided,
and a p-value of < 0.05 was considered statistically significant. Significant variables from univariable
regression, or those factors that were plausible confounders, were included in a multivariable logistic
regression model using a stepwise method. Potential confounding factors that were not significant at a
p-value of < 0.05 in the initial multivariable regression (blood loss of ≤ 500 ml, pre-eclampsia and previous
miscarriage) were removed from the final model. Interactions between demographic and clinical variables
were assessed using likelihood ratio tests (LR-tests) with a significance level of p< 0.01; no interactions
were identified in the final adjusted model. Only two cases occurred antenatally and removal of these
cases did not significantly change the regression results, so the antenatal cases were retained in the final
regression models. Multivariable regression results were adjusted for calendar time and all other factors in
the model. Results are reported as unadjusted OR (uOR) and aOR with 95% CIs.
Research ethics committee approval for use of anonymised data was not required. Approval of the
research protocol was obtained from the Steering Committee of the AMND before data extraction.
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Intensive Care National Audit & Research Centre
A cohort study of all pregnant and ‘recently pregnant’ women who were reported in the CMP from
2008 to 2010, and who were either admitted with or developed severe sepsis within the first 24 hours of
admission, was conducted. Recently pregnant women were defined as having been pregnant within
42 days of admission to the critical care unit. Severe sepsis was defined according to a modified version
of the Recombinant Human Activated Protein C Worldwide Evaluation in Severe Sepsis (PROWESS)
clinical trial definition.117 Septic shock was defined as severe sepsis with cardiovascular organ system
dysfunction.118 Readmissions of women to critical care during the same hospital stay were excluded.
The total number of maternal critical care admissions with severe sepsis was estimated based on the
number of severe maternal sepsis admissions observed in the CMP database each year, the CMP reporting
coverage rate for each year and the total number of adult general critical care units in England, Wales and
Northern Ireland. Using all maternities in England, Wales and Northern Ireland as the comparison group,
the RR with 95% CI for maternal critical care admission with severe sepsis was calculated for each variable.
The characteristics of cohort survivors were compared with those of non-survivors in a univariable logistic
regression model. Based on previous literature and plausible confounding, variables were then modelled
using multivariable logistic regression. Mortality was measured by death at ultimate discharge from acute
hospital. Multivariable regression results were adjusted for calendar time and all other factors in the model.
The continuous variables age and body mass index (BMI) were treated as categorical variables in the
multivariable regression model as there was a large amount of missing information for BMI and there was
evidence of departure from linearity for age. Missing data for BMI were accounted for by retaining a
category for ‘unknown BMI’ within the BMI variable in all regression models. After accounting for missing
BMI data, complete-case analyses were used as levels of missing data were very low for all other variables.
Assuming a prevalence of exposure of at least 15% among survivors, the model had 80% power at
p< 0.05 (two-sided) to detect a statistically significant OR of ≥ 3.5. The results are reported as uORs and
aORs with 95% CIs.
UK Obstetric Surveillance System
A national prospective case–control study of all peripartum women diagnosed with severe sepsis (including
septic shock), irrespective of the source of infection, was carried out in all obstetrician-led maternity units
in the UK from 1 June 2011 to 31 May 2012.
As there is currently no standardised definition for severe sepsis in pregnant and peripartum women, the
study definition for surveillance purposes was developed based on previous literature and by consensus of
the UKOSS steering committee.10 In the non-obstetric population, consensus definitions of sepsis severity
(SIRS, sepsis, severe sepsis and septic shock) were developed in 1992.119 However, these definitions and
subsequent improvements are often not applicable to pregnant and peripartum women because clinical
signs and symptoms of severe infection differ in this population. Specifically, SIRS can be a sign of ruptured
membranes and changing biochemistry associated with labour and delivery, as well as a clinical marker of
severe infection. Therefore, the clinical parameters of SIRS in the presence of an infection are often altered
in the obstetric population. We adopted the ‘obstetric SIRS’ criteria from a 2001 study of severe obstetric
morbidity4 and took into account clinical management (level 2 or level 3 critical care)120 and whether or not
the woman died. The full case definition for this study is listed in Box 2. Controls were women who did
not have severe sepsis and who delivered immediately before each case in the same hospital. For women
transferred to higher-level hospitals, controls were drawn from the delivery hospital. The source population
was, thus, all women giving birth in the UK.
The study included a descriptive analysis of the incidence, causative organisms, sources of infection and
outcomes of severe sepsis, and a case–control analysis of factors associated with severe sepsis and septic
shock. In order to assess risk factors for developing severe sepsis, all cases were compared with non-septic
controls. To assess the risk of progression to septic shock, cases with a diagnosis of septic shock were
compared with all other cases with severe sepsis that did not develop into septic shock.
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The incidences of severe maternal sepsis and septic shock with 95% CIs were calculated using the number
of maternities reported in the most recent national birth data78,90,91 as the denominator. Women with signs
and symptoms of sepsis prior to delivery were classified as antepartum cases. Sources of infection,
causative organisms, and sepsis severity characteristics were tabulated for all cases and stratified according
to partum status, as pathogenesis is known to differ between pregnant and postpartum women.121
For risk factor analyses, sociodemographic, medical history and delivery characteristics with a priori
evidence of an association with sepsis were compared between cases and controls, and between cases
with and without septic shock. Sources of infection and causative organisms were also assessed as risk
factors in the latter comparison. The proportion of missing data in this study was very low; the only
variables with substantial missing data (> 1%) were source and organism of infection and socioeconomic
group. In order to account for the missing data for sources of infection, causative organisms and
socioeconomic group, the subcategories of ‘unknown’ and ‘no laboratory-confirmed infection’ were
included for these variables in all analyses.
The odds of severe sepsis and septic shock associated with each risk factor were estimated using
univariable unconditional logistic regression and were then adjusted using multivariable unconditional
logistic regression. For both the severe sepsis and septic shock outcome groups, factors were adjusted in
two stages. First, all a priori sociodemographic and medical history factors, with the exception of previous
caesarean delivery and previous pregnancy problem (as these were dependent on parity) and partum
status (as the control population was only women who had delivered), were included in a primary model.
Second, delivery factors were then adjusted for a priori risk factors using a more parsimonious approach in
order to avoid overadjustment or substantial colinearity given the large number of variables. Results were
adjusted only for a priori factors from the primary model that were known risk factors, were significant in
the primary model at a p-value of < 0.05, or were plausible confounders as identified in previous literature.
Delivery characteristics were evaluated for postpartum cases only, as this set of risk factors pertained
specifically to delivery.
BOX 2 Study definition of severe sepsis. Note that this definition is for surveillance purposes only and does not
represent clinical triggers for action
Applied to women at any point in pregnancy and up to 6 weeks postpartum:
1. death related to infection or suspected infection
2. any woman requiring level 2 or level 3 critical care (or obstetric HDU-type care) with severe sepsis or
suspected severe sepsis
3. a clinical diagnosis of severe sepsis:
l temperature > 38 °C or < 36 °C, measured on two occasions at least 4 hours apart
l heart rate > 100 b.p.m., measured on two occasions at least 4 hours apart
l respiratory rate > 20 breaths per minute, measured on two occasions at least 4 hours apart
l white cell count > 17 × 109/l or < 4 × 109/l or with > 10% immature band forms, measured on
two occasions.
Level 2 care is defined as patients requiring more detailed observation or intervention, single failing organ
system or postoperative care, and higher levels of care. Level 3 care is defined as patients requiring advanced
respiratory support alone or basic respiratory support together with support of at least two organ systems.
This level includes all complex patients requiring support for multiorgan failure.
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Results of both stages of adjustment are reported as uORs and aORs and their 95% CIs for severe sepsis.
For ease of presentation of risk factors for progression to septic shock, results are reported only for factors
included in the final adjusted models. LR-tests with a significance level of p< 0.01 were used to check for
interactions between variables; no significant interactions were identified in the final adjusted models.
Within a 1-year study period, we anticipated approximately 316 cases of severe sepsis based on an
estimated incidence of 4 per 10,000 maternities.4 For the severe sepsis risk factor analysis, with two
controls per case, and for a risk factor prevalence of at least 5% in control women, the study was
estimated to have had 80% power at p< 0.05 (two-sided) to detect a statistically significant OR of ≥ 2.3.
The actual number of cases and controls identified during the study period of 12 months generated an
estimated power of 80% at the 5% level of significance to detect an OR of ≥ 2.1, for the same risk factor
prevalence level. For the septic shock risk factor analysis, for a risk factor prevalence of at least 15% in
women without septic shock, the analysis had 80% power at the 5% level of significance to detect an OR
of ≥ 2.6.
Results
Aberdeen Maternity and Neonatal Databank
The total study population comprised 89 cases of uncomplicated maternal sepsis, 14 cases of severe
maternal sepsis and 412 control women. The majority of all cases occurred postpartum and before hospital
discharge [98.9% (n= 88) of women with uncomplicated sepsis and 92.9% (n= 13) of women with
severe sepsis]. One woman had uncomplicated sepsis antepartum and one women with severe sepsis was
diagnosed with an infection during delivery, which later progressed to septic shock postpartum. Sepsis
case rates for the 23-year study period are shown in Figure 2. Although rates of severe sepsis remained
relatively constant over the study period, rates of sepsis overall have increased significantly since 2003
(p= 0.002) compared with the previous two decades. Given the increase in awareness of sepsis, we
cannot exclude that this represents an increase in diagnosis/reporting rather than an increase in disease.
Over the 23-year study period, the proportion of spontaneous vaginal deliveries decreased while the
proportion of operative vaginal deliveries and caesarean sections increased significantly (p< 0.001,
p= 0.009 and p< 0.001, respectively). Despite these trends, sepsis case rates remained predominantly the
highest among women who had a caesarean section throughout the study period, although rates
increased in all modes from 2003 onwards. Antibiotic usage (before discharge from the labour ward) in
the overall study population increased steadily from 1986 to 1996 (p< 0.001) and plateaued from 1997 to
2009. Although there was no significant difference between cases and controls in the total proportion
of antibiotic usage across all modes of delivery (Table 11) among the women with sepsis who had a
caesarean section, 38.5% received antibiotics during pregnancy or delivery, which was significantly lower
than the 70.2% of control women who had a caesarean section and received antibiotics (p< 0.001). In
addition, antibiotic usage among control women who had a caesarean section increased significantly over
time (p= 0.003), whereas antibiotic usage among cases who had a caesarean section did not increase over
time. There was no significant difference in antibiotic usage among women in the case and control groups
who had a manual placenta removal or an operative vaginal delivery.
After adjusting for changes over time and the other factors in each model, factors significantly associated
with both uncomplicated sepsis and severe sepsis were younger age, multiparity, anaemia, operative
vaginal delivery and caesarean section (compared with spontaneous vaginal delivery) (see Table 11).
Obesity was significantly associated with uncomplicated sepsis; however, this association was not present
with severe sepsis. Additionally, operative vaginal delivery and pre-term birth were associated with
uncomplicated sepsis, whereas induced labour was associated with severe sepsis.
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Intensive Care National Audit & Research Centre
In the CMP database between 2008 and 2010, there were 646 pregnant or recently pregnant women
who met the case definition for severe sepsis, which represented 14.4% of maternal critical care unit
admissions and 10.6% (n= 474) had septic shock. The absolute risk of maternal critical care admission
with severe sepsis was 4.1 per 10,000 maternities (95% CI 2.9 to 5.6).
Characteristics of the cohort are shown in Table 12. Women had a significantly higher risk of admission
to critical care with severe sepsis if they were aged < 20 years or ≥ 40 years than if they were aged
25–29 years. Increased risk of severe sepsis was also significantly and progressively associated with
increasing deprivation based on area of residence.
TABLE 12 Characteristics and relative risks of severe sepsis among pregnant and recently pregnant women
admitted to critical care units in England, Wales and Northern Ireland from 2008 to 2010
Critical care admissions
with sepsis All maternities Relative risk (95% CI)
Total, n (%) 646 (100.0) 2,186,818
Recently pregnant 413 (63.9)
Maternal age (years), mean (SD) 28.3 (6.9) 29.0 (–)
< 20 80 (12.4) 129,167 (5.9) 2.5 (1.9 to 3.3)
20–24 133 (20.6) 419,944 (19.2) 1.3 (1.0 to 1.6)
25–29 148 (23.0) 602,716 (27.6) 1a
30–34 153 (23.7) 600,694 (27.5) 1.0 (0.8 to 1.3)
35–39 95 (14.7) 352,364 (16.1) 1.1 (0.9 to 1.4)
≥ 40 36 (5.6) 81,933 (3.7) 1.8 (1.2 to 2.6)
Black and other minority ethnic
groups, n (%)
154 (23.8) 609,250 (27.9) 0.9 (0.8 to 1.0)
IMD (quintiles),b n (%)
1 (least deprived) 63 (10.1) 589,784 (27.6) 1a
2 75 (12.0) 475,573 (22.2) 1.5 (1.1 to 2.1)
3 109 (17.5) 395,137 (18.5) 2.6 (1.9 to 3.5)
4 148 (23.8) 346,002 (16.2) 4.0 (3.0 to 5.4)
5 (most deprived) 228 (36.6) 330,916 (15.5) 6.5 (4.9 to 8.5)
BMI (kg/m2), median (IQR)b (n= 312) 26 (22–30)
History of immunosuppression, n (%) 15 (2.3)
Weeks’ gestation
Antenatal, median (IQR) 26 (20–31)
Postnatal, median (IQR) 38 (31–41)
Recently pregnant women only
Parity,b n (%)
0 193 (48.4)
1 96 (24.1)
≥ 2 110 (27.6)
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The source of infection could be identified from the primary reason for admission to the critical care unit
for 598 women (92.6%). Frequencies of the reported source of infection among women admitted with
severe sepsis are shown in Figure 3. The most common source of infection was pneumonia/respiratory
infection (n= 257; 40%). Of these, only 27 were identified as laboratory confirmed cases of AH1N1
influenza (2009 and 2010 were AH1N1 influenza pandemic years).
Of all severe maternal sepsis admissions, 4.6% (n= 29) died. The absolute risk of acute hospital mortality
of women admitted was 1.8 per 100,000 maternities (95% CI 1.1 to 2.8). Pneumonia/respiratory infection
was the most common source of sepsis among women who died (n= 12; 41.4%). Factors associated with
mortality are shown in Table 13. After adjustment for a priori factors and changes over time, deprivation,
being overweight or obese, respiratory dysfunction and haematological dysfunction were significant
independent risk factors for mortality.
UK Obstetric Surveillance System
During the study period, there were a total of 365 confirmed cases of severe sepsis out of 780,537
maternities in the UK,11–13 representing an incidence of 4.7 per 10,000 maternities (95% CI 4.2 to 5.2).
Seventy-one women (20%) developed septic shock, which represents an incidence of 0.91 per 10,000
maternities (95% CI 0.71 to 1.15). Data were collected on 757 controls.
TABLE 12 Characteristics and relative risks of severe sepsis among pregnant and recently pregnant women
admitted to critical care units in England, Wales and Northern Ireland from 2008 to 2010 (continued )
Critical care admissions
with sepsis All maternities Relative risk (95% CI)
Assisted conception,b n (%) 24 (8.1)
Mode of delivery,c n (%)
Spontaneous vaginal 98 (25.9) 1,334,242 (61.0) 1a
Assisted vaginal 28 (7.4) 273,340 (12.5) 1.4 (0.9 to 2.1)
Caesarean section 242 (64.0) 535,999 (24.5) 6.2 (4.9 to 7.8)
Unknown 10 (2.7)
All multiple births (live births and
stillbirths), n (%)
28 (7.6) 34,663 (1.6) 4.4 (3.1 to 6.3)
Pregnancy outcomes, n (%)
Live births 321 (77.7)
Stillbirths 47 (11.4) 11,697 (0.5%) 21.3 (16.3 to 27.9)
First/second trimester loss 25 (6.1)
Ectopic pregnancy 10 (2.4)
Otherd 2 (0.5)
Unknown 10 (2.4)
Hysterectomy, n (%)b 20 (5.4)
Days since delivery, median (IQR) 3 (0–8)
IMD, Index of Multiple Deprivation; IQR, interquartile range.
a 1 (reference).
b Of those reported.
c National rates are total deliveries.
d Two women each had one live birth and one stillbirth from the most recent pregnancy.
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FIGURE 3 Source of infection among pregnant or recently pregnant women admitted to critical care units in
England, Wales and Northern Ireland 2008–10.
TABLE 13 Clinical characteristics of survivors and non-survivors of severe maternal sepsis following critical
care admission
Characteristic
Severe sepsis
survivors
(n= 610), n (%)
Severe sepsis
deaths
(n= 29), n (%) uOR (95% CI) aOR (95% CI)
Recently pregnant 387 (63.4) 22 (75.9) 1.8 (0.8 to 4.3) 1.1 (0.2 to 3.0)
Maternal age (years)
< 25 234 (38.4) 5 (17.2) 1a 1a
25–34 254 (41.7) 15 (51.7) 2.8 (1.0 to 7.7) 2.2 (0.71 to 7.0)
≥ 35 121 (19.9) 9 (31.0) 3.5 (1.1 to 10.6) 3.3 (0.4 to 11.2)
Black and other minority
ethnic groups
147 (24.1) 7 (24.1) 1.0 (0.4 to 2.5) 0.6 (0.21 to 1.6)
IMD quintiles 4 and 5 354 (58.1) 17 (58.6) 1.02 (0.5 to 2.2) 2.6 (1.3 to 6.7)
BMI (kg/m2)
Unknown 317 (52 1) 13 (44.8) 0.8 (0.2 to 3.7) 1.2 (0.2 to 9.1)
< 25 126 (20.7) 3 (10.3) 1a 1a
≥ 25 to < 30 90 (14.8) 7 (241) 3.3 (0.8 to 13.3) 5.2 (1.4 to 18.9)
≥ 30 76 (12.5) 6 (20.7) 3.5 (0.9 to 14.6) 6.3 (1.5 to 27.0)
History of immunosuppression 13 (2.1) 2 (6.9) 3.3 (0.7 to 15.7)
Weeks’ gestation
Antenatal
≥ 37 16 (7.0) 0 (0.0) –
25–36 104 (47.5) 3 (42.9) 1a
< 25 99 (45.2) 4 (57.1) 1.4 (0.3 to 6.4)
Postnatal
≥ 37 202 (54.9) 14 (66.7) 1a
25–36 114 (31.0) 3 (14.3) 0.4 (0.1 to 1.3)
< 25 52 (14.1) 4 (19.1) 1.1 (0.4 to 3.5)
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TABLE 13 Clinical characteristics of survivors and non-survivors of severe maternal sepsis following critical
care admission (continued )
Characteristic
Severe sepsis
survivors
(n= 610), n (%)
Severe sepsis
deaths
(n= 29), n (%) uOR (95% CI) aOR (95% CI)
Recently pregnant women only
Parity
0 183 (48.9) 9 (42.9) 1a
1 88 (23.5) 7 (33.3) 1.6 (0.6 to 4.5)
≥ 2 103 (27.5) 5 (23.8) 1.0 (0.3 to 3.0)
Assisted conception 24 (8.7) 0 (0.0)
Mode of delivery
Spontaneous vaginal 89 (23.6) 8 (36.4) 1a
Assisted vaginal 28 (7.4) 0 (0.0) –
Caesarean section 227 (60.2) 12 (54.6) 0.6 (0.2 to 1.5)
Termination 23 (6.1) 2 (9.1) 1.0 (0.2 to 4.9)
Ectopic 10 (2.7) 0 (0.0) –
All multiple births 24 (7.0) 3 (15.0) 2.3 (0.6 to 8.6)
Stillbirth(s) 42 (21.9) 4 (33.3) 1.8 (0.5 to 6.2)
Hysterectomy 16 (4.6) 3 (15.0) 3.6 (1.0 to 13.7)
< 24 hours since
delivery
104 (27.6) 8 (36.4) 1.5 (0.6 to 3.7)
Source of infectionb
Pneumonia (chest
infection)
216 (35.4) 12 (41.4) 1.3 (0.6 to 2.7)
Intrauterine infection 69 (11.3) 2 (6.9) 0.6 (0.1 to 2.5)
Pelvic infection 47 (7.7) 0 (0.0) –
UTI/pyelonephritis 43 (7.1) 0 (0.0) –
Number of organ system dysfunctions
1 221 (36.2) 2 (6.9) 1a
2 224 (36.7) 8 (27.6) 3.9 (0.8 to 18.7)
≥ 3 165 (27.1) 19 (65.5) 12.7 (2.9 to 55.1)
Organ system dysfunctionc
Cardiovascular 444 (72.8) 24 (82.8) 1.8 (0.7 to 4.8)
Respiratory 349 (57.2) 26 (89.7) 6.5 (1.9 to 21.6) 8.1 (1.8 to 36.0)
Metabolic acidosis 322 (52.8) 18 (62.1) 1.5 (0.7 to 3.1)
Renal 39 (6.4) 8 (27.6) 5.6 (2.3 to 13.4) 2.9 (0.9 to 9.3)
Haematological 52 (8.5) 11 (37.9) 6.5 (2.9 to 14.6) 5.7 (2.0 to 16.0)
–, no comparison group, i.e. zero incidence in either case or control group; IMD, Index of Multiple Deprivation;
UTI, urinary tract infection.
a 1 (reference).
b Known sources of infection with > 5% frequency.
c Organ system dysfunctions not mutually exclusive.
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Laboratory-confirmed infection was reported for 233 (63.8%) severe sepsis cases and a source of infection
was identified for 270 cases (74.0%); 60 cases (16.4%) had neither a source of infection nor causative
organism identified. The distribution of sources of infection, causative organisms and severity characteristics
are shown in Table 14 and Figure 4. Overall, the largest proportion of cases was due to genital tract
infection (31.0%) and the most common organism causing infection was Escherichia coli (21.1%).
However, the distributions of both the infection source and the causative organism differed significantly
between women with antepartum and postpartum sepsis (p< 0.0001 for both), as did the risk of septic
shock. Readmission (for reasons other than delivery) also differed significantly between the two groups: 108
(48%) women with postpartum sepsis were readmitted, compared with six (5%) women with antepartum
sepsis (p< 0.0001). Of all cases, 286 (78%) received level 2 or intensive care and five women died (see
Table 14). Of the women who died, two had infection with E. coli and three women had an unknown
causative organism. Twenty-nine women (8%) with severe sepsis had either a miscarriage or a termination
of pregnancy. For women diagnosed with severe sepsis antenatally, 5 of 137 infants were stillborn (3.6%)
and 7 died in the neonatal period (5.1%). Fifty-eight infants (42.3%) were admitted to the NICU.
There were 296 cases with recorded dates and times for the first sign of SIRS and the severe sepsis
diagnosis. For 245 (83%) severe sepsis cases and for 49 (85%) septic shock cases, there were < 24 hours
between the first sign of SIRS and the diagnosis of severe sepsis, and for 264 (89%) severe sepsis cases
and for 55 (95%) septic shock cases there were < 48 hours between the first sign of SIRS and the
diagnosis of severe sepsis. Additionally, for 16 (50%) women with a group A streptococcal infection there
were < 2 hours and for 24 (75%) women there were < 9 hours, between the first sign of SIRS and the
diagnosis of severe sepsis.
A priori sociodemographic and medical history characteristics of women with severe sepsis compared with
control women are listed in Table 15. After adjustment and compared with controls, women who were of
black or other minority ethnic origin, were primiparous, had a pre-existing medical problem, or had a
febrile illness or were taking antibiotics in the 2 weeks prior to presentation were at significantly increased
odds of severe sepsis. There was no statistically significant association between premature rupture of
membranes and severe sepsis in either antenatal cases (n= 20, aOR 1.72, 95% CI 0.98 to 3.02) or
postnatal cases (Table 16). In addition to significant a priori factors, the following factors significantly
increased the odds of severe sepsis in women with postpartum sepsis: having an operative vaginal delivery
(aOR 2.49, 95% CI 1.32 to 4.70), having a pre-labour caesarean section (aOR 3.83, 95% CI 2.24 to 6.56),
having a caesarean section after the onset of labour (aOR 8.06, 95% CI 4.65 to 13.97), or having a
complication of delivery (aOR 1.69, 95% CI 1.09 to 2.63) (see Table 16). Of note, of all women who had a
caesarean section, 96.6% of cases and 94.8% of controls received prophylactic antibiotics at delivery.
Multiple pregnancy (aOR 5.75, 95% CI 1.54 to 21.5) and group A Streptococcus as the causative
organism (aOR 4.84, 95% CI 2.17 to 10.8) were significantly associated with an increase in the odds of
progression from severe sepsis to septic shock. Before adjustment for group A streptococcal infection,
spontaneous vaginal delivery (aOR 3.85, 95% CI 1.35 to 10.96) and operative vaginal delivery (aOR 3.12,
95% CI 1.03 to 9.57) were significantly associated with an over threefold increase in the odds of
progression to septic shock.
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TABLE 14 Characteristics of infection in women with severe antepartum and postpartum sepsis
Characteristic
Antepartum, n (%)
(N= 134)
Postpartum,a n (%)
(N= 231) p-value
Total, n (%)
(N= 365)
Source of infection < 0.0001
Genital tract 27 (20.2) 86 (37.2) 113 (31.0)
Urinary tract 45 (33.6) 27 (11.7) 72 (19.7)
Wound 0 (0.0) 33 (14.3) 33 (9.0)
Respiratory 12 (9.0) 8 (3.5) 20 (5.5)
Other 10 (7.5) 22 (9.5) 32 (8.8)
Unknown 40 (29.9) 55 (23.8) 95 (26.0)
Organism < 0.0001
Escherichia coli 33 (24.6) 44 (19.1) 77 (21.1)
Group A Streptococcus 2 (1.5) 30 (13.0) 32 (8.8)
Group B Streptococcus 13 (9.7) 17 (7.4) 30 (8.2)
Other Streptococcus 6 (4.5) 15 (6.5) 21 (5.7)
Staphylococcus 2 (1.5) 21 (9.1) 23 (6.3)
Mixed organisms 5 (3.7) 14 (6.1) 19 (5.2)
Other 12 (9.0) 13 (5.6) 25 (6.9)
Unknown 5 (3.7) 1 (0.4) 6 (1.6)
No laboratory-confirmed
infection
56 (41.8) 76 (32.9) 132 (36.2)
Severity
Level 2 or ITU admission 103 (76.9) 183 (79.2) 0.598 286 (78.4)
Level 2 admission 64 (47.8) 107 (46.3) 0.79 171 (46.9)
ITU admissionb 39 (29.1) 75 (32.5) 0.504 114 (31.2)
Septic shock 16 (11.9) 55 (23.8) 0.006 71 (19.5)
Death 2 (1.5) 3 (1.3) 0.915 5 (1.4)
a Includes first/second trimester losses (n= 29).
b Irrespective of level 2 admission.
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FIGURE 4 Distribution of causative organisms according to (a) source of infection; and (b) mode of delivery.
Stacked bars represent the number of cases with specific causative organisms according to infection source and
mode of delivery categories. Data are mutually exclusive.
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Conclusions and implications for practice
In the AMND study we identified that obesity, younger maternal age, operative vaginal delivery and other
known factors such as multiparity, anaemia, labour induction, caesarean section and pre-term birth were
associated with maternal sepsis. Women with sepsis who had a caesarean section were less likely than
controls to receive antibiotics, highlighting the need for prophylaxis. The association we observed between
operative vaginal delivery and maternal sepsis emphasises the importance of strict aseptic technique and
infection control measures in clinical practice. The association between obesity and maternal sepsis is also
of clinical significance given the concurrent increase in maternal obesity in the UK.13 However, this AMND
analysis, despite using a large population database, had limited power to investigate factors associated
with severe maternal sepsis. Therefore, we undertook further research, including an analysis of intensive
care admission data and a national prospective cohort study, to comprehensively evaluate the magnitude
of severe maternal sepsis morbidity.
We found that severe sepsis and septic shock morbidity are common among pregnant and recently
pregnant women admitted to intensive care (one in seven and one in nine obstetric ICU admissions,
respectively). We further identified several findings with clinical and health-care policy implications:
pneumonia/respiratory infection is a leading source of sepsis irrespective of epidemic influenza periods;
there are major significant disparities in socioeconomic status and the risk of severe sepsis; and deprivation,
increased BMI, respiratory and haematological organ system dysfunctions are significant independent risk
factors for mortality due to sepsis.
Forty per cent of women with severe sepsis had pneumonia/respiratory infection as the source of sepsis.
Despite the significant influenza epidemic, which occurred from 2009 to 2010, only 10.5% (27/257) of
pneumonia/respiratory infection cases were due to the epidemic AH1N1 strain.
These results indicate that in addition to genital tract infection, respiratory infection is a major source of
severe maternal sepsis irrespective of an influenza epidemic. Immediate implications are that the
significance of respiratory tract infection in pregnant and recently pregnant women should be recognised,
and there is clearly a precedent to improve timely recognition of severe respiratory tract infection as well as
genital tract sepsis in pregnant and recently pregnant women. Most maternal deaths and critical illnesses
from severe sepsis occur because of a delay in recognition and diagnosis.2 Obstetric and front-line clinicians
should therefore maintain a high index of suspicion, as well as alert pregnant and recently pregnant
women to the possible severity of any infection, in particular the clinical symptoms of respiratory and
genital tract infection and the dangers of delay in seeking medical care. From an economic perspective,
an improvement in recognition before onset of severe infection could have a substantial effect on intensive
care resource utilisation.
Obesity is clearly a risk factor for sepsis mortality100 and ICU admission,122 but it was evident from the
missing data in the ICNARC study that BMI was often not routinely recorded, which has subsequently
been addressed in obstetric guidelines.123
The UKOSS national cohort study found that for each maternal sepsis death in the UK, approximately
50 women have life-threatening morbidity from sepsis and the onset of severe sepsis from SIRS occurs very
rapidly. Genital tract and urinary tract infections (UTIs) are the predominant sources of infection in women
admitted to obstetric units with sepsis; all modes of operative delivery carry significant risks for severe sepsis
and although the largest proportion of cases of severe sepsis is caused by E. coli, outcomes are significantly
worse for women with group A streptococcal infection. Importantly, women who are treated with antibiotics
in the perinatal period are at significant risk of severe sepsis, suggesting that a significant proportion of
infections progress even following antibiotic treatment. These findings highlight a number of key messages
for clinical practice in both primary and secondary care, with the high levels of life-threatening morbidity
identified indicating that pregnant or recently pregnant women with suspected infection need closer
attention than women who are not pregnant.
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Severe sepsis in pregnancy presents in primary care and the previously undescribed association between
antibiotic prescription in the perinatal period and risk of severe sepsis suggests that primary care
practitioners should have a low threshold for referral of women in pregnancy with signs of infection.
Over 40% of women with severe sepsis had a febrile illness or were taking antibiotics prior to
presentation, which suggests that at least a proportion were not adequately diagnosed, treated or
followed up. It cannot be assumed that antibiotics will prevent progression to severe sepsis and safety net
checks, for example follow-up appointments or instructions to return if symptoms do not resolve, should
therefore be in place to make sure a pregnant woman who has been treated for infection has recovered.
Simply prescribing antibiotics alone may not be appropriate. This message applies equally to secondary
care and there is a need to ensure that follow-up happens to ensure that treatment is effective.
As sepsis progresses along a spectrum of severity, the occurrence of life-threatening sepsis represents the
severest end, with the exception of maternal death and, therefore, only the ‘tip of the iceberg’ of serious
maternal morbidity. The rapid progression to severe sepsis highlights the importance of following the
international Surviving Sepsis Campaign’s guidelines124 in pregnancy and the recommendation for
administration of high-dose intravenous (i.v.) antibiotics within 1 hour of admission for anyone with
suspected sepsis.124
A challenge in all previous studies of maternal sepsis has been to assess the temporality of mode of
delivery in relation to infection and sepsis. These studies show that after controlling for illness before
delivery, as well as clinical risk factors such as premature rupture of membranes, all modes of operative
delivery (operative vaginal, pre-labour caesarean and caesarean after the onset of labour) were
independent risk factors for severe sepsis. Even though antibiotic prophylaxis at caesarean section is
routine practice in the UK, these results suggest that women are still at heightened risk of severe sepsis,
despite the administration of antibiotics, and emphasise the importance of attention to prophylaxis
particularly in emergency deliveries. The risk associated with operative vaginal delivery suggests that there
is a need for further investigation of the role of prophylactic antibiotics in a randomised controlled trial
(RCT), as well as stringent attention to infection control measures for these deliveries. Further to this
programme of work and as a direct consequence of these findings, a trial of a single dose of prophylactic
antibiotic following operative vaginal delivery has been funded and is now in progress.125
The different patterns of infection we observed in antenatal and postnatal women suggest that overall
greater consideration needs to be given to the source of infection and, therefore, the most appropriate
antibiotic to prescribe. This study highlights that UTIs remain an important cause of severe sepsis,
particularly antenatally, so prompt treatment and follow-up in primary care to ensure that the infection is
eradicated is important.
Our results indicate that although severe sepsis is more common following caesarean delivery, women
delivering vaginally are at a heightened risk of group A streptococcal infection and those that are infected
with group A Streptococcus are at significantly increased risk of progression to septic shock compared with
women infected with another organism. Fifty per cent of proven group A streptococcal infections in our
study population led to septic shock, with very rapid progression from the first sign of SIRS. This has a direct
implication for decisions about the availability of rapid antigen diagnostic tests for group A Streptococcus in
obstetrics. Although culture remains the gold standard for confirmation of group A Streptococcus, it takes
1–2 days to obtain results, which is significantly longer than the time course from the first signs of SIRS to
septic shock for most women. In the absence of rapid diagnostics, a positive culture for group A
Streptococcus should be reported urgently by telephone as soon as it is discovered in the laboratory and,
prior to this, a clinical suspicion of group A Streptococcus should be regarded as a red flag for urgent
action, including administration of antibiotics and very close monitoring. In addition, training about group A
streptococcal infection should be routinely included in all obstetric emergency training courses.
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In conclusion, this workstream emphasises that both primary and secondary care practitioners should
remain aware that pregnant or recently pregnant women with suspected infection need closer attention
than women who are not pregnant. Antibiotic prescription does not necessarily prevent progression to
severe sepsis and women should be followed up to ensure recovery. The rapid progression to severe sepsis
highlights the importance of following the international Surviving Sepsis Campaign guideline of
administration of high-dose i.v. antibiotics within 1 hour of admission to hospital for anyone with
suspected sepsis. Signs of severe sepsis, particularly with confirmed or suspected group A streptococcal
infection, should be regarded as an obstetric emergency and should be routinely included in obstetric
emergency training courses. Vigilant infection control at vaginal delivery should be maintained, with a
potential role for prophylactic antibiotics at operative vaginal delivery. Future research should assess the
efficacy of rapid antigen diagnostic tests for group A Streptococcus in obstetrics.
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Chapter 5 Extending the uses of observational
data on severe maternal morbidity: economic
evaluation of second-line managements for
postpartum haemorrhage
Background
Randomised controlled trials of treatments for conditions that are both rare and occur in emergency
situations are particularly difficult owing to the time limitations in the emergency situation as well as the
large collaboration needed to conduct studies of sufficient size.126 Studies of effectiveness and particularly
cost-effectiveness are thus rarely undertaken in this setting. National observational data, such as those
obtained through UKOSS, have fewer of the biases classically attributed to many observational studies.127
This information may therefore be used to explore effectiveness of different current treatments for
near-miss maternal morbidities. In the absence of evidence from RCTs it is necessary to rely on these
observational data, but given the known variation in the use of specific interventions, national
recommendations will rely on these data supplemented by economic data. For example, providing uterine
artery embolisation for postpartum haemorrhage (PPH) involves substantial capital outlay associated with
the provision of a dedicated out-of-hours interventional radiology service. Therefore, investigating the
utility of these observational data for economic evaluation is important.
The basic management of PPH consists of initial medical care and the use of uterotonic drugs and/or an
intrauterine balloon. When these initial therapies fail, an escalated series of second-line therapies are
currently implemented before hysterectomy is considered to avoid maternal death. These second-line
therapies include uterine compression sutures, factor VIIa, pelvic vessel ligation and interventional
radiological techniques, which have been widely introduced into clinical practice and recommended by
national guidelines.128 Little was known until recently about the effectiveness of these therapies in
practice.129 Kayem et al.129 reported that uterine compression sutures and interventional radiology
techniques experienced higher success rates than recombinant factor VIIa (rFVIIa) and pelvic vessel ligation
using a cohort of women with PPH identified through UKOSS. The authors concluded that before
recommending uterine compression sutures or interventional radiology as part of clinical practice, a full
assessment of the costs and effects of the interventions should be conducted.
Conducting a cost-effectiveness analysis alongside observational studies as the sole vehicle for the
economic evaluation is subject to problems such as selection bias and confounding, particularly
confounding by indication.130 However, the use of appropriate statistical methods to deal with this type
of bias is recommended to estimate particular cost-effectiveness information using observational data
(e.g. transition probabilities, costs associated to a health state, utility decrements) that can be synthesised
alongside other sources of data in a decision economic model.130–132 The aim of this workstream was to
conduct a cost–utility analysis of second-line interventions for PPH using a decision-analytic model that
synthesised effectiveness data from the national cohort UKOSS study, cost data obtained through
interviews and the literature, and health-related quality-of-life information extracted from the literature.
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Research questions
l What is the relative cost-effectiveness of treatment for peripartum haemorrhage with uterine
compression sutures, factor VIIa and major vessel ligation or embolisation?
l What additional data should be collected in a primary study of therapies for near-miss maternal
morbidity to inform an economic evaluation?
Methods
A cost–utility analysis was conducted from the UK NHS perspective to determine which second-line
therapies for PPH represent value for money of scarce NHS resources. The main outcome measure used in
this economic evaluation was quality-adjusted life-years (QALYs).
Structure of cost-effectiveness model
A decision-tree model of the acute clinical pathway of women (mean age 32 years; interquartile range
29–36 years) with PPH was developed using TreeAge Pro Suite 2015 software (TreeAge Software, Inc.,
Williamstown, MA, USA). This type of model is recommended for acute conditions that need immediate
effective interventions.133 A time horizon of 12 months was used in the economic model. Treatment
success was defined as no requirement for either a further therapy to treat PPH or hysterectomy.
The model commenced when first-line treatment for PPH failed and one of the four second-line treatments
was used as potential therapies to stop the bleeding. If the second-line therapy was successful, the model
stopped and costs and effects were calculated for that therapy. If second-line therapy failed, the woman
either underwent hysterectomy or was treated with one of the remaining second-line therapies as a
third-line therapy. After receiving third-line therapy, the final possible outcomes were successful treatment
or hysterectomy. We assumed that if third-line therapy failed, women underwent hysterectomy and not a
fourth-line treatment, as this is most likely in clinical practice.2,128
Estimation of baseline probabilities
Baseline probabilities were extracted from the UKOSS study.10,129 Table 17 presents the probabilities used in
the model for each intervention that were computed as the number of occurrences divided by the total
number of women receiving a particular therapy. Probabilities are presented either as intervention specific
or common to all regimes. For the intervention-specific probabilities, the probability of a successful
outcome after second-line treatment and the probability of hysterectomy after a failure of second-line
treatment were extracted from the epidemiological study. The probability of a failure outcome after
second-line therapy was estimated as residuals (i.e. 1 – probability of a successful outcome). The
probability of having a particular third-line therapy was also estimated as the residual. The probabilities of
having a particular third-line treatment and the outcomes after third-line treatment were common to all
regimes. No clear evidence about the probability of use of a particular intervention as third line compared
with the remaining ones was observed in the study by Kayem et al.129 Therefore, we assumed that women
were equally likely to receive one of the remaining therapies as third-line treatment. We pooled the
number of hysterectomies performed across all interventions used as third line, to estimate the probability
of having hysterectomy after third-line treatment.
Incorporating treatment effect in the economic model
The treatment effect in the model was introduced by modifying the baseline probability of successful
outcome after uterine compression sutures by a treatment modifier reflecting the treatment effect of
uterine compression sutures against one of the remaining second-line therapies. The baseline probability
of uterine compression was used because it was the most commonly used intervention among the
272 women identified in the UKOSS study. As treatment modifier, we used the OR of successful outcome
after second-line treatment between pelvic vessel ligation, rFVIIa or interventional radiology compared with
uterine compression sutures. We used the UKOSS data to obtain ORs from a logistic regression using a
binary dependent variable indicating whether or not second-line therapy was successful and treatment
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TABLE 17 Baseline probabilities obtained from the UKOSS study used in the model to determine the
cost-effectiveness of different second-line regimes to treat PPH and associated uncertainty around mean
estimates used in the PSA
Second-line regime Baseline probability α β n PSA distribution
Uterine compression sutures
Successful outcome after second-line treatment 0.704 140 59 199 Beta
Failure outcome after second-line treatmenta 0.296
Hysterectomy after a failure outcome post
second-line treatment
0.166 33 166 199 Beta
Third-line treatment after a failure outcome
post second-line treatmenta
0.834
Pelvic vessel ligation
Successful outcome after second-line
treatmentb
0.286
Failure outcome after second-line treatmenta 0.714
Hysterectomy after a failure outcome post
second-line treatment
0.100 2 18 20 Beta
Third-line treatment after a failure outcome
post second-line treatmenta
0.900
rFVIIa
Successful outcome after second-line
treatmentb
0.291
Failure outcome after second-line treatmenta 0.709
Hysterectomy after a failure outcome after
second-line treatment
0.452 14 17 31 Beta
Third-line treatment after a failure outcome
after second-line treatmenta
0.548
Interventional radiology
Successful outcome after second-line
treatmentb
0.857
Failure outcome after second-line treatmenta 0.143
Hysterectomy after a failure outcome post
second-line treatment
0.091 2 20 22 Beta
Third-line treatment after a failure outcome
post second-line treatmenta
0.909
Probability of having a particular intervention as
third-line treatment (common to all regimes)
0.333
Outcomes after third-line treatment (common to all regimes)
Successful outcome after third-line treatmenta 0.474
Hysterectomy after third-line treatment 0.526 20 18 38 Beta
PSA, probabilistic sensitivity analysis.
a Residual probabilities.
b Estimated as the product of baseline probability of successful outcome after second-line uterine compression sutures
treatment by treatment modifier. Empirical distribution of ORs used in the PSA.
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indicators as well as a set of women’s characteristics and mode of labour as explanatories. The ORs (95% CIs)
estimating treatment success for rFVIIa, pelvic vessel ligation and interventional radiology compared with
uterine compression sutures were estimated to be 0.173 (0.068 to 0.469), 0.169 (0.053 to 0.537) and 2.533
(0.531 to 12.087), respectively. Baseline probabilities of successful outcome after second-line rFVIIa, pelvic
vessel ligation and interventional radiology were converted first into odds before being multiplied by the OR
and were converted back into probabilities when informing the parameters in the model.
Costs
The direct health-care costs associated with the second-line interventions were the only costs included in
the model and were calculated using a detailed costing analysis. Any other health-care costs (e.g. length of
stay, hospital readmissions, primary care visits) were assumed to be similar across interventions and,
therefore, cancelling out in the calculation of the incremental costs and hence were excluded from the
model. This is based on the clinical assumption that the outcomes of successful treatment of PPH
do not differ in a treatment-dependent manner. The main resource use and cost drivers associated with
the interventions were elucidated through interviews with a haematologist, two obstetricians and an
anaesthetist all based in UK hospitals. The results from the interviews suggested that staff, equipment, key
drugs and a set of general measures common to all regimes were the main cost drivers. General measures
included common resources to all therapies such as intra-arterial monitoring, control venous pressure
monitoring, active warming and fresh-frozen plasma. Unit costs associated with the resource use were
primarily obtained from national sources when available134 and from the literature. If no published cost
data were readily available, commercial companies were contacted to obtain such information. All unit
costs were expressed in 2012–13 Great British pounds and discounting was not implemented given that
only intervention costs were included in the model. A summary of the mean interventions costs used in the
model is presented in Table 18.
Base-case utility values
Evidence suggests that women who have a PPH but have a successful outcome after second- or third-line
treatment experience a complete recuperation at 1-year follow-up with quality-of-life levels similar to
women of the same age from the general population. Utility values associated with a successful outcome
health state in the model were therefore extracted from responses to the European Quality of Life-5
Dimensions-3 Level (EQ-5D-3L) instrument135 in the Health Survey for England in 2011 from women aged
< 40 years in the general population. The utility value of a successful outcome was based on 359 young
women’s responses and we applied the UK value set to estimate utilities obtaining a mean (SE) utility value
of 0.923 (0.008). We sought published sources to identify quality-of-life weights associated with women of
childbearing age undergoing hysterectomy in an emergency situation by conducting a literature search
from inception to May 2014 in MEDLINE, Cumulative Index to Nursing and Allied Health Literature and
EMBASE using a combination of the terms quality of life, fertility, infertility and hysterectomy and found no
evidence of published utilities. We searched the national health surveys in the UK and USA to explore
whether or not such data could potentially be available. We found that in the 2003 US Medical
Expenditure Panel Survey (MEPS),136 women who completed the EQ-5D-3L were asked whether or not they
had undergone a hysterectomy (which may or may not have been related to PPH) in the previous year.
Full details are available from the MEPS survey web site.137 We identified 148 women under the age of
40 years who underwent a hysterectomy (for any reason) in the 2003 MEPS dataset and estimated a mean
(SE) utility weight of 0.744 (0.024). We used the UK value set to calculate utilities from the EQ-5D-3L
responses obtained in MEPS.138 We had originally anticipated using data from the study reported in
Chapter 9 to produce utility estimates, but the questionnaire response rate was too low to be
considered representative.
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TABLE 18 Summary of intervention costs used in the model to determine the cost-effectiveness of different
second-line regimes to treat PPH with selected ranges for sensitivity analysis
Mean
estimate (£)
Range used in one-way sensitivity analysis (£)
± 20% of mean
estimate
± 40% of mean
estimate
± 60% of mean
estimate
Uterine compression sutures
Intervention-specific drugs 81
Staff 312
Equipment 34
General measuresa 2564
Total 2991 2393–3589 1795–4187 1196–4786
Pelvic vessel ligation
Staff 934
Equipment 28
General measuresa 2564
Total 3525 2820–4230 2115–4935 1410–5640
rFVIIa
rFVIIa unit cost 3935
Staff 295
General measures 2564
Total 6794 5435–8153 4076–9512 2718–10,870
Interventional radiology
Intervention-specific
drugs
366
Staff 2425
Equipment 1111
Ambulance transfer 261
General measuresa 2564
Total 6727 5382–8072 4036–9418 2691–10,763
Hysterectomy
Staff 583
Equipment 46
General measuresa 2564
Total 3193
a General measures include common resources to all therapies such as intra-arterial monitoring, control venous pressure
monitoring, active warming, fresh-frozen plasma and platelets.
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Analytical methods
All analyses are carried out from the perspective of the UK NHS and are reported in terms of incremental
cost-effectiveness ratios (ICERs) and net-benefit statistics. The primary health outcome measure in the
economic analysis was QALYs but the results of the analysis are also presented using hysterectomy
avoided. Therefore, ICER results are presented using cost per QALY gained and cost per hysterectomy
avoided. QALYs for each treatment strategy were estimated attaching a utility value to the successful
outcome or hysterectomy health states and assuming women spent 12 months in that state. Dominated
strategies (one strategy is found to be both cheaper and produces more QALYs) were eliminated before
conducting any incremental analysis. Uncertainty in the model parameters (probabilities, treatment
effect and utility parameters) was evaluated through a probabilistic sensitivity analysis (PSA).139 In PSA,
each input parameter in the model is assigned a specific statistical distribution for which values are
randomly drawn generating a large number of pairs of mean costs and effects for each strategy.
These estimates are then used to create an empirical distribution of the differences in costs and effects
between interventions.
We generated 10,000 random draws and used beta distributions for both probabilities and utilities.140
As we had access to patient-level data to inform the uncertainty around treatment effects of the
interventions, we used the empirical distribution of the ORs reported in Chapter 5, Sensitivity analysis, from
10,000 bootstrap samples for the PSA. We reported the PSA summary results for the total costs and
effects per patient associated to each second-line regime to treat PPH for our base case in line with current
recommendations.140 Uncertainty around cost-effectiveness results is presented using cost-effectiveness
acceptability curves (CEACs) that indicate the probability that a particular intervention is cost-effective for
different thresholds of willingness to pay (WTP) for a QALY or hysterectomy avoided. Current thresholds of
WTP for a QALY as suggested by National Institute for Health and Care Excellence (NICE) were used in this
study to determine value for money.141
To estimate the impact of individual parameters on the results of the analysis, we performed an analysis of
covariance. Using this approach, the proportion of the sum of squares in the output parameters (i.e.
incremental costs and incremental QALYs) explained by uncertainty in each input parameter was identified.140
Costs were treated deterministically in the economic model, as there were no reliable stochastic estimates
to inform SEs. We implemented a one-way sensitivity analysis to determine how the main base cost-
effectiveness results varied when the total costs associated with uterine compression sutures, pelvic vessel
ligation, rFVIIa and interventional radiology were increased/reduced by 20%, 40% and 60%, as informed
by the ranges in Table 18.
Although our literature search found no published evidence on quality-of-life weights associated with
women of childbearing age undergoing hysterectomy in an emergency situation, it identified proxy utilities
associated with the health state of convalescence after hysterectomy in women with heavy menstrual
bleeding.142 In addition, the 2011 US MEPS143 had also available hysterectomy treatment information
and data on the generic quality of life Short Form questionnaire-12 items144 that we translated into
EQ-5D-3L utility values using a validated a mapping algorithm.145 We evaluated the robustness of our
original base-case utility estimates running the economic model using these two additional sources of
utility information.
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Results
Base-case summary results
Table 19 presents a summary of the base-case probabilistic analysis ranking all interventions in ascending
order of costs. Both pelvic vessel ligation and rFVIIa were dominated strategies (more expensive and
produce fewer QALYs/avoid fewer hysterectomies) by interventional radiology and uterine compression
sutures. Therefore, pelvic vessel ligation and rFVIIa were removed and not evaluated further in the base
case with the incremental analysis comparing interventional radiology versus uterine compression sutures.
The interventional radiology strategy was more expensive but also produced more QALYs than uterine
compression sutures, with an estimated incremental cost of £2827 (95% non-parametric CI £1909 to
£3948) and incremental QALYs of 0.013 (95% CI –0.006 to 0.032). The ICER representing the value of the
additional benefit of interventional radiology compared with uterine compression sutures was estimated to
be £210,585 per QALY gained. This indicates that for current NICE thresholds of WTP for QALY gained,
interventional radiology does not represent a good use of NHS resources. This was also corroborated by
the results of the net monetary benefit analysis that indicated uterine compression sutures had the largest
monetary benefit of £12,843, assuming a WTP of £20,000 per QALY gained. Similar results were obtained
using hysterectomies avoided as the main outcome measure but in this case, interventional radiology had
an estimated ICER of £37,533 per hysterectomy avoided.
Analysis of uncertainty
The CEACs associated with uterine compression sutures and interventional radiology, using QALYs or
hysterectomy avoided as measures of outcome in the economic evaluation, are presented in Figure 5.
Using QALYs, the use of uterine compression sutures as a second-line treatment strategy always had a
higher probability of being cost-effective than interventional radiology for any value of WTP for QALY
gained. When using hysterectomy avoided as the outcome measure, interventional radiology had a higher
probability of being cost-effective than uterine compression sutures at values of WTP > £30,000 per
hysterectomy avoided.
The results of the analysis of covariance suggested that the probability of success after uterine compression
sutures had the largest contribution to the uncertainty around incremental costs explaining 71.7% of the
variability of incremental costs and 19.8% of the variability in incremental QALYs. The utility estimate
associated with the hysterectomy state contributed to 44.7% of the variability of the incremental QALYs.
The remaining parameters did not contribute greatly to the uncertainty around cost-effectiveness results.
Sensitivity analysis
Reducing or increasing uterine compression suture costs by 20%, 40% or 60% did not affect the baseline
cost-effectiveness results and uterine compression sutures were still the most cost-effective option for any
threshold of WTP. A similar output was obtained when the costs of pelvic vessel ligation and rFVIIa were
reduced/increased. Increasing the costs of interventional radiology improved the cost-effectiveness of
uterine compression sutures to an almost asymptotic CEAC towards a probability of 1. However, if the
costs of interventional radiology were reduced by 40%, it became the most cost-effective intervention for
thresholds of WTP > £19,000 per QALY gained but asymptotically to a maximum probability of 70%.
Interventional radiology became the most cost-effective intervention for any threshold of WTP per QALY
gained if the costs of interventional radiology were reduced by 60%.
The CEACs of uterine compression sutures compared with interventional radiology using alternative utility
estimates to inform the quality-of-life weights associated with women undergoing hysterectomy in an
emergency situation suggest little impact on cost-effectiveness results compared with the base-case analysis.
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FIGURE 5 Cost-effectiveness acceptability curves indicating the probability that uterine compression sutures or
interventional radiology is cost-effective for different values of WTP for health gained. (a) QALYs as the measure
of outcome; and (b) hysterectomy avoided as the measure of outcome.
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Conclusions and implications for practice and service provision
In this study we have synthesised evidence on treatment effect, intervention costs and health-related
quality of life using data from UKOSS and the literature of the main four second-line strategies for the care
of PPH using a decision-analytic model (see Results).
This study suggested that, given the available evidence, use of uterine compression sutures was the most
cost-effective strategy when compared with interventional radiology. Interventional radiology was more
effective than uterine compression sutures but significantly more expensive, and both pelvic vessel ligation
and rFVIIa were dominated strategies, indicating that they were less effective and more expensive than
both uterine compression sutures and interventional radiology. Note, however, that this analysis was
limited by the following factors: expert report and published sources (see Methods, Costs) were used to
derive health-care costs, as we were not able to collect information from women directly about resource
use, and utility estimates were based on data from general population studies of women post
hysterectomy, rather than women specifically undergoing postpartum hysterectomy.
The sensitivity analysis suggested that the base-case results were robust to changes in the costs of uterine
compression sutures, pelvic vessel ligation and rFVIIa. However, if the costs of interventional radiology were
significantly reduced (e.g. as might be the case in hospitals already providing a 24-hour radiology service),
it would become the most cost-effective intervention for the NHS. The evidence on health-related quality
of life associated with health states in women of childbearing age undergoing hysterectomy in an
emergency situation, as informed by our literature search, was limited. We used different proxy utility
weights to inform this parameter in the model and the sensitivity analysis suggested that the base-case
results were robust using different sources of utility information.
The treatment effect used to inform the effectiveness parameters in the model was estimated using logistic
regression. Although we controlled for women’s characteristics and mode of delivery in the regression, it is
likely that we have not removed confounding completely in this analysis. Residual confounding is a widely
known, recognised problem when using observational data to estimate treatment effects.146 It is possible
that women treated with compression sutures were different in unmeasured ways from those treated with
interventional radiology, pelvic vessel ligation and rFVIIa, and this is an important limitation in the study.
Nevertheless, in the absence of RCTs, UKOSS was one of the best sources available to determine treatment
effect of the treatments. This analysis would be strengthened by a systematic review of the literature to
identify any other sources of data with which to estimate treatment effects. To recognise the current
uncertainty associated with the estimates of treatment effect, we used the empirical distribution of the
ORs obtained from the data using bootstrapping in the PSA. We also implemented a log-normal
distribution (data not reported) to inform the uncertainty around this parameter but the main base-case
cost-effectiveness results did not vary.
Only direct health-care costs associated with the second-line interventions were included in the model.
We excluded any other health-care costs based on the premise that they were similar across interventions
but also because of lack of follow-up resource-use and cost data available either from our work or the
literature. In addition, possible costs to the extended family in terms of indirect costs were also omitted in
our study. Future work should assess how our results would change if any of these resources were
incorporated in the model if new evidence becomes available. These data items represent the key ones
that should be considered as additional items in any future UKOSS observational studies comparing
different treatment modalities for severe maternal morbidities.
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The analysis of covariance results identified the probability of successful uterine compression sutures
and the quality-of-life weight associated with the hysterectomy health state as the main parameters with
the largest contribution to the uncertainty in incremental costs and QALYs of the main comparison
between uterine compression sutures and interventional radiology. Prospective work should evaluate what
additional research and funding would be necessary to reduce the uncertainty around these parameters
using value-of-information methods.
The analytical techniques used here provide a model for the future of evidence synthesis using a
decision-analytic model to conduct an economic evaluation in a situation in which RCTs are challenging;
however, further work is required to strengthen the fundamental inputs into the analytical model.
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Chapter 6 Factors associated with
disease progression
Background
The UK led the world in the development of confidential enquiries into maternal deaths. Since the
introduction of these confidential enquiries, maternal mortality has decreased 10-fold.1 Data from UKOSS
studies have been used to provide contextual information about underlying maternal morbidity to
complement the detailed examination of mortality,3 but formal comparison between the information
concerning women who suffered near-miss maternal morbidity and those who died from the same
conditions had not been undertaken. The aim of this comparison was to quantify the risks associated with
identified factors in order to inform policy and practice to improve survival. This workstream undertook this
comparison through two studies.
The initial study compared data on women who died from specific maternal conditions obtained from the
UK Confidential Enquiries into Maternal Deaths undertaken through the Centre for Maternal and Child
Enquiries (CMACE) from 2003 to 20083,100 with UKOSS data and identified four maternal characteristics
(age ≥ 35 years, obesity, belonging to unemployed or manual socioeconomic groups, and black Caribbean
and African ethnic backgrounds) to be associated with progression from severe morbidity to death.
However, the data available for women who died limited detailed investigation of factors potentially
underlying these associations, in particular medical comorbidities, substance misuse, inadequate antenatal
care and problems during current and previous pregnancies. Therefore, a subsequent unmatched
case–control study further investigated the potential role of these factors in the progression from severe
morbidity to direct maternal death among pregnant women in the UK using new and more detailed data
on maternal deaths.
Research questions
l What are the characteristics of women with fatal and non-fatal specific severe maternal morbidities?
l What factors are associated with maternal death, including core demographic and pregnancy
characteristics (such as maternal age, ethnicity, socioeconomic and smoking status, BMI, parity, multiple
pregnancy, inadequate use of antenatal care, pre-existing medical conditions and current and previous
pregnancy problems)?
Methods
Data sources
Centre for Maternal and Child Enquiries/UK Obstetric Surveillance
System study
Information about women who died from specific causes (AFLP, antenatal pulmonary embolism, AFE,
antenatal thromboembolic and haemorrhagic stroke, eclampsia) identified through the maternal deaths
enquiry conducted by CMACE (2003–8)3,100 was compared with information on women with near-miss
morbidity from the same conditions identified through UKOSS studies of near-miss morbidity.28–30,74
The methodology of the confidential enquiries into maternal deaths conducted through CMACE has been
described in detail previously.3,100 In summary, cases of maternal death were reported to CMACE through
several different sources and, in addition, ascertainment of cases was undertaken through linkage of
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routine birth and death vital statistics records. Cases of maternal death from eclampsia, antenatal
pulmonary embolism, AFE, AFLP and antenatal stroke occurring between 2003 and 2008 were identified
by interrogating the CMACE database and contacting the clinicians on the confidential enquiry panel
responsible for assessing the cause of death where the exact cause of death was unclear in the database.
The UKOSS methodology is described in Chapter 3.
Mothers and Babies: Reducing Risk through Audits and Confidential
Enquiries across the UK/UK Obstetric Surveillance System study
The second study used data from the more recent confidential enquiries into maternal death (2009–12)
conducted through Mothers and Babies: Reducing Risk through Audits and Confidential Enquiries across
the UK (MBRRACE-UK)2 and data on severe life-threatening complications from the UKOSS (2005–13), to
investigate the association of medical comorbidities, current and previous pregnancy problems, substance
misuse and inadequate use of antenatal care with direct maternal deaths in the UK. Five major causes of
direct maternal deaths in the UK – eclampsia, pulmonary embolism, severe sepsis, AFE and peripartum
haemorrhage – for which data were available from both databases, were included in this analysis.
Confidential enquiries into maternal deaths in the UK occurring since 2009 have been undertaken through
the MBRRACE-UK collaboration.2,147 Deaths of women during or after pregnancy are identified through a
variety of sources, the majority being notified to the MBRRACE-UK office directly from the unit in which
the maternal death occurred. Other sources include coroners/procurators fiscal or pathologists, local
supervising authority midwifery officers, members of the public and inquest reports from the media.
In addition, case ascertainment is cross-checked with routine birth and death vital statistics records from
the ONS and the National Records of Scotland. For every death reported, basic demographic and clinical
details are collected.
Analyses
Centre for Maternal and Child Enquiries/UK Obstetric Surveillance
System study
Four hundred and seventy-six women who suffered from eclampsia, antenatal pulmonary embolism,
AFE, AFLP and antenatal stroke, but survived, were compared with 100 women who died from the
same conditions.
In order to investigate trends in continuous variables, unadjusted relative risks with 95% CIs were
calculated across groups and Spearman’s rank-order correlation was used to examine the associations
between age and BMI and the risk of death. We further investigated the potential factors underlying
mortality differences in severe maternal morbidities by using a logistic regression analysis. Factors were
included if there was a pre-existing hypothesis or evidence to suggest that they may be associated with
maternal mortality. In order to adjust for any effect relating to the individual morbidities, we included an
adjustment factor for each condition in the analysis. We developed a full regression model by including
both potential explanatory and confounding factors. We tested continuous variables for departure
from linearity by the addition of quadratic terms to the model and subsequent likelihood ratio testing.
There was no evidence of departure from linearity. We calculated aORs with 95% CIs.
The factors included in the model were maternal age, parity, BMI, smoking during pregnancy, ethnicity
and socioeconomic classification based on occupation. Data about the coexisting medical conditions of
women who died were not included in the CMACE database for the entire time period and, thus, we
could not robustly examine any putative association with maternal medical comorbidities. Occupation was
classified according to the ONS socioeconomic classification,148 on the basis of the woman’s occupation,
unless she was not in paid employment in which case the occupation of her partner was used. Ethnicity
was categorised according to the UK census classification.149
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Data were missing for ethnicity and BMI for between 12% and 23% of women who died. We investigated
two different methods of analysis to account for this. In a first analysis we included all participants, with
creation of a categorical indicator variable for missing responses (missing indicator). The second analysis
included all participants with missing responses by using multiple imputation. Missing data for BMI, type of
employment, age, parity, smoking and ethnicity were imputed using chained equations.150,151 The multiple
imputation prediction model included all variables in the conceptual framework. In addition, indicator
variables for the following characteristics were included in the prediction model – cause of death or
morbidity and route of recruitment into the analysis (CMACE or UKOSS). Twenty imputed data sets were
created and analysed together. Standard logistic regression models were fitted using Stata 10. The
imputed data sets were analysed in Stata 10 using the ice suite of commands.150
We assessed the additive effect of the presence of multiple risk factors on the risk of death in a model
including all factors found to be significantly associated. Because of the limited statistical power of the
study, binary variables were used for all maternal characteristics, using standard cut-off points ensuring that
groups were not too small to provide unstable estimates. The final model included maternal age ≥ 30 years,
BMI ≥ 30 kg/m,2 black Caribbean or African ethnicity, and unemployed, routine or manual occupation.
We used Stata 10 software for all analyses.
Mothers and Babies: Reducing Risk through Audits and Confidential
Enquiries across the UK/UK Obstetric Surveillance System study
One hundred and thirty-five women who died from five conditions (eclampsia, pulmonary embolism,
severe sepsis, AFE and peripartum haemorrhage) and 1661 women who suffered one of these five
conditions but survived were compared using a multivariable logistic regression model. Fourteen known
risk factors for severe maternal morbidity and mortality were included as independent variables: gestational
diabetes, hypertensive disorders of pregnancy during the current pregnancy, anaemia, multiple pregnancy,
inadequate use of antenatal care services, smoking, substance misuse, previous pregnancy problems,
pre-existing medical conditions, parity, BMI, employment status, maternal age and ethnicity.32,152–155
Women were categorised as having gestational diabetes, hypertensive disorders of pregnancy and anaemia
during the current pregnancy, based on clinician-recorded conditions in the medical records. The variable
‘ethnicity’ was categorised according to the UK national census classification.149 Maternal age, BMI and
parity were each categorised into three groups.156–159 In order to compare the findings with that of the
previous study,160 we also categorised parity and BMI into binary variables and recategorised age and
tested these in a separate regression model. Medical comorbidities were grouped initially as a single
variable and subsequently into 18 categories (Box 3). This study had 80% power to detect an OR of ≥ 1.6
of maternal death at a significance level of p< 0.05 (two-sided) associated with the presence of medical
comorbidities, which had a prevalence of 29% in the survivors.
We further investigated the role of medical comorbidities by examining different subgroups of comorbidity.
We conducted univariable analyses to assess the association of the 18 specific pre-existing medical
comorbidities with the outcome. Thirteen variables found to be associated with the outcome at p< 0.05
(two-tailed) and those identified as important factors associated with maternal morbidity and mortality in
previous literature were included in a second multivariable logistic regression model (model 2). This was
followed by an additional exploratory regression analysis to examine the factors that were associated with
medical comorbidities in the study population.
A ‘risk factors’ score was generated to understand the additive odds associated with the presence of one
or more factors that were found to be statistically significantly associated with maternal death. Using the
same method as in the CMACE/UKOSS study, we assigned a score of one to each factor (see Analysis,
Centre for Maternal and Child Enquiries/UK Obstetric Surveillance System study). We also calculated the
population attributable fraction (PAF) for the ‘risk factors’ score and the individual factors using standard
methods for calculating PAF in case–control studies.161 All analyses were performed using Stata 13.
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BOX 3 Pre-existing medical conditions
Asthma.
Autoimmune diseases (e.g. systemic lupus erythematosus).
Known malignancies.
Cardiac problems (congenital and acquired).
Diabetes mellitus (type 1 or 2).
Diseases caused by blood-borne viruses (e.g. HIV and hepatitis B and C).
Endocrine disorders, excluding diabetes mellitus (e.g. hypothyroidism and hyperthyroidism).
Renal problems (e.g. pyelonephritis, nephrectomy and recurrent UTI).
Neurological disorders (e.g. migraine).
Mental health problems.
Haematological disorders (e.g. thalassemia, sickle cell anaemia, iron deficiency anaemia and
procoagulant states).
Epilepsy.
Inflammatory disorders and allergic/atopic conditions (e.g. eczema and ulcerative colitis).
Essential hypertension.
Thrombotic events.
Musculoskeletal disorders (e.g. osteoarthritis and hip replacement).
Other infections, excluding blood-borne viruses (e.g. sexually transmitted infections, tuberculosis and group B
streptococcal infection).
Treated for infertility.
HIV, human immunodeficiency virus.
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Results
Maternal characteristics associated with death during pregnancy
and childbirth
Increasing maternal age and BMI were significantly associated with the risk of death in the CMACE/UKOSS
analysis (Figure 6). Results from the multivariable models are presented in Table 20. The final model using
a missing indicator analysis produced very similar effect estimates to those from the multiple imputation
analysis. Women who were ≥ 30 years, black Caribbean or African, unemployed or with routine or manual
occupation had higher odds of progressing to death. Women who had a BMI ≥ 30 kg/m2 were more likely
to die from these severe maternal morbidities (aOR 1.71, 95% CI 0.91 to 3.19), although the increased
odds were not statistically significant.
Analysis of the combined effects of the risk factors present showed that the odds of death associated with
these severe maternal morbidities increased progressively in the presence of more than one of the risk
factors identified (Table 21), although of note was the high degree of uncertainty around the estimated
odds associated with the presence of all four risk factors.
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FIGURE 6 Risk of death according to (a) age; and (b) BMI. Bars show risks with 95% CIs.
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TABLE 20 Factors associated with the odds of death from specific causes of maternal morbidity
Factor
Maternal deaths,
n (%) (N= 100)
Survivors,
n (%) (N= 476)
Crude ORa
(95% CI)
aOR,a missing
indicator model
(95% CI)
aOR,a multiple
imputation
model (95% CI)
Age (years)
< 30 32 (32) 269 (57) 1 1 1
30–34 40 (40) 120 (25) 2.80
(1.68 to 4.68)
2.89
(1.56 to 5.36)
2.58
(1.36 to 4.90)
≥ 35 27 (27) 85 (18) 2.67
(1.51 to 4.71)
2.04
(1.01 to 4.11)
2.36
(1.22 to 4.56)
Missing 1 (1) 1 (0)
Parity
Nulliparous 46 (46) 286 (60) 1 1 1
Multiparous 53 (53) 189 (40) 1.74
(1.13 to 2.70)
0.75
(0.44 to 1.28)
0.76
(0.45 to 1.29)
Missing 1 (1) 1 (0)
Ethnicity
White 65 (64) 352 (74) 1 1 1
Black Caribbean
and African
19 (20) 45 (9) 2.44
(1.34 to 4.44)
2.40
(1.14 to 5.06)
2.38
(1.15 to 4.92)
Other minority
ethnic groups
15 (15) 72 (15) 1.20
(0.64 to 2.23)
1.16
(0.54 to 2.51)
1.31
(0.65 to 2.76)
Missing 1 (1) 7 (1)
BMI (kg/m2)
< 30 53 (53) 327 (67) 1 1 1
≥ 30 24 (24) 84 (18) 1.83
(1.06 to 3.14)
1.57
(0.83 to 2.97)
1.71
(0.91 to 3.19)
Missing 23 (23) 65 (14)
Occupational classification
Managerial 20 (25) 113 (24) 1 1 1
Intermediate
occupation
19 (23) 101 (21) 1.06
(0.54 to 2.10)
1.41
(0.65 to 3.07)
1.33
(0.59 to 2.95)
Manual or
unemployed
42 (52) 207 (43) 1.14
(0.64 to 2.05)
2.33
(1.13 to 4.80)
2.19
(1.03 to 4.68)
Missing 19 (19) 55 (12)
Smoking during pregnancy
Yes 13 (14) 89 (19) 0.67
(0.35 to 1.26)
0.62
(0.29 to 1.32)
0.58
(0.27 to 1.26)
No 82 (86) 376 (79) 1 1 1
Missing 5 (5) 9 (2)
a Odds of death.
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Role of medical comorbidities and other factors associated with direct
maternal deaths
Medical comorbidities were found to be significantly associated with direct maternal deaths from
eclampsia, pulmonary embolism, severe sepsis, AFE and peripartum haemorrhage, after controlling for a
number of known risk factors for maternal mortality (Table 22). The adjusted odds of having pre-existing
medical conditions were almost fivefold higher among women who died than women who survived
(aOR 4.82, 95% CI 3.14 to 7.40). In addition, we also found substance misuse (aOR 10.16, 95% CI 1.81
to 57.04), inadequate use of antenatal care (aOR 15.87, 95% CI 6.73 to 37.41), previous pregnancy
problems (aOR 2.21, 95% CI 1.34 to 3.62), hypertensive disorders of pregnancy during current pregnancy
(aOR 2.44, 95% CI 1.31 to 4.52) and Indian ethnic background (aOR 2.70, 95% CI 1.14 to 6.43) to be
independently associated with maternal deaths (see Table 22). At a population level, 70% (95% CI 66%
to 73%) of the increased risk could be attributed to these six factors, the most important being medical
comorbidities (PAF 48.9%, 95% CI 40.5% to 56.2%) followed by previous pregnancy problems,
hypertensive disorders of pregnancy, inadequate use of antenatal care services, Indian ethnicity and
substance misuse (see Table 24).
TABLE 21 Odds ratio associated with death in cases of severe maternal morbidity according to the number of risk
factors present
Number of risk factors present OR (95% CI)
0 1
1 1.35 (0.67 to 2.75)
2 2.77 (1.33 to 5.76)
3 4.40 (1.76 to 11.0)
4 8.45 (0.49 to 149)
Risk factors included age ≥ 30; unemployment, routine or manual occupation; black Caribbean or African ethnicity; and
BMI ≥ 30 kg/m2.
TABLE 22 Factors associated with maternal death from direct pregnancy complications
Risk factors
Cases, n (%)
(N= 135)
Controls, n (%)
(N= 1661) uOR (95% CI) aORa (95% CI)
Age (years)
< 20 7 (5.2) 105 (6.3) 0.83 (0.37 to 1.84) 0.76 (0.29 to 2.03)
20–34 84 (62.2) 1044 (62.9) 1 1
≥ 35 44 (32.6) 512 (30.8) 1.06 (0.73 to 1.56) 0.94 (0.60 to 1.48)
Parity
Nulliparous 49 (36.3) 692 (41.7) 0.81 (0.55 to 1.19) 1.05 (0.62 to 1.78)
1–3 61 (45.2) 697 (41.9) 1 1
> 3 23 (17.0) 269 (16.2) 0.98 (0.59 to 1.61) 0.79 (0.43 to 1.43)
Missing 2 (1.5) 3 (0.2) 7.62 (1.25 to 46.46) 1.22 (0.02 to 67.56)
continued
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TABLE 22 Factors associated with maternal death from direct pregnancy complications (continued )
Risk factors
Cases, n (%)
(N= 135)
Controls, n (%)
(N= 1661) uOR (95% CI) aORa (95% CI)
BMI (kg/m2)
< 18.5 6 (4.4) 45 (2.7) 1.83 (0.76 to 4.41) 1.56 (0.57 to 4.28)
18.5–30 84 (62.2) 1152 (69.4) 1 1
≥ 30 35 (25.9) 325 (19.6) 1.48 (0.98 to 2.23) 1.05 (0.66 to 1.70)
Missing 10 (7.4) 139 (8.3) 0.99 (0.50 to 1.95) 0.35 (0.13 to 0.94)
Multiple pregnancy
No 129 (95.5) 1588 (95.6) 1 1
Yes 4 (3.0) 73 (4.4) 0.67 (0.24 to 1.87) 0.67 (0.22 to 2.01)
Missing 2 (1.5) 0 (0.0) Omitted
Gestational diabetes
No 118 (87.4) 1605 (96.6) 1 1
Yes 8 (5.9) 50 (3.0) 2.18 (1.01 to 4.70) 1.43 (0.59 to 3.44)
Missing 9 (6.7) 6 (0.4) 20.40 (7.14 to 58.29)
Hypertensive disorders of pregnancy
No 106 (78.5) 1555 (93.6) 1 1
Yes 20 (14.8) 100 (6.0) 2.93 (1.75 to 4.93) 2.44 (1.31 to 4.52)
Missing 9 (6.7) 6 (0.4) 22.0 (7.69 to 62.98)
Anaemia
No 123 (91.1) 1632 (98.2) 1 1
Yes 3 (2.2) 23 (1.4) 1.73 (0.51 to 5.84) 2.39 (0.60 to 9.47)
Missing 9 (6.7) 6 (0.4) 19.90 (6.97 to 56.82)
Inadequate utilisation of antenatal careb
No 106 (78.5) 1637 (98.6) 1 1
Yes 21 (15.6) 18 (1.1) 18.02 (9.32 to 34.84) 15.87 (6.73 to 37.41)
Missing 8 (5.9) 6 (0.3) 20.59 (7.02 to 61.43)
Smoking status
Non-smoker 95 (70.4) 1285 (77.4) 1 1
Smoker 27 (20.0) 346 (20.8) 1.05 (0.68 to 1.64) 0.79 (0.45 to 1.39)
Missing 13 (9.6) 30 (1.8) 5.86 (2.96 to 11.61) 2.92 (0.93 to 9.14)
Substance misuse
No 123 (91.1) 1651 (99.4) 1 1
Yes 6 (4.4) 4 (0.2) 20.13 (5.61 to 72.29) 10.16 (1.81 to 57.04)
Missing 6 (4.4) 6 (0.4) 13.42 (4.27 to 42.24) 2.94 (0.19 to 47.67)
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TABLE 22 Factors associated with maternal death from direct pregnancy complications (continued )
Risk factors
Cases, n (%)
(N= 135)
Controls, n (%)
(N= 1661) uOR (95% CI) aORa (95% CI)
Previous pregnancy problemsc
No 76 (56.3) 1247 (75.1) 1 1
Yes 56 (41.5) 407 (24.5) 2.26 (1.57 to 3.25) 2.21 (1.34 to 3.62)
Missing 3 (2.2) 7 (0.4) 7.03 (1.78 to 27.73) 0.25 (0.01 to 5.32)
Pre-existing medical problemsd
No 37 (27.4) 1175 (70.7) 1 1
Yes 93 (68.9) 481 (29.0) 6.14 (4.13 to 9.12) 4.82 (3.14 to 7.40)
Missing 5 (3.7) 5 (0.3) 31.76 (8.81 to 114.45) 18.93 (1.63 to 220.32)
Employment status
Employed 91 (67.4) 1211 (72.9) 1 1
Unemployed 17 (12.6) 188 (11.3) 1.20 (0.70 to 2.07) 1.27 (0.65 to 2.47)
Missing 27 (20.0) 262 (15.8) 1.37 (0.87 to 2.15) 0.81 (0.44 to 1.51)
Ethnicity
White European 88 (65.2) 1226 (73.8) 1 1
Indian 8 (5.9) 47 (2.8) 2.37 (1.09 to 5.17) 2.70 (1.14 to 6.43)
Pakistani 7 (5.2) 73 (4.4) 1.34 (0.60 to 2.99) 2.10 (0.86 to 5.11)
Bangladeshi 2 (1.5) 39 (2.4) 0.71 (0.17 to 3.01) 1.21 (0.27 to 5.45)
Other Asian 4 (3.0) 66 (4.0) 0.84 (0.30 to 2.37) 1.08 (0.36 to 3.27)
Black Caribbean 3 (2.2) 40 (2.4) 1.04 (0.32 to 3.45) 0.93 (0.24 to 3.64)
Black African 13 (9.6) 105 (6.3) 1.72 (0.93 to 3.19) 1.09 (0.51 to 2.31)
Other/mixed 10 (7.4) 65 (3.9) 2.14 (1.06 to 4.32) 1.46 (0.59 to 3.61)
a Model 1 includes all 14 variables specified in the table.
b Women who concealed pregnancy, were late bookers or did not receive minimal antenatal care.
c Women who were reported to have suffered from any pregnancy-related problem in a previous pregnancy, the major
categories of which included thrombotic events, placental problems, haemorrhage, pre-eclampsia, eclampsia and
puerperal psychosis.
d Women who were reported to have any medical comorbidity during current pregnancy including the 18 specific
conditions described in Box 3. Women were categorised as having gestational diabetes, hypertensive disorders of
pregnancy and anaemia based on clinician-recorded condition/s in the medical records.
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Eight out of the 18 medical comorbidities were significantly associated with maternal death (Table 23).
The odds of pre-existing musculoskeletal disorders was 12 times higher and the odds of inflammatory/
atopic disorders (excluding asthma) was 10-fold higher among women who died than women
who survived. Women who died had five times higher odds of suffering from autoimmune diseases and
infections, such as sexually transmitted infections, tuberculosis and group B Streptococcus infection,
fourfold higher odds of having a pre-existing haematological disorder and more than three times higher
odds of essential hypertension than the women who survived. The odds of suffering from mental health
problems and asthma were more than two times higher among women who died than women
who survived.
The odds associated with maternal death increased by more than three and a half times per unit increase
in the ‘risk factor’ score (aOR 3.59, 95% CI 2.83 to 4.56; p< 0.001), after controlling for other variables
that are not included in the score. On a population basis, 70% (95% CI 66% to 73%) of the increased
risk associated with maternal death could be attributed to the six identified factors, the most important
being medical comorbidities followed by previous pregnancy problems, hypertensive disorders of
pregnancy, inadequate use of antenatal care services and Indian ethnicity (Table 24).
TABLE 23 Medical comorbidities associated with maternal death from direct pregnancy complications
Risk factors Cases, n (%) (N= 135) Controls, n (%) (N= 1661) uOR (95% CI) aORa (95% CI)
Asthma
No 111 (82.2) 1562 (94.0) 1 1
Yes 19 (14.1) 94 (5.7) 2.84 (1.68 to 4.83) 2.36 (1.19 to 4.65)
Inflammatory disorders and allergic/atopic conditions (excluding asthma)
No 116 (85.9) 1645 (99.0) 1 1
Yes 14 (10.4) 11 (0.7) 18.05 (8.01 to 41.65) 9.79 (3.50 to 27.36)
Haematological disorders
No 117 (86.7) 1617 (97.4) 1 1
Yes 13 (9.6) 39 (2.3) 4.61 (2.39 to 8.87) 4.29 (1.88 to 9.76)
Infertility
No 122 (90.4) 1640 (98.7) 1 1
Yes 8 (5.9) 16 (1.0) 6.72 (2.82 to 16.02) 3.08 (0.87 to 10.84)
Neurological disorders
No 125 (92.6) 1650 (99.3) 1 1
Yes 5 (3.7) 6 (0.4) 11.00 (3.31 to 36.55) 3.83 (0.71 to 20.74)
Musculoskeletal disorders
No 120 (88.9) 1648 (99.2) 1 1
Yes 10 (7.4) 8 (0.5) 17.17 (6.65 to 44.30) 12.65 (3.56 to 44.98)
Mental health problems
No 110 (81.5) 1585 (95.4) 1 1
Yes 20 (14.8) 71 (4.3) 4.06 (2.38 to 6.91) 2.63 (1.28 to 5.44)
Infection (other than blood-borne viruses)
No 122 (90.4) 1646 (99.1) 1 1
Yes 8 (5.9) 10 (0.6) 10.79 (4.18 to 27.84) 5.31 (1.63 to 17.23)
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TABLE 23 Medical comorbidities associated with maternal death from direct pregnancy complications (continued )
Risk factors Cases, n (%) (N= 135) Controls, n (%) (N= 1661) uOR (95% CI) aORa (95% CI)
Essential hypertension
No 122 (90.4) 1626 (97.9) 1 1
Yes 8 (5.9) 30 (1.8) 3.55 (1.59 to 7.92) 3.35 (1.25 to 9.00)
Thrombotic event
No 125 (92.6) 1640 (98.7) 1 1
Yes 5 (3.7) 16 (1.0) 4.10 (1.48 to 11.38) 2.74 (0.68 to 11.08)
Autoimmune diseases
No 125 (92.6) 1637 (98.6) 1 1
Yes 5 (3.7) 19 (1.1) 3.45 (1.27 to 9.38) 5.16 (1.63 to 16.39)
Cardiac disease (congenital or acquired)
No 126 (93.3) 1632 (98.3) 1 1
Yes 4 (3.0) 24 (1.4) 2.16 (0.74 to 6.32) 1.32 (0.34 to 5.15)
Diabetes mellitus
No 127 (94.1) 1641 (98.8) 1 1
Yes 3 (2.2) 15 (0.9) 2.58 (0.74 to 9.04) 2.09 (0.50 to 8.79)
Blood-borne viruses
No 127 (94.1) 1644 (99.0) 1
Yes 3 (2.2) 12 (0.7) 3.24 (0.90 to 11.62) Excluded
Renal problems
No 126 (93.3) 1629 (98.1) 1
Yes 4 (3.0) 27 (1.6) 1.92 (0.66 to 5.56) Excluded
Endocrine disorders
No 127 (94.1) 1625 (97.8) 1
Yes 3 (2.2) 31 (1.9) 1.24 (0.37 to 4.11) Excluded
Known malignancies
No 129 (95.6) 1650 (99.3) 1
Yes 1 (0.7) 6 (0.4) 2.13 (0.25 to 17.84) Excluded
Epilepsy
No 130 (96.3) 1642 (98.9) 1
Yes 0 (0.0) 14 (0.8) 1 (omitted) Excluded
a Adjusted for 13 of the 18 medical conditions listed in the table and all variables included in Table 22, except
‘pre-existing medical conditions’. Five medical comorbidities were excluded from the adjusted model because they were
not found to be significantly associated with the outcome at p< 0.05 after univariable analysis: blood-borne viruses,
renal problems, endocrine disorders, known malignancies and epilepsy. Diabetes mellitus and cardiac disease were
retained in the model because these are known important risk factors for maternal morbidity and mortality.
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Conclusions and implications for policy and practice
The most recent UK Confidential Enquiries into maternal deaths (2009–12) showed that while direct
maternal deaths related to obstetric causes have significantly decreased over the last 10 years, deaths due
to indirect medical causes outnumber direct deaths by two to one and have remained unchanged since
2000–2.2 We found six factors to be associated with maternal death from direct pregnancy complications
after adjustment: inadequate use of antenatal care, substance misuse, medical comorbidities, hypertensive
disorders of pregnancy, previous pregnancy problems and Indian ethnicity. Together, these account for
70% of the increased population risk. Belonging to other ethnic minority backgrounds was also associated
with increased odds of death but the ORs were not statistically significant, possibly because of a smaller
number of cases in each of these groups resulting in low statistical power. Specific medical comorbidities,
including asthma, autoimmune diseases, inflammatory/atopic disorders, mental health problems, essential
hypertension, haematological disorders, musculoskeletal disorders and infections were found to be
associated with a higher risk of dying from the conditions included in this study. Medical comorbidities
accounted for half of the increased risk of fatality in the study population.
Several studies have demonstrated individual medical comorbidities, such as pre-existing asthma,
hypertension, malignancy, chronic ischaemic and congenital heart disease, chronic renal disease, systemic
lupus erythematosus, hypercoagulability states, human immunodeficiency virus and diabetes mellitus, to be
associated with both severe maternal morbidity and mortality,25,153,162–168 but the extent of the population
risk attributable to medical comorbidities as a whole in the UK has not previously been quantified. Uptake
of antenatal care was found to be poorer among women with medical comorbidities in our study
population, which could increase the adverse effects associated with these conditions. Our findings
suggest that the association of older maternal age and obesity with increased odds of dying observed in
the CMACE/UKOSS study160 could be mediated to some extent through medical comorbidities. Unlike
other studies,25,153 we did not find pre-existing diabetes mellitus and cardiac conditions to be associated
with maternal death. Whether or not this reflects improved obstetric care of women with diabetes and
cardiac disease is unclear and requires further research.
Hypertension during pregnancy has been shown in other analyses to be associated with an increased risk
of intracerebral haemorrhage, eclampsia or end-organ dysfunction culminating in death.169–172 Studies from
different parts of the world, including the UK, show a higher risk of mortality among women who do not
receive adequate antenatal care.156,169,171,173 Although there is a debate about the role of antenatal
care in preventing maternal deaths caused by acute conditions that emerge close to the time of delivery,
its role in identifying pregnant women at high risk (such as women with hypertensive disorders, medical
comorbidities, anaemia and infections) and lowering their risk of mortality is widely accepted.174
TABLE 24 The PAFs for specific associated factors
Risk factors PAF (%) 95% CI
‘Risk factors’ score 69.8 66.1 to 73.0
Specific factors
Medical comorbidities 48.9 40.5 to 56.2
Previous pregnancy problems 21.1 11.7 to 29.5
Hypertensive disorders of pregnancy 12.0 7.7 to 16.1
Inadequate use of antenatal care 10.5 9.7 to 11.4
Indian ethnicity 2.9 0.3 to 5.5
Substance misuse 1 0.03 to 1.4
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Confidential enquiries into maternal deaths in the UK have identified that a number of women who die
during or after pregnancy are substance misusers, although the association with maternal death has not
been formally quantified before now.100 Studies have shown that women who suffered problems during a
previous pregnancy were more likely to develop severe morbidity in subsequent pregnancies.4,154,175 There is
mixed evidence about ethnic inequalities in maternal death. Although our first study160 found an association
with black African and Caribbean ethnicity in the UK, Geller et al.9 did not find any association with minority
ethnicity in the USA. Among the ethnic minority groups examined in this study, the association with maternal
death was higher among the Indian group, but only for sepsis and haemorrhage. This is likely to explain the
difference between our findings and the previous UK study, which did not include these conditions.160
Although factors such as pre-existing medical conditions, previous pregnancy problems and being of Indian
origin cannot be altered, their adverse consequences can be potentially minimised through extra vigilance
and proactive management.
The messages from this study can be used to inform actions to reduce maternal mortality throughout the
developed world. Ongoing high-quality national surveillance programmes still have an important role to
play in addressing new challenges in maternal health and care. Women from vulnerable populations in
high-resource countries remain at increased risk of maternal death in the presence of severe maternal
morbidities. This national study has identified six risk factors associated with maternal death from direct
pregnancy complications: inadequate use of antenatal care services; substance misuse; medical
comorbidities; hypertensive disorders of pregnancy; previous pregnancy problems; and Indian ethnicity.
As noted earlier, maternal deaths arising from indirect (medical) causes now outnumber direct deaths
arising from obstetric causes in most high-resource countries, with mortality rates either remaining static
or increasing.2,101,156,176,177 This study shows that medical comorbidities are also important factors associated
with deaths arising from obstetric causes (direct deaths) in the UK; almost 50% of the population-
attributable risk is associated with the presence of medical comorbidities. This highlights the importance of
optimal care for women with pre-existing medical problems in pregnancy. Further studies are required to
understand whether or not specific aspects of care could be improved to reduce maternal deaths among
women with medical comorbidities.
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Chapter 7 Inequalities in severe maternal
morbidities: investigation of the roles of maternal
age, ethnic group and socioeconomic status
Background
The characteristics of women giving birth are changing. Women are, on average, older, more likely to have
been born outside the UK and more likely to suffer from pre-existing medical conditions than in the past.
In addition, the impact of technologies such as IVF with ovum donation may contribute to an increasing
incidence of pregnancies in women outside the normal reproductive age.
Addressing inequalities in health is an important aspect of public health policy in the UK, including a call
for specific action to improve the quality of antenatal care.19 Identifying and describing such inequalities is
an important first step in developing strategies to address them.19 An analysis of rates of selected near-miss
morbidities identified through UKOSS has shown important inequalities in the occurrence of these
disorders in ethnic minority women.158 However, this study, because of its relatively small size, was not able
to investigate in-depth potential causes for the observed differences between individual minority groups,
only between ethnic minority women as a whole and white women. Recent work has also suggested
poorer outcomes of pregnancy in older women178 and an over-representation of socially disadvantaged
women among mothers who died.3 Infant mortality is known to be much higher among routine and
manual socioeconomic groups179,180 but social inequalities in near-miss maternal morbidity have not been
investigated on a national basis in the UK. The aim of this workstream was to identify and investigate
inequalities in maternal morbidity among specific population groups, with the aim of identifying actions to
address any inequality identified.
Research questions
l Are there differences in the incidence of near-miss maternal morbidity between women from different
age, socioeconomic and ethnic groups?
l What are the roles of differences in demographic, pregnancy-related and other factors, such as poor
attendance for antenatal care, in any differences observed?
l What near-miss maternal morbidities occur in women of ≥ 48 years giving birth in the UK? What
proportion of pregnancies in these women follow assisted reproductive technologies? How are these
women managed?
l What are the outcomes of pregnancy for women from different age, socioeconomic and
ethnic groups?
Methods
This workstream investigated inequalities in maternal morbidity in three specific groups: older mothers,
women from routine and manual socioeconomic groups, and ethnic minority women. Information about
the entire cohort of women with near-miss morbidity identified through UKOSS was analysed to determine
rates of near-miss morbidity and the outcomes within subgroups. In addition, a cohort study was
conducted, collecting information about all women ≥ 48 years of age delivering in the UK to describe
comprehensively the morbidities, their management and pregnancy outcomes within this group.
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Secondary data analysis
Two unmatched case–control analyses were conducted using existing UKOSS data collected between
February 2005 and January 2013 to examine the associations of ethnic and socioeconomic groups with
severe maternal morbidity in the UK. Two sets of cases and controls were used. Cases included in the
analysis of socioeconomic inequalities were women who suffered from one of the following six conditions
of severe maternal morbidity directly attributable to pregnancy causes: AFE,32 AFLP,30 eclampsia,28
peripartum hysterectomy,31 peripartum haemorrhage129 and uterine rupture.181 For the ethnic inequality
study, in addition to these six conditions, cases were included from a further five conditions: antenatal
pulmonary embolism,29 stroke in pregnancy,74 placenta accreta,72 HELLP syndrome54 and severe sepsis.99
These data sets represented the entirety of data available on direct maternal morbidities and control
women at the time the analyses were conducted. The controls were women who delivered immediately
before the cases in the same hospital.158 In total, 1144 cases and 2256 controls were included in the
socioeconomic inequality study182 and 1753 cases and 3310 controls were included in the ethnic
differences study.154 For the included sample sizes, assuming a prevalence of exposure of 1.1% (the
prevalence of the smallest ethnic minority group, the Bangladeshi group), the analysis had 80% power to
detect an OR of ≥ 1.8 associated with severe maternal morbidity at p< 0.05.
Maternal occupation (or husband’s/partner’s occupation if information about women’s occupational
status was not available) was used to categorise women into four socioeconomic groups: managerial/
professional, intermediate, routine/manual and unemployed (additional category), using the National
Statistics Socio-economic Classification.183 The ethnic groups were classified based on self-reported
ethnicity noted in medical records according to the UK national census classification.149 Potential
confounders were those that were adjusted for in previous studies – pregnancy-related factors such as
parity, problems during current and previous pregnancies, multiple pregnancy, medical comorbidities,
utilisation of antenatal care, maternal age, BMI and smoking status.152,155,158
Univariable analyses were conducted to assess the association of the exposure variables socioeconomic
status and ethnicity, and other independent variables with the outcome (severe maternal morbidity).
Multivariable unconditional logistic regression analyses were performed to control for confounders. For the
socioeconomic analysis, the potential confounders were added to a model that included the outcome and
socioeconomic status variable one at a time with subsequent likelihood ratio testing. All variables found to
be associated with the outcome at p< 0.05 (two-tailed) and those identified as important confounders
from the literature were included in the final model.
The multivariable models for ethnicity analysis included all variables that were found to be associated with
the outcome at p< 0.1 (two-tailed) in the univariable analyses and those identified as important potential
confounders in previous literature. Four models were built in a hierarchical fashion. Model 1 adjusted for
anaemia in current pregnancy, diabetes in current pregnancy, previous pregnancy problems, pre-existing
medical problems and parity. In model 2, smoking status and inadequate utilisation of antenatal care
services were added to the other variables. Model 3 included socioeconomic status in addition to those
variables included in model 2, and model 4 adjusted for all variables including women’s age and BMI. In
addition to controlling for the known risk factors, this approach enabled understanding of their effects on
the association between ethnicity and severe maternal morbidity.
Plausible interactions were tested by adding interaction terms and using LR-tests (p< 0.05) and no
significant interactions were identified. Information on ethnicity was not available for 1.8% of the sample.
Based on the method used in two previous studies, women with unknown ethnicity were included in the
‘white European’ group because the redistributed proportions matched more accurately with the estimated
ethnic profiles in the UK population census.158,184 Although for a majority of the independent variables the
number of participants with missing data was < 1% and their distribution did not differ significantly
between the cases and controls and among the ethnic groups, for four variables, ‘socioeconomic status’,
‘BMI’, ‘smoking’ and ‘previous pregnancy problems’, the proportion of participants with missing
information was > 1%. The data were assumed to be not missing at random and thus coded ‘missing’ as a
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separate group for these variables. In addition, a series of sensitivity analyses were performed by assuming
extreme scenarios and accordingly redistributing the missing observations into the extreme groups; this
had no material effect on the findings.
The continuous variables were tested for deviations from linearity,185 which showed non-linear associations
between the variables and the outcome. Thus, in the final model the variables were incorporated as
categorical variables for the ease of interpretation of the ORs and the advantage of including and testing
the missing data as a separate category. All analyses were carried out using Stata 11.
Primary data collection
A national, population-based cohort study was conducted using UKOSS as described in Chapter 3.
The cohort included any pregnant woman in the UK of ≥ 20 weeks’ gestation who was of very advanced
maternal age. Although very advanced maternal age has generally been used to refer to women aged
≥ 45 years, for pragmatic reasons so as to not overburden reporting clinicians, very advanced maternal age
was defined for our purposes as women aged ≥ 48 years at their date of delivery. The cohort was
identified through UKOSS between 1 July 2013 and 30 June 2014. The UKOSS reporting clinicians were
also asked to identify comparison women, defined as the two pregnant women of ≥ 20 weeks’ gestation
who were < 48 years of age at their estimated date of delivery and delivered immediately before the older
woman in the same hospital.
The ORs with 95% CIs were estimated throughout using unconditional logistic regression. ORs were
adjusted for factors if there was a pre-existing hypothesis or evidence that the factors were potential
confounders or mediators of the relationship between advanced maternal age and the outcome in
question. To help examine the relative influence of the potential confounders and mediators on the
association between maternal age and the outcome in question, models were adjusted in a hierarchical
fashion: model 1 adjusted for sociodemographic factors; model 2 additionally adjusted for previous
medical history; and model 3 additionally adjusted for relevant pregnancy related factors. ‘Missing’ was
included as an extra category for variables that had ≥ 10% of missing data. Continuous variables were
tested for evidence of departure from linearity by the addition of first-order fractional polynomials to the
model and subsequent likelihood ratio testing. Continuous variables that showed evidence of non-linearity
were treated and presented as categorical in the analysis, while those showing evidence of linearity were
treated as continuous linear terms when adjusting for them in the analysis but presented as categorical for
ease of interpretation. Plausible interactions were tested in the full regression model by the addition of
interaction terms and subsequent likelihood ratio testing on removal, with p< 0.01 considered evidence of
significant interaction to account for multiple testing.
Women who initially had a multiple pregnancy but then had fetal reduction were classified in the analysis
according to the number of fetuses left after the reduction. Spontaneous first-trimester losses in women
known initially to have a multiple pregnancy were classified in the analysis according to the post loss
number of fetuses. Second-trimester losses in a multiple pregnancy were classified according to the
pre-loss number of fetuses in the main analysis, but were not included when examining neonatal
outcomes unless they occurred after 24 weeks. Logistic regression using robust SEs to allow for
non-independence of neonates from multiple births was used when comparing neonatal outcomes.
Using the most recent national birth data,12,186,187 we anticipated identifying 406 women aged ≥ 48 years
at their date of delivery and 812 comparison women. With these numbers of women the study would
have had an estimated power of 80% at the 5% level of statistical significance to detect ORs of ≥ 1.5 and
≥ 2.0, assuming outcomes have an incidence of 40% and 5%, respectively. The actual number of older
and comparison women identified during the study gave an estimated power of 80% at the 5% level of
significance to detect ORs of ≥ 1.6 and ≥ 2.5, assuming the same outcome incidence levels.
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Results
Maternal socioeconomic status
A substantial proportion of the sample did not have information on socioeconomic status (17% for cases
and 13% for controls); thus, bias owing to missing data could not be ruled out. The results of multivariable
regression analysis showed that, compared with controls, the cases were 1.51 (95% CI 1.18 to 1.94) times
more likely to have missing socioeconomic information. Although not statistically significant, the odds of
belonging to the routine/manual group was 1.17 (95% CI 0.94 to 1.45) times higher and belonging to an
unemployed group was 1.22 (95% CI 0.92 to 1.61) times higher among women who suffered from severe
maternal morbidity than among the controls (Table 25).
Maternal ethnic group
After accounting for other factors and possible confounders sequentially, the fully adjusted model 4 showed
that compared with white European women, the odds of severe maternal morbidity were 83% higher
among black African women, 80% higher among black Caribbean women, 74% higher in Bangladeshi
women, and 56% and 43% higher in the other non-white (non-Asian) and Pakistani groups, respectively
(Table 26). There was remarkably little change in ORs with adjustment for other factors across the models
suggesting that other sociodemographic and clinical factors had little or no confounding effects. Women
with inadequate utilisation of antenatal care services were twice as likely to be at risk of severe morbidity as
women who adequately utilised the services (aOR 1.97, 95% CI 0.96 to 4.04) and the odds of inadequate
utilisation of antenatal was higher among black African (OR 4.46, 95% CI 1.47 to 11.48) and Caribbean
(OR 4.35, 95% CI 0.49 to 18.19) women than among white European women. In this analysis, which
included additional potential confounders, notably inadequate utilisation of antenatal care and had greater
statistical power, there was no evidence of any association between maternal socioeconomic status and
severe morbidity.
TABLE 25 Maternal socioeconomic status and severe morbidity
Characteristic
Cases n= (%),
N= 1144
Controls n= (%),
N= 2256 uOR (95% CI) aORa (95%CI)
Socioeconomic group
Managerial/
professional
292 (25.5) 567 (25.1) 1.0 1.0
Intermediate 244 (21.3) 482 (21.4) 0.98 (0.80 to 1.21) 1.17 (0.94 to 1.45)
Routine/
manual
273 (28.7) 595 (26.4) 0.89 (0.73 to 1.09) 1.16 (0.93 to 1.45)
Unemployed 142 (14.9) 309 (13.7) 0.89 (0.70 to 1.14) 1.22 (0.92 to 1.61)
Missing 193 (16.9) 303 (13.4) 1.24 (0.98 to 1.56) 1.51 (1.18 to 1.94)
Ethnic group
White 827 (72.3) 1796 (79.6) 1.0 1.0
Asian 139 (12.2) 197 (8.7) 1.53 (1.22 to 1.93) 1.57 (1.23 to 2.00)
Black 108 (9.4) 116 (5.1) 2.02 (1.54 to 2.66) 1.77 (1.32 to 2.36)
Other 52 (4.6) 69 (3.1) 1.64 (1.13 to 2.37) 1.50 (1.02 to 2.19)
Missing 18 (1.6) 78 (3.5) 0.50 (0.30 to 0.84) 0.51 (0.28 to 0.91)
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TABLE 25 Maternal socioeconomic status and severe morbidity (continued )
Characteristic
Cases n= (%),
N= 1144
Controls n= (%),
N= 2256 uOR (95% CI) aORa (95%CI)
Age (years)
< 20 56 (4.9) 139 (6.2) 0.98 (0.70 to 1.39) 1.08 (0.75 to 1.56)
20–24 127 (11.1) 449 (19.9) 0.69 (0.54 to 0.89) 0.71 (0.55 to 0.92)
25–29 225 (19.7) 549 (24.3) 1.0 1.0
30–34 341 (29.8) 622 (27.6) 1.34 (1.09 to 1.64) 1.33 (1.08 to 1.64)
≥ 35 392 (34.3) 479 (21.2) 2.00 (1.63 to 2.45) 1.98 (1.60 to 2.45)
Missing 3 (0.3) 18 (0.8) 0.41 (0.12 to 1.39) 2.66 (0.22 to 26.00)
Smoking status
Non-smokers 899 (78.6) 1642 (72.8) 1.0 1.0
Smokers 217 (19.0) 553 (24.5) 0.72 (0.60 to 0.86) 0.89 (0.73 to 1.08)
Missing 28 (2.5) 61 (2.7) 0.84 (0.53 to 1.32) 0.95 (0.54 to 1.67)
BMI (kg/m2)
Continuous (per kg/m2 increase in BMI) 1.01 (1.00 to 1.03)
< 25 513 (44.8) 1121 (49.7) 1.0 1.0
25–29.9 297 (26.0) 545 (24.2) 1.19 (1.00 to 1.42) 1.10 (0.92 to 1.32)
≥ 30 206 (18.0) 371 (16.5) 1.21 (0.99 to 1.48) 1.09 (0.88 to 1.34)
Missing 128 (11.2) 219 (9.7) 1.28 (1.00 to 1.63) 1.24 (0.95 to 1.61)
Coexisting medical conditionsb
No 1045 (91.4) 2126 (94.2) 1.0 1.0
Yes 93 (8.1) 103 (4.6) 1.84 (1.38 to 2.46) 1.60 (1.18 to 2.17)
Missing 6 (0.5) 27 (1.2) 0.45 (1.18 to 1.10) 0.76 (0.17 to 3.41)
Parity
Nulliparous 403 (35.2) 984 (43.6) 1.0 No significant effect on
fit of model (excluded)
Multiparous 738 (64.5) 1250 (55.4) 1.44 (1.24 to 1.67)
Missing 3 (0.3) 22 (1.0) 0.33 (0.10 to 1.12)
Multiple pregnancy
No 1083 (94.7) 2211 (98.0) 1.0 1.0
Yes 59 (5.2) 27 (1.2) 4.46 (2.81 to 7.08) 3.88 (2.42 to 6.22)
Missing 2 (0.2) 18 (0.8) 0.23 (0.53 to 0.98) 0.20 (0.02 to 2.54)
Past pregnancy conditionsc
No 1041 (91.0) 2121 (94.0) 1.0 1.0
Yes 94 (8.2) 104 (4.6) 1.81 (1.38 to 2.46) 1.58 (1.16 to 2.14)
Missing 9 (0.8) 31 (1.4) 0.59 (0.28 to 1.25) 1.12 (0.36 to 3.54)
a All variables adjusted for all other variables in the table.
b Cardiac disease, diabetes mellitus, epilepsy, essential hypertension, haematological disorders, past thrombotic event,
recent/current anticoagulation, i.v. drug use and/or alcohol abuse.
c AFE, gestational diabetes, pregnancy-induced hypertension, pre-eclampsia, eclampsia, thrombotic event, AFLP, manual
removal of placenta, placenta accreta and/or past classical caesarean section.
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TABLE 26 Adjusted odds ratios for severe maternal morbidity by ethnic group
Risk factors
Unadjusted, OR
(95% CI)
Model 1, aOR
(95% CI)
Model 2, aOR
(95% CI)
Model 3, aOR
(95% CI)
Model 4, aOR
(95% CI)
Ethnicity
White European 1a 1a 1a 1a 1a
Indian 0.97 (0.68 to 1.38) 0.98 (0.69 to 1.40) 0.95 (0.66 to 1.36) 0.94 (0.66 to 1.35) 1.00 (0.70 to 1.44)
Pakistani 1.37 (1.03 to 1.81) 1.38 (1.04 to 1.84) 1.33 (0.99 to 1.77) 1.32 (0.98 to 1.76) 1.43 (1.07 to 1.92)
Bangladeshi 1.73 (1.07 to 2.80) 1.67 (1.02 to 2.74) 1.61 (0.98 to 2.65) 1.65 (1.00 to 2.72) 1.74 (1.05 to 2.88)
Other Asian 1.29 (0.90 to 1.85) 1.32 (0.92 to 1.90) 1.27 (0.88 to 1.83) 1.28 (0.89 to 1.84) 1.27 (0.87 to 1.84)
Black Caribbean 1.79 (1.16 to 2.76) 1.89 (1.21 to 2.94) 1.84 (1.18 to 2.88) 1.90 (1.21 to 2.97) 1.80 (1.14 to 2.82)
Black African 2.05 (1.58 to 2.65) 1.90 (1.46 to 2.48) 1.80 (1.38 to 2.35) 1.83 (1.39 to 2.39) 1.83 (1.39 to 2.40)
Other non-white
(non-Asian)b
1.59 (1.08 to 2.34) 1.61 (1.09 to 2.38) 1.56 (1.05 to 2.31) 1.55 (1.04 to 2.30) 1.56 (1.05 to 2.33)
Mixed 1.33 (0.82 to 2.16) 1.35 (0.82 to 2.23) 1.37 (0.83 to 2.26) 1.35 (0.82 to 2.23) 1.28 (0.77 to 2.13)
Pregnancy-related factors
Current pregnancy problems
Anaemia
No 1a 1a 1a 1a
Yes 1.80 (0.99 to 3.26) 1.82 (1.01 to 3.31) 1.83 (1.01 to 3.32) 1.82 (1.00 to 3.32)
Diabetes
No 1a 1a 1a 1a
Yes 1.26 (0.87 to 1.83) 1.26 (0.87 to 1.83) 1.27 (0.87 to 1.85) 1.20 (0.82 to 1.75)
Previous pregnancy problems
No 1a 1a 1a 1a
Yes 1.28 (1.09 to 1.50) 1.28 (1.09 to 1.50) 1.28 (1.09 to 1.50) 1.27 (1.08 to 1.50)
Pre-existing medical problems
No 1a 1a 1a 1a
Yes 1.53 (1.33 to 1.75) 1.55 (1.35 to 1.77) 1.55 (1.35 to 1.77) 1.54 (1.34 to 1.77)
Parity
Primiparous 0.98 (0.86 to 1.12) 0.98 (0.85 to 1.11) 0.97 (0.85 to 1.11) 1.00 (0.87 to 1.15)
1–3 1a 1a 1a 1a
> 3 1.79 (1.35 to 2.37) 1.83 (1.38 to 2.42) 1.82 (1.37 to 2.41) 1.64 (1.23 to 2.20)
Behavioural factors, demographic factors and BMI
Smoking
Non-smoker 1a 1a 1a
Smoker 0.84 (0.73 to 0.98) 0.86 (0.74 to 1.01) 0.88 (0.75 to 1.03)
INEQUALITIES IN SEVERE MATERNAL MORBIDITIES
NIHR Journals Library www.journalslibrary.nihr.ac.uk
96
Older maternal age
A total of 233 women of very advanced maternal age were notified to UKOSS and 454 comparison
women. The median age of the older women was 49 years (range 48–61 years) while the median age of
the comparison women was 31 years (range 16–46 years). Older women were significantly more likely
than comparison women to be overweight or obese, to not smoke in pregnancy, have had previous
uterine surgery not including previous caesarean section, have previous or pre-existing medical condition(s),
be nulliparous, have a multiple pregnancy and have conceived following assisted conception (Table 27).
Table 28 shows the pregnancy complications experienced by the older and comparison women.
Unadjusted analysis suggests that older women were more likely than comparison women to have a range
of complications including gestational hypertensive disorders, gestational diabetes, PPH, caesarean delivery,
iatrogenic and spontaneous pre-term delivery and ITU admission. However, with the exception of
gestational diabetes, caesarean delivery and ITU admission, these effects were attenuated and became
non-significant after adjustment for confounding or mediating factors. The higher rate of multiple
pregnancy and use of assisted conception in the older women explained most of this attenuation (see
Table 28). There was evidence of significant interaction between caesarean delivery and parity: the raised
odds of having a caesarean delivery were only apparent in nulliparous older women (aOR 9.90, 95% CI
3.64 to 26.92 in nulliparous women; aOR 0.71, 95% CI 0.31 to 1.66 in parous women). No other
significant interactions were found. Among the older women who had a caesarean delivery, maternal age
was the primary indication for 21% (36/175).
TABLE 26 Adjusted odds ratios for severe maternal morbidity by ethnic group (continued )
Risk factors
Unadjusted, OR
(95% CI)
Model 1, aOR
(95% CI)
Model 2, aOR
(95% CI)
Model 3, aOR
(95% CI)
Model 4, aOR
(95% CI)
Inadequate utilisation of antenatal care services
No 1a 1a 1a
Yes 2.07 (1.02 to 4.23) 2.04 (1.00 to 4.17) 1.97 (0.96 to 4.04)
Occupational classification
Managerial 1a 1a
Intermediate 0.99 (0.83 to 1.18) 1.04 (0.87 to 1.24)
Routine
and manual
0.88 (0.75 to 1.04) 0.94 (0.79 to 1.11)
Unemployed 0.91 (0.74 to 1.12) 0.92 (0.74 to 1.15)
Age (years)
< 20 1.63 (1.23 to 2.17)
20–34 1a
≥ 35 1.58 (1.37 to 1.82)
BMIc (kg/m2)
< 18.5 1.11 (0.77 to 1.60)
18.5–30 1a
≥ 30 1.03 (0.88 to 1.21)
a 1 denotes the baseline comparison group.
b The non-white (non-Asian) group included women from any other black background and other ethnic groups such as
Hispanics/Latin Americans.
c BMI at the time of booking.
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TABLE 27 Characteristics of older and comparison women
Characteristic
n (%)a of older
women (N= 233)
n (%)a of comparison
women (N= 454) uOR (95% CI) p-value
Sociodemographic characteristics
Ethnic group
White 165 (71) 323 (71) 1
Non-white 67 (29) 129 (29) 1.02 (0.72 to 1.44) 0.9259
Marital status
Married or cohabiting 194 (85) 375 (84) 1
Single 35 (15) 71 (16) 0.95 (0.61 to 1.48) 0.8299
Socioeconomic group
Managerial and professional
occupations
91 (39) 144 (32) 1
Other 103 (44) 231 (51) 0.71 (0.50 to 1.00) 0.0511
Missing 39 (17) 79 (17)
BMI (kg/m2)
< 25 101 (44) 260 (58) 1
25–29.9 75 (33) 103 (23) 1.87 (1.29 to 2.73) 0.0011
≥ 30 52 (23) 85 (19) 1.57 (1.04 to 2.38) 0.0318
Smoking status
Never/ex-smoker 226 (99) 407 (90) 1
Smoked during pregnancy 3 (1) 45 (10) 0.12 (0.04 to 0.39) 0.0004
Previous medical history
Previous uterine surgery not including previous caesarean section
No 168 (74) 418 (93) 1
Yes 60 (26) 33 (7) 4.52 (2.85 to 7.17) < 0.0001
Previous or pre-existing medical condition
No 129 (56) 328 (72) 1
Yes 101 (44) 126 (28) 2.04 (1.46 to 2.84) < 0.0001
Pregnancy-related characteristics
Parity
0 122 (53) 200 (44) 1
≥ 1 108 (47) 252 (56) 0.7 (0.51 to 0.97) 0.0299
Previous caesarean section
No 179 (79) 379 (84) 1
Yes 49 (21) 72 (16) 1.44 (0.96 to 2.16) 0.0765
Multiple pregnancy
No 189 (82) 444 (98) 1
Yes 41 (18) 10 (2) 9.63 (4.73 to 19.63) < 0.0001
Conceived following assisted conception
No 50 (22) 425 (96) 1
Yes 176 (78) 19 (4) 78.74 (45.13 to 137.38) < 0.0001
a Percentage of individuals with complete data unless missing category shown.
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TABLE 28 Pregnancy complications of older and comparison women
Complication
n (%)a of
older
women
(N= 233)
n (%)a of
comparison
women
(N= 454) uOR (95% CI)
Model 1 aOR
(95% CI)
Model 2 aOR
(95% CI)
Model 3 aOR
(95% CI)
Any gestational hypertensive disorder
No 196 (85) 430 (95) 1 1 1 1
Yes 34 (15) 24 (5) 3.11
(1.79 to 5.38)
2.88
(1.63 to 5.09)
2.84
(1.60 to 5.06)
2.13
(0.75 to 6.02)
Any gestational hypertensive disorder managed by early delivery
No 219 (95) 442 (97) 1 1 1 1
Yes 11 (5) 12 (3) 1.85
(0.80 to 4.26)
1.72
(0.74 to 4.01)
1.8
(0.77 to 4.22)
1.28
(0.27 to 6.01)
Pregnancy-induced hypertension
No 209 (91) 440 (97) 1 1 1 1
Yes 21 (9) 14 (3) 3.16
(1.57 to 6.33)
2.85
(1.38 to 5.88)
2.81
(1.35 to 5.84)
2.82
(0.79 to 10.05)
Pre-eclampsia
No 217 (94) 444 (98) 1 1 1 1
Yes 13 (6) 10 (2) 2.66
(1.15 to 6.16)
2.55
(1.07 to 6.07)
2.53
(1.05 to 6.09)
1.16
(0.22 to 6.09)
Gestational diabetes
No 188 (82) 436 (96) 1 1 1 1
Yes 42 (18) 18 (4) 5.41
(3.04 to 9.65)
4.97
(2.73 to 9.04)
4.78
(2.61 to 8.77)
4.81
(1.93 to 12.00)
Gestational diabetes requiring insulin
No 221 (96) 452 (100) 1 1 1 1
Yes 9 (4) 2 (0) 9.2
(1.97 to 42.96)
8.12
(1.72 to 38.31)
7.54
(1.57 to 36.17)
3.64
(0.50 to 26.55)
Placenta praevia
No 222 (97) 453 (100)
Yes 8 (3) 0 (0)
Placental abruption
No 226 (99) 451 (100) 1 1 1 1
Yes 3 (1) 2 (0) 2.99
(0.50 to 18.04)
4.7
(0.65 to 34.09)
4.31
(0.60 to 30.89)b
1.2
(0.08 to 19.02)c
Diagnosed PPH
No 169 (74) 385 (85) 1 1 1 1
Yes 59 (26) 69 (15) 1.95
(1.32 to 2.88)
1.89
(1.26 to 2.84)
1.74
(1.13 to 2.66)b
2.03
(0.97 to 4.27)c
continued
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TABLE 28 Pregnancy complications of older and comparison women (continued )
Complication
n (%)a of
older
women
(N= 233)
n (%)a of
comparison
women
(N= 454) uOR (95% CI)
Model 1 aOR
(95% CI)
Model 2 aOR
(95% CI)
Model 3 aOR
(95% CI)
Diagnosed PPH requiring blood transfusion
No 210 (94) 441 (98) 1 1 1 1
Yes 14 (6) 8 (2) 3.67
(1.52 to 8.90)
3.53
(1.39 to 8.92)
2.30
(0.87 to 6.05)
4.33
(0.94 to 19.96)
Thrombotic event
No 229 (100) 453 (100)
Yes 0 (0) 1 (0)
Labour induced
No 156 (69) 321 (71) 1 1 1 1
Yes 71 (31) 133 (29) 1.1
(0.78 to 1.55)
1.18
(0.82 to 1.69)
1.1
(0.75 to 1.61)b
1.91
(1.03 to 3.54)c
Caesarean delivery
No 50 (22) 305 (67) 1 1 1 1
Yes 178 (78) 149 (33) 7.29
(5.03 to 10.55)
6.41
(4.39 to 9.37)
5.9
(3.98 to 8.75)b
2.78
(1.44 to 5.37)c
Gestational age at delivery (weeks)
Term
(37+ weeks)
176 (78) 420 (93) 1 1 1 1
Iatrogenic
pre-term
(< 37 weeks)
32 (14) 17 (4) 4.49
(2.43 to 8.30)
4.49
(2.39 to 8.43)
4.23
(2.19 to 8.18)b
1.01
(0.30 to 3.45)c
Spontaneous
pre-term
(< 37 weeks)
18 (8) 17 (4) 2.53
(1.27 to 5.02)
2.44
(1.17 to 5.09)
2.34
(1.09 to 5.00)b
1.11
(0.28 to 4.45)c
Admitted to ITU
No 224 (97) 453 (100) 1 1 1 1
Yes 6 (3) 1 (0) 12.13
(1.45 to 101.40)
10.98
(1.28 to 94.01)
10.96
(1.28 to 94.17)
33.53
(2.73 to 412.24)
a Percentage of individuals with complete data.
b See Model 2 below.
c See Model 3 below.
Model 1: adjusted for sociodemographic factors (ethnic group, marital status, socioeconomic group, BMI and
smoking status).
Model 2: adjusted for variables included in model 1 plus previous medical history (previous uterine surgery not including
previous caesarean section and previous or pre-existing medical conditions where b is shown, or just previous or pre-existing
medical conditions where b is not shown).
Model 3: adjusted for variables included in model 2 plus pregnancy related factors (parity, multiple pregnancy, how
conceived and previous caesarean delivery where c is shown, or just parity, multiple pregnancy and how conceived if c is
not shown.
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Among the older women, a total of 268 fetuses survived beyond 24 weeks’ gestation (35 sets of twins,
three sets of triplets and 189 singletons). Of these 268 fetuses known to be alive in utero beyond
24 weeks, three were stillborn antepartum; two of these were a set of twins, of which both were stillborn,
and the other occurred in a women who initially had a triplet pregnancy but had already spontaneously
lost one of the triplets in the second trimester before 24 weeks. A further two of the fetuses died shortly
after birth following very pre-term delivery (< 28 weeks’ gestation), equating to a perinatal mortality rate
of 18.7 per 1000 (95% CI 6.1 to 42.9 per 1000). Although this was more than double the national rate of
7.5 per 1000,95 the difference was not statistically significant (RR 2.5, 95% CI 1.0 to 5.9), noting the
limited statistical power of this comparison.
The proportion of fetuses surviving beyond 24 weeks that had a congenital anomaly was similar between
the older women and the comparison women (1.9%, 5/263 vs. 1.5%, 7/460; p= 0.702), as was the
proportion that had other major complications such as respiratory distress syndrome and severe infection
(2%, 4/205 vs. 3.8%, 13/344; p= 0.240). The proportion of fetuses that had a low birthweight (< 2500 g)
was higher among those born to older women than comparison women (32%, 85/267 vs. 8%, 38/463;
p< 0.001), although this difference disappeared after controlling for gestational age at delivery.
Conclusions and implications for policy and service provision
These national studies clearly demonstrate an increased risk of severe maternal morbidity among women
of all ethnic minority backgrounds in the UK, except among women of Indian and mixed origins, and
provide important insights into the independent association of inadequate utilisation of antenatal care,
high parity and pregnancy in younger and older age with the odds of severe maternal morbidity. However,
there is no clear association with maternal socioeconomic status after adjustment for confounding factors
including inadequate utilisation of antenatal care.
As the population of ethnic minority groups in the UK continues to increase, it is important to focus on
these ethnic disparities. The known risk factors for severe maternal morbidity explained very little of this
disparity. There could be residual confounding in the analysis owing to factors that were not measured well
(e.g. socioeconomic status) or not measured at all (e.g. the educational level of the women, cultural factors
and social status). It is important to understand the role of these factors in increasing the risk of severe
morbidity among pregnant women from diverse socioeconomic and ethnic backgrounds in the UK. This
provides a focus for further research into possible pathways of prevention of severe maternal morbidity.
Policies have been developed by NICE for cardiovascular disease screening and prevention in which NICE
recommends that certain ethnic groups that are at a higher risk of cardiovascular disease should be
targeted for primary prevention and are considering measures to develop a UK-population-based risk
scoring system, taking into account the ethnic differences in cardiovascular disease prevalence.188 It may
be time to consider a similar approach for care in pregnancy. While the ‘Maternity Matters’ guidance
for service commissioning in England emphasised the need for maternity services to address the
disproportionately higher risk of severe maternal morbidity among socially disadvantaged women, it does
not provide any specific recommendations.17 Our results suggest a continuing focus is needed on ensuring
access to antenatal care among all pregnant women, including those from disadvantaged groups, as
highlighted in 2010 NICE guidance.189
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This national cohort study clearly shows that women giving birth who are aged ≥ 48 years are at very high
risk of both maternal and infant complications and adverse outcomes. Many of the increased risks in
women of very advanced maternal age appear to be largely explained by the higher rate of multiple
pregnancy or use of assisted conception in the older women, all of which are inextricably inter-related to
older maternal age, with older age leading to a need for IVF if conception is to occur and age itself and IVF
leading to an increased risk of multiple birth. These findings should be considered when counselling and
managing women of very advanced maternal age. There may be a place for considering fetal reduction in
women of very advanced age with multiple pregnancies although the long-term effects of fetal reduction
on surviving infants is unclear. Organisations making recommendations regarding assisted conception
including egg donation in older mothers, as well as single embryo transfer, should take these findings
into account.
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Chapter 8 Local versus external review of cases of
severe maternal morbidity
Background
Methodical and detailed case review is commonly used as a strategy to improve health professionals’ care
of pregnant women,190 not only through documenting the number and causes of morbidity and mortality,
but also through identifying preventable factors.3,9 Two approaches have been taken nationally to learning
from adverse incidents in maternity care: external anonymised case review (confidential enquiries)2,3 and
local (facility-based) reviews using tools such as root cause analysis.168 Neither of these approaches has
been applied systematically to investigate cases of near-miss maternal morbidity or compared with each
other to assess the impact on local learning from adverse events. The aim of this workstream was to assess
what types of severe maternal morbidity undergo local review in the UK and to compare the lessons
identified for future care through external review (confidential enquiry) and local review of cases of severe
maternal morbidity, in order to inform development of a strategy for reviewing ‘near-miss’ cases.
Research questions
l What types of incidents trigger local reviews in the UK?
l What is the quality of local guidance on conducting reviews of severe maternity incidents in the NHS?
l What local approaches are being used to review near-miss maternal morbidity cases and how do these
compare with an external case review approach (confidential enquiry)?
Methods
Conditions eliciting local reviews
All 211 consultant-led maternity units in the UK were contacted up to three times, via letter, e-mail and
telephone, and asked to supply a copy of the list of incidents that triggered a local review as well as a copy
of their maternity risk management strategy and/or their incident review procedure during 2012. Definitions
for each type of incident were documented a priori. Conditions included sepsis, massive obstetric
haemorrhage, abruption, cardiac arrest and severe blood loss. Varying thresholds were accepted for several
categories, including ‘severe blood loss’, ‘low Apgar score’, ‘low cord pH’, ‘prolonged inpatient stay’ and
‘prolonged second/third stage’. The conditions included were classified by two researchers individually
(AS and Olaa Mohamed-Ahmed) and disagreement resolved by discussion with a third reviewer if required
(MK). Incidents that were listed by at least 5% of maternity units were reported under the following
categories: maternal, neonatal or organisational incidents. The lists of incidents were compared with
incidents recommended for review by the Royal College of Obstetricians and Gynaecologists (RCOG).191
Protocols for local reviews
The Appraisal of Guidelines for Research and Evaluation (AGREE) II instrument was used to assess the
quality of the incident review guidelines obtained from the mailing, using 23 items organised into six
domains.192 The domains were ‘scope and purpose’, ‘stakeholder involvement’, ‘rigour of development’,
‘clarity of presentation’, ‘applicability’ and ‘editorial independence’.
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Each item was scored on a 7-point Likert scale ranging from 7 ‘strongly agree’ to 1 ‘strongly disagree’ with
a mid-point of 4. An overall assessment of the quality of the guideline was made by calculating the mean
average score from the 23 scores for each AGREE criteria. Any score of 0–2.9 was classified as ‘poor
quality’, a score of 3–3.9 was ‘average quality’, a score of 4–4.9 was ‘good quality’ and a score of ≥ 5 was
considered to be ‘high quality’.
Two researchers (AS and Olaa Mohamed-Ahmed) met to discuss and agree how best to apply each
question within the AGREE II criteria to incident reporting within maternity services, prior to evaluating any
guidelines. Each guideline was assessed independently by each researcher and if the score for any item
differed by > 2 points, they met to discuss and resolve discrepancies in interpretation. Scores were revised
accordingly, with a third researcher qualified in midwifery providing clarification on any outstanding issues.
Analyses were based on the revised scores. Four additional issues were considered when appraising
each guideline: the method(s) used for reviewing an incident, the types of professionals involved in the
review, the methods for disseminating the outcomes and whether or not units had a process to audit
changes in clinical practice arising from incidents.
Standardised domain quality scores for each guideline were calculated according to the AGREE II
instrument standard methods. The possible range for standardised domain scores is 0–100%. Median
domain scores with 95% CI and the proportion of guidelines scoring < 30%, 30–60% and > 60% were
calculated. Scores for the lowest and highest scoring domains were compared with scores for other
domains using the Wilcoxon matched pairs signed rank-sum test for non-parametric data.
External versus local reviews
Six sites were randomly selected following stratification from all NHS consultant-led maternity units in
England [two large teaching hospital units (5000+ deliveries per year), two medium units (2–4999
deliveries per year) and two small units (1–1999 deliveries per year)] and on the basis of their Clinical
Negligence Scheme for Trusts (CNST) level at the time of selection (one of each size with CNST level 1, the
basic risk management level, and one of each size with CNST level 3, the highest risk management level).
Each unit provided a list of all cases of direct (obstetric) near-miss maternal morbidity that had triggered a
local review assessment process during the previous 6 months. From these lists, six cases were randomly
selected from each unit and full sets of clinical notes, together with their local review report, were
requested. In total, 33 sets of anonymised clinical records were obtained and reviewed and the remaining
three sets of notes were unavailable. The methodology used for and lessons identified from local reviews
were described.
Eleven external reviewers, comprising five obstetricians, four midwives and two anaesthetists, assessed each
set of anonymised medical records, using the confidential enquiry approach used by the MBRRACE-UK
Confidential Enquiry into Maternal Deaths.2,147 Two obstetricians, a midwife and two anaesthetists assessed
the care of each woman. Five reviewers thus examined each woman’s care. Each primary assessor
completed an independent review of the woman’s care, highlighting the lessons to be learned to improve
care in the future. This was checked by a second assessor in the relevant specialty. External assessors were
located throughout England and, to maintain anonymity, assessors were only asked to review the care of
women who had been cared for outside their region. The assessment process and all individual findings
were strictly confidential; all assessors were required to sign a confidentiality agreement.
Qualitative and quantitative approaches were used to compare the reviews. The reviews were read and
reread, a coding frame was constructed and the data coded. Anticipated and emergent themes were then
examined. A qualitative interpretive approach was taken, combining thematic analysis with constant
comparison.44,45 NVivo 9 was used to facilitate the analysis. Once the themes had been identified, the
number of reviews identifying each theme was quantified and compared using a chi-squared or Fisher’s
exact test as appropriate.
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Results
Conditions eliciting local reviews
Of the 211 consultant-led maternity units in the UK, 71% (n= 150) provided a list of incidents that would
trigger a local review. The conditions listed were highly variable, although those recommended by the
RCOG were most frequently represented. No single incident or condition was recommended for review by
every maternity unit.
The majority of units (> 90%) that responded included maternal and neonatal deaths, stillbirths, intensive
care admissions, severe blood loss, shoulder dystocia, third- or fourth-degree tears, eclampsia, low Apgar
scores and unplanned home birth (Table 29). The most commonly listed maternal conditions that had
not been recommended for review by the RCOG included cord accidents (77%), cardiac arrest (69%)
and sepsis (64%). Meconium aspiration (14%) and hypothermia on admission (9%) were often listed
in addition to the other neonatal conditions recommended for review by the RCOG. A variety of
organisational incidents featured on the trigger checklists including inadequate staffing levels (70%)
and delay in access to theatre (61%).
TABLE 29 Frequency of maternity, neonatal and organisational incidents listed for local review by maternity units
in the UK, 2012 (n= 150)
Maternal incidents n (%) Neonatal incidents n (%) Organisational incidents n (%)
Severe blood lossa 148 (99) Stillbirtha 144 (96) Unplanned home birth including born
before arrival and delivery outside warda
138 (92)
Maternal deatha 147 (98) Term baby admitted
to neonatal unita
142 (95) Medication errora 124 (83)
ICU admissiona 145 (97) Neonatal deatha 140 (93) Retained swab or instrumenta 124 (83)
Shoulder dystociaa 143 (95) Low Apgar scorea 138 (92) Unavailability or malfunctioning of
equipment, facilities or cotsa
124 (83)
Third-/fourth-degree
tearsa
141 (94) Low cord pHa 134 (89) Hospital-acquired infectiona 112 (75)
Eclampsiaa 139 (93) Undiagnosed fetal
anomalya
134 (89) Unavailability of health recorda 105 (70)
Return to theatrea 129 (86) Birth traumaa 128 (85) Inadequate staffing levels 105 (70)
Undiagnosed breecha 127 (85) Neonatal seizures or
encephalopathya
100 (67) Delay in response to call for assistancea 101 (67)
Uterine rupturea 127 (85) Fetal laceration at
caesarean sectiona
95 (63) Delay in access to theatre or > 30 minutes
for category 1 caesarean section
91 (61)
Readmission
of mothera
127 (85) EUROCAT major
congenital anomalya,b
27 (18) Delayed/missed diagnosis including
cardiotocography
67 (45)
Unsuccessful
forceps/ventousea
118 (79) Meconium aspiration 21 (14) Antenatal misdiagnosis including
undiagnosed small for gestational age
67 (45)
Cord accident 115 (77) Hypothermia on
admission
14 (9) Violation of local protocola 65 (43)
Hysterectomy/
laparotomya
112 (75) Incidents relating
to anti-D
immunoglobulin
10 (7) Transfers (in or ex utero transfer, in
from community)
65 (43)
Anaesthetic
complicationsa
106 (71) Potential service user complainta 55 (37)
Cardiac arrest 103 (69) Conflict over case managementa 55 (37)
continued
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Protocols for local reviews
Of all 211 consultant-led maternity units in the UK, 70% (n= 148) provided an incident review protocol or
risk management strategy. Trusts or health boards that had more than one unit (n= 22) all indicated that
the same guideline was in use across all units. Thus, 120 guidelines applicable to 148 maternity units were
included in the appraisal. Many of the guidelines received were maternity specific (n= 82, 68%) and the
remainder applied to all incidents, irrespective of speciality, that occurred in a trust or board.
Scores for the ‘scope and purpose’ domain were significantly higher than scores for the other domains
(p< 0.001). The median score for this domain was 86% and 112 of the 120 guidelines (93%) scored
> 60%. Only 49 guidelines scored > 60% for the ‘stakeholder involvement’ domain, which includes being
authored by a range of health professionals or consulting with staff. Scores for the ‘rigour of development’
domain were significantly less than for any other domain (p< 0.001). For the ‘clarity of presentation’
domain, 93% of guidelines scored > 60%. The median score for the ‘applicability’ domain was 56%, but
only six guidelines scored < 30%. None of the guidelines referred to the independence of the guidelines
from the funding body or any competing interests of the guideline development group members (see
Methods, Conditions eliciting local reviews).
Root cause analysis was most commonly suggested as the methodology for reviewing serious maternity
incidents (n= 97, 81%), with case review analysis at regular meetings for less-serious incidents. The
TABLE 29 Frequency of maternity, neonatal and organisational incidents listed for local review by maternity units
in the UK, 2012 (n= 150) (continued )
Maternal incidents n (%) Neonatal incidents n (%) Organisational incidents n (%)
Sepsis 96 (64) Child protection incident 48 (32)
Trauma to bladder or
other organs
95 (63) Closure of unit or suspension of services 39 (26)
Pulmonary embolisma 91 (61) Transfusion error 29 (19)
Venous
thromboembolisma
83 (55) Consent issues 24 (16)
Prolonged second/
third stage
71 (47) ‘Near-miss’ 22 (15)
Perineal breakdown 30 (20) Confidentiality issues 21 (14)
Pressure sore 29 (19) Identification error including incorrect
labelling of specimens or baby
19 (13)
Significant retention
of urine
22 (15)
Placental abruption 17 (11)
Late booking or
concealed pregnancy
13 (9)
Anaphylaxis 12 (8)
Prolonged inpatient
stay
11 (7)
Untreated group
B streptococci
10 (7)
AFE 9 (6)
HELLP syndrome 8 (5)
a Conditions recommended for review by the RCOG.
b EUROCAT derived from original name European Concerted Action on Congenital Anomalies and Twins.
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guidelines for six units (4%) did not state the approach to be used for reviewing incidents. Other approaches
to review incidents that were mentioned were significant event analysis (five units), trend analysis (four units)
and one unit recommended choosing an approach from systems analysis with a contributory factor
framework, brainstorming, the five whys, incident decision tree, fishbone diagram and gap analysis.
Most review guidelines required one or two designated people to review reports of all incidents, such as a
risk midwife or manager. Other guidelines designated a team of people to review each incident including
senior risk managers, lead clinicians and specialist midwives in risk (see Methods, Conditions eliciting local
reviews). Incidents could be escalated to a supervisor of midwives, maternity risk management boards,
adverse events committees, patient safety co-ordinators, relevant executive directors or arrangements
made to have a committee with external professionals and an independent chairperson, as required.
Lessons learned from incident reviews were most commonly disseminated at meetings, in reports,
newsletters and posters (n= 110, 92%), with individual feedback and support given to those involved in
the incident. Other means of communication included e-mail, intranet, memos, via line managers, local
and multidisciplinary forums, in the minutes of meetings and ‘message of the week’. Only 10 guidelines
(8%) did not mention any means of communicating the findings of reviews with staff.
Many guidelines (n= 83, 69%) included details of a process to audit the impact of recommendations
arising from incidents. A further 28 (23%) guidelines included mention of having an auditing process or a
committee that would consider governance and assurance issues. It was not clear if the audit cycle around
incidents would be completed. Only nine units that responded made no mention of audits.
External versus local reviews
The care of 33 women with near-miss maternal morbidities was assessed by the confidential enquiry panel.
The majority of women (73%) had severe haemorrhage (> 1500 ml of blood loss).
Local reviews of the care of 28 of the women (85%) had been conducted and for the remainder a local
review had not been conducted either because the incident had been assessed locally as not needing a
review, or because cases were not selected for review owing to capacity issues. A formal report of the local
review process and outcome had been written in only 11 cases (33%) and four of these local reviews used
root cause analysis. For 12 cases (36%), a review group had discussed the incident and a summary of the
outcome had been noted in a spreadsheet. For an additional five cases the documented local review
comprised a timeline of events with brief notes on evidence of good care and if issues had occurred.
The categories of staff involved in conducting reviews varied between units. An individual midwife
conducted four reviews, a group of midwives conducted two reviews, and five reviews (15%) involved both
obstetricians and midwives. One of these five reviews included an anaesthetist and one included an obstetric
trainee. It was not possible to identify the specialty or grade of reviewers in 17 local review reports. In five
local reviews (15%) it was documented that the woman concerned had asked the review group to consider
specific questions about her care and that she was later notified of the group’s conclusions and action plans.
In the local review reports, action plans had been written for 14 cases (42%). The conclusions from three
local review reports (9%) included a recommendation to audit the subsequent change to clinical practice.
Costs of external reviews
The administrative time spent on organising, photocopying, anonymising and scanning each case and
liaising with external assessors was a mean of 17 hours, which amounts to an average administrative cost
of £300 per case. On average it took each external assessor 3 hours to read and report on each case.
The cost of five external assessors’ time, based on estimated consultant and senior midwife salary costs,193
was £1800 per case. Thus, the total cost of conducting an external review into a near-miss case of
maternal morbidity per case was estimated as £2100.
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Comparison between local and external reviews
Many additional, detailed messages for care were identified in the external reviews (Table 30). Importantly,
the external reviews highlighted aspects of good care in every case (n= 33, 100%) compared with only
55% (n= 18) of the local reviews that identified good care (p< 0.0005). The local reviews included
individual disciplinary actions, for example four (12%) recommended individual supervisory action, which
was not identified in any external reviews (p= 0.11). For 21% of the cases (n= 7), local review reports
noted local factors affecting the situation, such as ‘staff were dealing with two emergencies
simultaneously’ and ‘insufficient room for resuscitation’. External reviewers, making their assessment solely
on the basis of the medical records, did not identify any local factors.
TABLE 30 Number of cases where themes were noted in local and external reviews (n= 33). Note that several
themes may have been identified for each woman and, therefore, the total number of themes identified exceeds
the total number of cases examined
Theme Local reviews External reviews
National guidelines (e.g. RCOG, NICE) or good practice points
Followed 13 28
Not followed 11 24
Senior review
Consultant involvement 14 28
Lack of consultant involvement 7 12
Communication
Good
with the patient and family 2 19
between staff members 4 14
Poor
with the patient and family 3 9
between staff members 4 11
Documentation
Some areas of good quality 8 13
Some areas of poor quality 10 29
Medication errors 2 11
Individual supervisory action 4 0
Delays in
Diagnosis 5 22
Obtaining a second opinion 2 3
Providing treatment (excluding drugs) 7 9
Administering drugs (e.g. antibiotics) 3 5
Requesting blood or clotting products 0 2
Gaining access to blood or clotting products 0 2
Transferring patients (e.g. to theatre or the labour ward) 2 6
Alternative suggestion for clinical approach 0 16
LOCAL VERSUS EXTERNAL REVIEW OF CASES OF SEVERE MATERNAL MORBIDITY
NIHR Journals Library www.journalslibrary.nihr.ac.uk
108
Examples of themes identified
Overall, the lessons for care identified in the local reviews were briefer and less focused than those
identified on external review. The following are examples of lessons identified from the local review of the
care of a woman with a PPH and hysterectomy. Please note that quotations from external assessors are not
attributed to maintain the confidentiality of the Confidential Enquiry process.
l Syntometrine not indicated.
l Incorrect dose of syntocinon.
l Incorrect practice.
l [Long] time scale between delivery of placenta and examination.
l No notes from registrar.
l No ongoing estimation of blood loss.
l Guidelines followed once gynaecologist consultant arrived.
l Incorrect estimation of blood loss.
l Timely decision for hysterectomy.
l Appropriate place for care.
In contrast, the external assessors’ reports into the same case gave more detailed comments:
l Care provided to this lady appears to have been extremely well managed (NICE guidance: routine
care for the healthy pregnant woman).194
l The multidisciplinary team appears to have responded quickly to the emergency situation.
l Consultant obstetricians and anaesthetists were actively involved in the care.
l In addition to the measures taken to control the haemorrhage, other procedures should have been
considered at or before laparotomy to preserve the uterus. The notes do not reflect consideration of
tying off the uterine arteries, calling for vascular surgical assistance or considering uterine artery
embolisation (prevention and management of PPH).195 I am unaware of the facilities available in the
unit and if any of these measures could have been taken but potentially this would have prevented
the need for hysterectomy.
l The resuscitation was excellent, including ensuring active warming and temperature monitoring.
l The medical notes are adequate but do not give a very clear picture of the events and the decision
process at each stage. Lack of observation charts.
The lessons identified in a case of maternal sepsis illustrate the different focus observed among local
compared with external reviews. The local review of the case noted the following points with respect to
suggestions for local service improvements:
l Delay in the administration of antibiotics within the ‘golden hour’.
l Consultant obstetrician informed who discussed the incident with consultant on A&E [accident
and emergency].
l All pregnant women over 20 weeks’ gestation who attend A&E should be transferred to either the
delivery suite or patient assessment unit (except those involved in major trauma when A&E should
call the obstetrics and gynaecology team to attend A&E).
l Feedback to A&E staff and include in communications diary.
l Raise awareness with [ambulance service] advising that all women of ≥ 20 weeks should be brought
straight to maternity.
In contrast, the external reviews of the same case focused more on specific aspects of clinical care and
noted wider actions in the whole care pathway (including the GP):
l There were delays in recognition and management of this woman’s sepsis.
l Only two of the six ‘sepsis six bundle’ measures were implemented by A&E staff – bloods and
oxygen therapy – and there was a significant delay in commencing IV antibiotics.
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l The ‘Surviving Sepsis’ campaign highlights the importance of early antibiotic therapy in the ‘golden
hour’ after presentation.
l Pregnancy should not be a reason to postpone antibiotic administration when sepsis is suspected
and neither is it a contraindication to chest X-ray.
l A MEWS [Modified Early Warning Score] of 7 should generate a more urgent medical assessment.
l There may have been some delay in recognising the severity of her illness by her GP as it was
documented she had been ill for 4–6 weeks.
There were several cases in which local reviews identified no lessons for care but for which external
reviews considered that there were important lessons to be learned. For example, the following was noted
from local assessment of the care of a woman with uterine inversion:
l All appropriate actions had been undertaken and no reason could be found for it to have occurred
and, therefore, no formal report was completed.
In contrast, the external reviewers noted clear lessons from reviewing the same woman’s care:
l The management of this woman’s labour and delivery was complicated by the fact that she was
not suitable for regional anaesthesia. There seems to be little planning for analgesia in labour
or if anaesthesia were required at delivery (the option of central neuraxial blockade having
been dismissed).
l The anaesthetist, however, did not recommend any alternative options, nor did an anaesthetist
review this woman in labour when pain management was clearly an issue. This led to a delay in the
first stage of labour because there was reluctance to commence [Oxytocin (Syntocinon®, Novartis)]
(despite this being a primip[arous] induction) as this would strengthen contractions and
consequently pain.
l There was also a delay in the second stage (more than 4 hours) as although earlier delivery was
considered it was thought a better option to allow this woman to continue pushing as vaginal
examination was so difficult owing to her distress.
l The alternative at this time was a general anaesthetic for a forceps delivery in theatre.
l Uterine inversion occurred within 9 minutes of delivery of the baby, so almost certainly
mismanagement of third stage.
l I am sure delivery was challenging for all concerned. There was immediate recognition that uterine
inversion had occurred and it was dealt with and managed appropriately.
l Query whether the patient was debriefed or whether the significance for future pregnancies
was discussed.
Conclusions and implications for practice
The three elements of this workstream have together identified that substantial variation exists in the local
review of severe maternal morbidities, in terms of the definition and scope of incidents that trigger a
review, the guidelines for conducting a review and the outputs and conclusions of reviews.
More importantly, it is clear that some units do not review individual cases of morbidity related to severe
maternal sepsis, for example, despite this being of major national concern. The incidents featuring on the
RCOG recommendations for incident reporting were the most commonly cited by individual centre trigger
checklists, although a wide range of additional incident types were also reported. Local approaches have
the advantage of being able to respond in a timely manner to incidents of emerging concern. Rates of
maternal death due to sepsis are known to be of concern in the UK.2 In response to this, almost two-thirds
of units specifically reviewed the care of women with severe infective complications, despite sepsis not
being listed among the conditions on the RCOG guidance.191 Processes should exist for ongoing review
and revision of the RCOG incident review trigger list, and addition of sepsis to this list would encourage
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local reviews to be conducted. Guidance on local serious incident review processes usually includes a list of
conditions that require mandatory review. Guidance should also include how the list of conditions triggering
a review should be maintained and adapted in the light of changing clinical and safety circumstances.
Consideration should be given to expanding stakeholder participation in guideline development. Although
some guidelines were circulated to certain staff groups to obtain their views during development, service
users, for example, were rarely consulted. Very few guidelines described facilitators or barriers to
implementing their recommendations, or stipulated the resources necessary to conduct incident reviews
(people, money and time). Only one guideline acknowledged that it may become necessary for reviewers
to delegate other pressing duties in order to prioritise the review process (see Methods, Conditions eliciting
local reviews). The independence of editorial involvement was often unclear and competing interests of
guideline developers were rarely stated.
It was unclear in over one-quarter of guidelines whether or not changes in practice in response to review
recommendations were audited or monitored, and such auditing is important to ensure that recommended
changes are being implemented and are driving change.168 Allied to this observation, very few of the local
reviews we examined in detail advocated auditing the changes to care that were recommended.
Local and external reviews of the care of women who have had severe morbidities in pregnancy clearly
add different perspectives. Both local and external review processes identified important messages to
improve future care, although the number of specific messages identified was greater in the external
reviews. The external reviews were more likely to comment on aspects of care that were considered good.
Importantly, one-fifth of local reviews identified specific local service or situation-specific factors that
impacted on women’s care; these lessons cannot be identified through external reviews alone. There was
little evidence of multidisciplinary review at a local level, although it is possible that the review reports did
not fully capture the multidisciplinary nature of discussions that may have occurred outside of the formal
review meetings. The majority were conducted solely by midwives and only one involved an anaesthetist.
Such differences may account for the greater number and scope of messages identified by the external
review processes. It was also apparent that local review groups had a role to institute individual disciplinary
procedures, when required, which may detract from the identification of generalised messages to improve
clinical care.
However, the external review process is labour intensive, requires administrative support and, on average,
we estimate it would cost £2100 per case. We were not able to capture costs for the local review
processes. Although the costs appear high, if lessons are learned and implemented in practice, preventing
future serious morbidity, the benefits would be potentially reaped in terms of future litigation costs
prevented. These costs were estimated by the National Audit Office in 2013 as £700 out of the £3700
spent on average on each birth in England.196 A further important research question would be to assess to
what extent this cost is offset by savings from enhanced treatment through compliance with guidelines.
In this comparison of local and external reviews, we were unable to establish whether it was the external
or the multiprofessional perspective that added to the lessons learned and, therefore, the apparent
advantages of external reviews. Further evaluation is needed to establish whether or not there is added
value to including an external perspective to local reviews once high-quality multidisciplinary local reviews
are fully implemented.
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Chapter 9 Quantifying the long-term impacts of
peripartum hysterectomy
Background
Most studies of near-miss maternal morbidity, because of their retrospective hospital-based nature, report
relatively short-term outcomes for women, for example admission to intensive care or the need for
hysterectomy to control haemorrhage.8,197,198 However, as evidenced by the study reported in Chapter 2,
near-miss morbidities may have significant long-term impacts, both physically and psychologically, on parents,
their infants and other children. Indeed, given that apparently normal birth may itself be associated with
negative outcomes such as post-traumatic stress disorder (PTSD),199,200 it is possible that such outcomes would
be even more evident in the situation of a severe life-threatening obstetric complication. One of the few studies
in a developed country to have followed up women who experienced a severe obstetric morbidity along
with a group of women who did not reported that a severe obstetric morbidity adversely affected the sexual
function and general health of women along with increasing their health service utilisation 6–12 months
post partum.27 Further exploration of the long-term impacts is important to inform service provision and
improve future care and outcomes. This workstream investigated the feasibility of long-term follow-up of
affected women and their infants by conducting a survey of the experiences of a cohort of women who had a
peripartum hysterectomy to control haemorrhage compared with women who did not.
Research questions
l Is it feasible to follow-up an anonymous cohort of women who had a peripartum hysterectomy
7–8 years after the index birth?
l What are the long-term health outcomes of women following a peripartum hysterectomy to control
haemorrhage and how do they differ from the long-term health outcomes of women who gave birth
but did not have a hysterectomy?
l What is the additional health service usage following hospital discharge of women who had a
peripartum hysterectomy to control haemorrhage?
l How does the near-miss experience of a peripartum hysterectomy to control haemorrhage affect the
women’s family and her relationships with her family?
l Are there any aspects of the care experience that were particularly good or bad or could be improved?
Methods
A questionnaire study of women who have had a peripartum hysterectomy to control haemorrhage (cases)
and women who gave birth but did not have a peripartum hysterectomy (controls) was undertaken.
Case and control identification and data collection
During a previous study,8 nominated clinicians in each obstetrician-led maternity unit in the UK reported
information through UKOSS about all women (n= 315) who had a peripartum hysterectomy between
February 2005 and February 2006. The clinicians also reported information on control women (n= 608),
identified as the two women delivering immediately before a woman who had a hysterectomy during this
time period. For ease of comparison with the previous study, we have continued to refer throughout to
the cohort of women who underwent a hysterectomy as cases and the comparison group who did not
have a hysterectomy as controls. All data requested were anonymous; no names, addresses, dates of birth,
hospital or NHS numbers were sought. Cases and controls were allocated unique UKOSS identification
numbers. The reporting clinicians were asked to keep their own record of this unique number and the
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patient identifiers. For the current study, we contacted the UKOSS reporting clinicians and asked them to
post the following to the women who had a hysterectomy and their matched controls: a letter inviting the
women to take part in the study, an information leaflet about the study and a questionnaire. Clinicians
were also asked to inform us whether or not they had posted the study materials on to the women
concerned. By including the UKOSS unique number for the women on the questionnaires we asked the
clinicians to send to the women, we were able to monitor the response rate from women and compare
the sociodemographic and index pregnancy characteristics of responders and non-responders. Women
who returned a completed questionnaire were deemed to have consented to participate in the study.
The questionnaire, information leaflet and invitation letter sent to potential participants were developed in
collaboration with the maternal near-miss surveillance programme advisory group made up of programme
users, members of voluntary, user and special interest groups. The questionnaire asked women about a
range of topics including their health and well-being; their care experience during and since the index
pregnancy; their health service usage; questions about the women’s family including her baby (or babies)
born in the index pregnancy; other pregnancies/births; stressful life events since the index pregnancy; and
questions to provide sociodemographic information. When possible, standard questions from the National
Maternity Survey were used.201 The questionnaire included the Short Form questionnaire-12 items version 2
(SF-12v2),202 the Hospital Anxiety and Depression Scale (HADS)203 and the Post-traumatic Stress Disorder
Symptom Scale Self-Report version (PSS-SR).204
The SF-12v2 was used to assess women’s current general health/quality of life. It produces eight scale scores
measuring eight domains of health (physical functioning, social functioning, role limitations due to physical
problems, role limitations due to emotional problems, mental health, energy/vitality, pain and general health
perception) and can yield two summary scores of physical and mental health. Scores range from 0 to 100,
with higher scores representing better health performance in the scale. The HADS was used to assess current
depression and anxiety symptoms in the women. It consists of a 7-item subscale that measures depression
symptoms and a 7-item subscale that measures anxiety symptoms, with each item scored on a 4-point scale.
Cut-off scores have been suggested for both scales to indicate whether someone is within the normal range
(score 0–7) or in a mildly (score 8–10), moderately (score 11–14) or severely (score 15–21) disordered state.
The PSS-SR was used to assess current PTSD in women in relation to their birth. The PSS-SR consists of
17 items corresponding directly to Diagnostic and Statistical Manual of Mental Disorders-Fourth Edition
diagnostic criteria for PTSD; the 17 items can be classified as belonging to one of three symptom clusters
(re-experiencing, avoidance and hyper-arousal), which are scored on a 4-point scale of frequency. A
diagnosis of PTSD is made when at least one re-experiencing, three avoidance and two hyperarousal
symptoms are rated as occurring at least once a week or less/once in a while. In addition, a total score
ranging from 0 to 51 is considered to be an indication of the severity of the disorder.
No identifiable personal information was requested; however, women were given the option of providing
us with their contact details if they wanted to be sent the study results or wished to be contacted by a
member of the research team to discuss any issues or concerns they might have had.
Study size
Assuming a response of 60% for cases and 50% for controls, we anticipated recruiting around 200 cases
and 300 controls. Ayers and Pickering205 estimated the prevalence of PTSD 6 months post partum to be
1.5% among women who had planned a normal labour excluding those who suffered a perinatal or
neonatal death. With 200 cases and 300 controls, this study would have had 80% power at the 5% level of
significance to detect an increase from 1.5% to 7% in the proportion of cases with PTSD compared with
controls. The prevalence of anxiety and depression symptoms of moderate to high severity among women in
the UK has been estimated to be 9% and 12%, respectively,206 and postnatally up to 20% of women have
depressive symptoms in the first 3 months after delivery.207 With 200 cases and 300 controls, this study
would have had 80% power at the 5% level of significance to detect an increase from 9% to 18% and an
increase from 12% to 22% in the proportion of cases with anxiety and depression symptoms, respectively,
compared with controls. The actual number of cases and controls who responded (30 cases and 48 controls)
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gave an estimated power of 80% at the 5% significance level to detect an increase from 1.5% to 25% in
the proportion of cases with PTSD compared with controls. The actual number of cases and controls also
gave an estimated power of 80% at the 5% significance level to detect an increase from 9% to 39% and an
increase from 12% to 43% in the proportion of cases with anxiety and depression symptoms, respectively,
compared with controls.
Statistical analysis
Descriptive statistics, including medians and proportions, were calculated. A chi-squared test, Fisher’s exact
test or Wilcoxon rank-sum test, as appropriate, was used to compare the sociodemographic and index
pregnancy characteristics of questionnaire responders and non-responders. These tests were also used, as
appropriate, to compare respondents’ self-reported sociodemographic, social and obstetric characteristics,
previous health, health outcomes, health-care usage, care experience and effect of the women’s birth
experience on her family and relationships with her family according to whether or not she had a
hysterectomy in the index pregnancy. Quantitative data analysis was performed using Stata 13 software.
Free-text questionnaire responses were analysed using thematic content analysis using NVivo 10 software.
Ethics Committee and NHS Management Approvals
This study was approved on 4 July 2012 by the London Research Ethics Committee (reference 12/LO/0882).
The Portfolio Adoption Form was submitted on 30 April 2012 and permission for the study to proceed using
the Coordinated System for Permissions was granted on 3 May 2012. The application was submitted to
NHS Research and Development Offices through the Coordinated System for Permissions on 17 May 2012.
Notification that global governance reviews had been completed satisfactorily was received on 13 July
2012. In the 17 months between 13 July 2012 and 31 December 2013, the research team and Thames
Valley Clinical Research Network staff attempted to acquire the required NHS Management permissions.
Results
Quantitative analysis
Response rate and sample characteristics
The 315 women who had a peripartum hysterectomy to control haemorrhage between February 2005 and
February 2006 and the 608 matched controls identified in a previous study8 were reported by UKOSS
clinicians working in 148 UK hospitals. After 17 months of seeking NHS management approval for the
study, approval was obtained from 75% (111/148) of these hospitals. Study materials for 243 of the
women who had a hysterectomy and 468 of the control women were sent out to the UKOSS clinicians.
The clinicians reported sending on the study materials to a total of 408 women (145 women who had a
hysterectomy and 263 control women) and reported not being able to post out the study materials to a
total of 59 women (13 women who had a hysterectomy and 46 control women) for various reasons
including not being able to identify or not having the address of the woman concerned (Table 31).
Completed questionnaires were received from 78 women (30 women who had a hysterectomy and 48
control women) representing an overall response rate of 19% (21% for women who had a hysterectomy
TABLE 31 Losses to follow-up at each stage of the study
Stage of the study, n (%) Cases Controls
Initial study population 315 608
Approvals obtained 243 (77) 468 (77)
Materials sent 145 (60) 263 (56)
Woman responded 30 (21) 48 (18)
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and 18% for control women). All the results must be interpreted with extreme caution given this low
response rate and limited study power.
The mean time after the index birth that the questionnaire was completed was 8.1 years (range 7.4–8.6
years) for women who had a hysterectomy and 7.8 years (range 7.3–8.8 years) for control women. The
women who had a hysterectomy that responded to the questionnaire were more likely than the women
who had a hysterectomy who did not respond to be of white ethnicity [97% (29/30) vs. 75% (84/112);
p= 0.009] and were more likely to have a lower BMI at the time of the index pregnancy [mean 24 kg/m2
(range 18–31 kg/m2) vs. mean 27 kg/m2 (range 18–44 kg/m2); p= 0.037]. No other significant differences
were found between the women who had a hysterectomy who did and did not respond in terms of the
following characteristics recorded at the time of the index pregnancy: maternal age, socioeconomic group,
marital status, smoking status, current parity, mode of delivery, and whether or not the woman had a
multiple pregnancy, experienced problems in her pregnancy, delivered prematurely, was admitted to
ITU/HDU or experienced major morbidity (data not shown). The control women that responded to the
questionnaire were more likely than the controls who did not respond to be of white ethnicity [98%
(45/46) vs. 85% (176/206); p= 0.021] and at the time of the index pregnancy were more likely to be
≥ 35 years of age [40% (19/48) vs. 19% (40/215); p= 0.002], were more likely to have, or have partners
who had, a managerial or professional occupation [52% (23/44) vs. 28% (52/188); p= 0.002], were more
likely to have experienced major maternal morbidity [6% (3/48) vs. 1% (2/215), p= 0.044] and were less
likely to have smoked during pregnancy [9% (4/46) vs. 26% (56/212); p= 0.01]. There were no statistically
significant differences between the control women who did and did not respond in terms of the following
characteristics recorded at the time of the index pregnancy: marital status, BMI, current parity, mode of
delivery, and whether or not the women had a multiple pregnancy, experienced problems in her
pregnancy, delivered prematurely or was admitted to ITU/HDU (data not shown).
Comparing the self-reported characteristics of the questionnaire respondents by whether or not the
woman had a hysterectomy in the index pregnancy showed that the women who had a hysterectomy
were more likely during the index pregnancy, labour or birth to have experienced other problems, to have
had a caesarean delivery, to have delivered prematurely and their baby (or babies if multiple) was more
likely to have been admitted to a neonatal unit; no other significant differences in obstetric, infant,
sociodemographic or social characteristics were found (Table 32).
Health outcomes and health service usage
No significant differences in current health status as assessed by the SF-12v2, HADS and PSS-SR were found
between the questionnaire respondents who had and had not had a hysterectomy in the index pregnancy
(data not shown). However, the women who had a hysterectomy were more likely than those who had not
to report experiencing the following health/well-being problems in the first year after the index birth: pain,
depression, difficulties/pain during intercourse, severe tiredness/fatigue, ‘flash-backs’ to the labour or birth,
menopausal symptoms and difficulties concentrating (Table 33). They were also more likely to report
currently experiencing ‘flash-backs’ to the labour or birth and menopausal symptoms, although no
significant differences were found in the proportion reporting consulting their GP since the index pregnancy
about the reported health/well-being problems. Self-reported use of inpatient hospital services for health/
well-being problems experienced since the index birth was also not significantly different between the
women who had a hysterectomy and the control women [proportion reporting usage: 37% (11/30) vs. 19%
(9/48); p= 0.078; median number of times used: 1 (range 1–3 times) vs. 1 (1–4 times); p= 0.263]. The same
was true for self-reported use of day or out-patient services [proportion reporting usage: 54% (15/28) vs.
33% (15/46); p= 0.075]. The reasons for use of day or outpatient services were highly diverse.
The women’s family
When given several positive and negative statements about the effect their index birth experience had on
their relationship with their family, women who had a hysterectomy were more likely than control women
to strongly agree or agree that their birth experience had made it difficult to initially bond with their baby
(or babies), but they were no more or less likely than control women to report, when applicable, that their
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TABLE 32 Characteristics of questionnaire respondents
Characteristic
n (%)a unless otherwise
stated of cases (N= 30)
n (%)a unless otherwise
stated of controls (N= 48) p-value
Sociodemographic characteristics
Age (years)
< 35 4 (14) 9 (20) 0.468
35–39 5 (17) 11 (25)
≥ 40 20 (69) 24 (55)
Median age in years (range) 42 (31–49) 40 (28–47) 0.091
Ethnic group
White 28 (97) 45 (98) 1
Non-white 1 (4) 1 (2)
Age when left full-time education (years)
≤ 16 10 (33) 8 (17) 0.086
17 or 18 12 (40) 16 (33)
≥ 19 8 (27) 24 (50)
Socioeconomic group
Managerial and professional occupations 12 (40) 18 (38) 0.825
Other 18 (60) 30 (63)
Experienced stressful life events since index pregnancy
No 7 (23) 12 (25) 0.868
Yes 23 (77) 36 (75)
Median number of stressful life events
experienced since index pregnancy (range)
3 (1–8) 1.5 (1–6) 0.220
Given enough help and support from partner/husband, other family members or friends in first year after index pregnancy
Yes, definitely, or to some extent 29 (100) 41 (87) 0.077
No 0 (0) 6 (13)
Given enough help and support from partner/husband, other family members or friends in the last 12 months
Yes, definitely, or to some extent 28 (93) 44 (92) 1
No 2 (7) 4 (8)
continued
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TABLE 32 Characteristics of questionnaire respondents (continued )
Characteristic
n (%)a unless otherwise
stated of cases (N= 30)
n (%)a unless otherwise
stated of controls (N= 48) p-value
Obstetric and previous health characteristics
Parity
1 7 (23) 10 (21) 0.061
2 10 (33) 28 (58)
≥ 3 13 (43) 10 (21)
Median parity (range) 2 (1–9) 2 (1–5) 0.214
Experienced other problems during index pregnancy, labour or birth
No 9 (30) 26 (57) 0.023
Yes 21 (70) 20 (43)
Caesarean delivery in index pregnancy
No 10 (33) 33 (69) 0.002
Yes 20 (67) 15 (31)
Pre-term delivery (< 37 weeks) in index pregnancy
No 16 (59) 42 (98) < 0.001
Yes 11 (41) 1 (2)
Baby (or babies) admitted to neonatal unit in index pregnancy
No 12 (40) 45 (94) < 0.001
Yes 18 (60) 3 (6)
Index pregnancy baby (or babies) have long-term health problems now
No 22 (73) 43 (90) 0.061
Yes 8 (27) 5 (10)
Woman had long-term health/well-being problems before index pregnancy
No 22 (76) 41 (87) 0.201
Yes 7 (24) 6 (13)
a Percentage of women with complete data.
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birth experience had positively or negatively affected their relationship with their other children or their
partner/husband. When asked when they first felt like their baby (or babies) from their index pregnancy
really belonged to them, as another indication of bonding, women who had a hysterectomy were less
likely than the control women to respond ‘during pregnancy’ or ‘at the birth’ [48% (14/29) vs. 89%
(42/47); p< 0.001]. Women who had a hysterectomy were also less likely than control women to report
first seeing, touching, holding or feeding their baby at the birth or the first day, were less likely to report
having as much contact as they wanted with their baby shortly after birth and were less likely to report
exclusively breastfeeding, although this difference in breastfeeding rates was only statistically significant in
the first 6 weeks after birth (Table 34). The proportion of women reporting planning/wanting to have
more children prior to the index labour/birth was similar between the women who had a hysterectomy and
the control women [50% (15/30) vs. 52% (24/46); p= 0.853].
TABLE 34 Respondents’ self-reported contact with and feeding their baby or babies from their index pregnancy
n (%)a of cases
(N= 30)
n (%)a of controls
(N= 48) p-value
When first got to see baby
At the birth or first day 23 (77) 46 (100) 0.001
First week or more than a week 7 (23) 0 (0)
When first got to touch baby
At the birth or first day 16 (53) 47 (100) < 0.001
First week or more than a week 14 (47) 0 (0)
When first got to hold baby
At the birth or first day 12 (40) 46 (100) < 0.001
First week or more than a week 18 (60) 0 (0)
When first got to feed baby
At the birth or first day 10 (33) 44 (94) < 0.001
First week or more than a week 20 (67) 3 (6)
Shortly after gave birth, whether or not able to have as much contact as wanted with baby
Yes 6 (21) 37 (77) < 0.001
No 23 (79) 11 (23)
How fed baby in the first week after birth
Breast milk only 11 (39) 28 (60) 0.089
Both breast and formula milk or formula milk only 17 (61) 19 (40)
How fed baby in the first 6 weeks after birth
Breast milk only 4 (14) 19 (40) 0.018
Both breast and formula milk or formula milk only 24 (86) 28 (60)
How fed baby in the 6 months after birth
Breast milk only 3 (12) 9 (19) 0.519
Both breast and formula milk or formula milk only 23 (88) 38 (81)
a Percentage of women with complete data.
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Experience during and after index pregnancy
When asked to describe their index birth experience using an adjective checklist, women who had a
hysterectomy were more likely than those who had not to describe their birth experience as terrifying,
traumatic, awful and upsetting (Table 35). They were also less likely to describe their birth experience as
rewarding, happy or joyful. Of the women who had expectations about their index birth experience prior
to their labour or birth, the proportion of women reporting their actual birth experience was ‘worse’ or ‘a
lot worse’ than expected was higher, although not statistically significantly so, in the women who had a
hysterectomy than the control women [74% (17/23) vs. 54% (21/39); p= 0.117].
There was no significant difference between the questionnaire respondents who had and had not had a
hysterectomy in terms of their rating of the overall quality of care they received in the labour/maternity
ward, postnatal ward, ITU/HDU or first 6 weeks after the index birth following discharge from hospital.
There was also no significant difference between the respondents who had and had not had a
hysterectomy in terms of the proportion reporting not being given enough information about their own
recovery after the index birth [22% (6/27) vs. 27% (12/45); p= 0.673]. When the women who had a
hysterectomy were asked how well they felt the problems and procedures leading up to their hysterectomy
were explained to them, 35% (9/26) responded ‘not very well’ or ‘not at all well’. There were no
significant differences in the proportion of women reporting that they would have liked, but had not,
TABLE 35 Adjective(s) questionnaire respondents used to describe index birth experience
Adjective n (%) of cases (N= 30) n (%) of controls (N= 48) p-value
Positive adjective
Straightforward 4 (13) 8 (17) 0.691
Rewarding 5 (17) 21 (44) 0.014
Wonderful 4 (13) 14 (29) 0.106
Perfect 2 (7) 4 (8) 1
Positive 1 (3) 9 (19) 0.079
Happy 4 (13) 16 (33) 0.049
Good 3 (10) 10 (21) 0.212
Joyful 4 (13) 19 (40) 0.013
Satisfying 1 (3) 4 (8) 0.644
Okay 2 (7) 8 (17) 0.301
Negative adjective
Terrifying 13 (43) 10 (21) 0.034
Traumatic 22 (73) 16 (33) 0.001
Unpleasant 9 (30) 6 (13) 0.056
Awful 12 (40) 4 (8) 0.001
Scary 17 (57) 23 (48) 0.452
Disappointing 8 (27) 5 (10) 0.061
Negative 7 (23) 4 (8) 0.064
Medicalised 10 (33) 9 (19) 0.144
Painful 17 (57) 25 (52) 0.693
Upsetting 17 (57) 9 (19) 0.001
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talked to a doctor/midwife present during their labour/birth (p= 0.722), another doctor/midwife not
present during their labour/birth (p= 0.515), a GP (p= 1.000), a health visitor (p= 1.000) or a counsellor/
therapist (p= 0.099). The proportion of women reporting that they were not offered, but would have
liked, the opportunity to look through their hospital notes since their index birth was similarly high among
the women who had and had not had a hysterectomy [63% (19/30) vs. 60% (28/47); p= 0.742]. When
asked whether or not they had heard of or found any useful support group(s) since their index birth,
women who had a hysterectomy were more likely to report that they had not, but would have liked to
have, found this [59% (17/29) vs. 23% (11/47); p= 0.002].
Qualitative analysis
Overall, 71% (55/78) of respondents to the questionnaire responded to the free-text question asking them if
there was anything else they would like to say about their care during their index pregnancy, labour and
birth or since birth. In addition, 23% (18/78) responded to the free-text question asking them if there was
anything else they wanted to tell us. There were no significant differences in the characteristics of the women
who did and did not respond to at least one of these free-text questions. The majority of the free-text
responses were either entirely negative or a mixture of negative and positive in their tone and content.
The content of the responses fell within a number of themes outlined below. In many themes, similar views
were expressed in both cases and controls; comments from both groups of women are, therefore, included.
Theme: the staff providing care
The majority of women’s comments concerned the staff caring for them. Although some women
expressed their views of the staff through single words such as ‘fantastic’ and ‘brilliant’, others wrote
larger responses which fell within four main themes: the clinical care and competence of staff; the
communication skills of and information provided by staff; listening skills/respect shown by staff; and the
helpfulness/supportiveness of staff.
Subtheme: the clinical care and competence of staff
Some women felt that they received all the correct clinical care and their outcome was an
unfortunate necessity:
I feel that everything that was done was the current management and unfortunately my hysterectomy
was a necessity in order to save my life
Case, multiparous
By contrast, it was not uncommon for both women who had a hysterectomy and control women to be left
questioning the clinical skill and competence of the staff caring for them having experienced an outcome
they considered to be avoidable:
. . . they did a regular (every 2 weeks) internal scan. However they never looked carefully enough to
realise the placenta [was] growing out of [my] womb and my baby and myself were in great danger
. . . They could have avoided this happening to me and my family.
Case, multiparous
I also had a catheter fitted wrong which did not let urine pass and I ended up with tremendous pain
in my kidneys. I could go on and on about the clinical errors!
Case, multiparous
I needed a C-section [caesarean section] in an emergency as my son got stuck – he was 10lb 1oz! –
I really feel this outcome could have been predicted and the trauma of an emergency section could
have been avoided. If I had been advised to have a planned section on the grounds of a big baby I
would have taken that advice. But I went through an ‘induction’, labour and then rushed to theatre.
Not a very pleasant experience.
Control, multiparous
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I felt that too little was done to assess whether it was worth me labouring on naturally for almost
20 hours and making no progress – my baby was in a difficult position and I think medical
intervention much earlier on would have been a better use of everybody’s time. I experienced a
vaginal delivery but was exhausted/completely numb and my baby had to be ‘yanked out’! Not
very natural!
Control, multiparous
Women from both groups expressed feeling traumatised having being given inadequate pain relief:
I could not move and I was in so much pain. My pain relief was stopped too early and it wasn’t until
I was in so much pain I couldn’t cope that they gave pain relief back. I felt like I was being tortured.
Case, multiparous
During the section I felt pain so badly, I was crying out to my husband, then I felt my self ‘going’ and
my husband said my face drained of colour and the lady gave me an injection.
Control, multiparous
Subtheme: the communication skills of and information provided by staff
Having a clear understanding of what was happening to them was very important to some of the women
who experienced complications. Several women who had a hysterectomy described good communication
with health professionals about this. For example, one woman reported how helpful she found discussions
with her consultant, who clearly explained the possible consequences of her condition before she gave
birth and 1 week after she gave birth talked her through exactly what had happened to her:
My consultant had full and frank discussions with my husband and me when the pregnancy
abnormalities were detected. So we were forewarned that the birth was likely to be premature with a
high risk of major bleeding and potential for high dependency/intensive care post delivery. About a
week after the birth my consultant talked me through the pregnancy and birth from the medical side,
explaining every event and decision in detail, sparing no information. This was really helpful to me as it
meant I had no gaps in knowledge and enabled me to quickly understand and accept what happened.
Case, multiparous
Although one woman who had a hysterectomy did not understand what had happened to her, possibly
because she was told but ‘too ill to take it in’, she describes how much her husband appreciated being
given a detailed explanation by a member of staff:
There was a member of staff at the hospital who spent a good 20 minutes explaining to my husband
about the hysterectomy I had (I was too ill). He was upset that I’d had to have it but she explained in
great detail . . . It was an informal chat that helped my husband enormously and he mentioned many
times how grateful he was for her taking the time. He was so relieved and it took a lot of worry away.
Case, multiparous
Some women in the control group were left unsure of what had happened to them and in need of
further explanation:
I was induced at 42 weeks and yet my daughter was underweight and subsequently lost weight.
I therefore stayed in hospital for 5–6 days following. I would have liked to understand why this was/
why the health professionals were so cautious with my next pregnancy (a year later) as a result.
Control, multiparous
Four days after being induced left in private room with only paracetamol for pain and no information
about what was happening to me.
Control, multiparous
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Consistent with the quantitative results, several women from both groups also commented that they
would have liked to have had the opportunity to look at their hospital notes.
It was also not uncommon for both women who had a hysterectomy and control women to report that
their experience had been affected by the way in which staff communicated with them or their partner:
The only complaint I have and had at the time was with one particular nurse . . . This nurse was so
unpleasant to me and others that I still think about her today. She was a very cruel lady and should
not be nursing.
Case, multiparous
The first midwife was a bully and frightened me to such an extent that despite being fully dilated my
contractions stopped. I felt I had no control over what was happening to me. The second midwife was
excellent and positive.
Control, multiparous
My child was born underweight and the consultant/doctor who came to see me in the hospital asked
‘what have you done to make her so small?’!!
Control, multiparous
She [midwife] referred me to the hospital one evening when I was in pain – this turned out to be
‘Braxton Hicks’ but I was never made to feel as if I was a nuisance. After my baby was born and my
placenta wasn’t delivered straight away I didn’t feel frightened that things weren’t going to plan.
The midwives were very positive in their actions and I didn’t feel rushed.
Control, primiparous
Subtheme: listening skills/respect shown by staff
There were women who had a hysterectomy and control women who felt that staff did not properly listen
to or respect their wishes, choices or concerns at various stages, which some found very upsetting:
After birth was in major pain and no one believed me for 6 hours until they did a ultrasound scan so
was very upsetting and scary.
Case, multiparous
Baby was quite high and as I was induced they told me they had to break my water. I asked them not
to as if I was a few more cm’s dilated it would be a very quick labour the same as my others. They
said it was hospital policy to break my waters at this stage!! They held me down 3 nurses. I told them
I didn’t want it done.
Case, multiparous
I was encouraged at prenatal classes to write a birth plan but this was ignored. The midwife at the
birth did not want me to use my preferred birthing method (stool) and I didn’t get to use one until
there was a shift change.
Control, multiparous
Baby had episodes of turning ‘blue’ – it was of great concern. Cord around neck at birth. I informed
staff who didn’t seem concerned and didn’t even look/examine baby. No information/
reassurance given.
Control, multiparous
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Subtheme: supportiveness/helpfulness of staff
There were women who had a hysterectomy and control women who were very positive about the care
and support they received from certain staff:
Excellent care from very caring staff pre and post surgery/birth.
Case, primiparous
I felt extremely looked after by people in the [hospital] during scans and regular check ups . . .
Midwife present [at the birth] was very good and helpful – let us get on with it and gave assistance
when/where necessary. She was brilliant.
Control, multiparous
Our midwife was wonderful – she had been the second midwife when our previous baby was
stillborn. She saw my name on the list and offered to be with us. She just knew how to look after me
and my mind. I wish I could see her again and tell her how truly wonderful she was.
Control, multiparous
However, many women reported feeling alone and unsupported by hospital staff shortly after giving birth,
in the sense that they felt they received inadequate basic care themselves and/or insufficient assistance
with the basic care of their baby. This was not limited to women who had a hysterectomy.
There were times when I had very bad bleeds and I was left on a few occasions to lie in my own body
fluids for a number of hours.
Case, multiparous
After birth on the ward I was hardly bothered with when it came to being washed and teeth cleaned.
I could not move and I was in so much pain.
Case, multiparous
My hospital care after my baby was born was sparse. The ward was very busy and as an older mum
I seemed to be left to my own devices – I really didn’t know what to do with my baby – I found
feeding her hard and I didn’t change her nappy until my husband came to see me later that day
(a good 5/6 hours after she was born). I could have done with more support just after the birth.
Control, multiparous
Next morning I woke to find that I was saturated in blood, bed was sodden I had to ask for help and if
the bed could be cleaned. Found picking up baby very difficult and so painful wasn’t offered any help
in doing so, could feel stitches pulling every time. Not a good experience for a 1st time mum.
Control, primiparous
Establishing breastfeeding can be difficult for women, particularly after a severe complication. Only one of
the women who had a hysterectomy commented about breastfeeding, describing an example of good
breastfeeding support in ITU:
When I woke in intensive care [a nurse] called maternity to ask for my son to be brought to intensive
care. While in intensive care a midwife helped me to express breast milk as they knew breast feeding
was important to me.
Case, primiparous
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However, it was not uncommon for control women to report receiving inadequate breastfeeding support:
Felt unsupported in breastfeeding. Midwife advised me to get formula even though baby was feeding
well. Not given advice on support group for breastfeeding.
Control, primiparous
Following discharge from hospital, while some women were happy with the care they received others
commented that they would have liked more support. This was not limited to women who had
a hysterectomy.
I suffered the most awful postnatal depression and there is a distinct lack of mental health support.
This needs to be addressed as I had suicidal thoughts often in the two-three years after the birth of
my son.
Case, primiparous
I saw a private physio[therapist] afterwards to help with pelvic floor after weakness – would have liked
some follow up care from NHS on this.
Control, multiparous
Theme: organisation/structure of care
Various aspects of the organisation/structure of care were commented on by several women, falling into
four main themes: length of postnatal stay in hospital, staffing levels, continuity of care and
setting/environment.
Subtheme: length of postnatal stay in hospital
While one control woman felt she was discharged too soon from hospital after giving birth, a few were
happy to leave sooner, some because of poor care:
I was discharged after 6 hours, I feel it was too early.
Control, primiparous
I was then taken to [the ward], this care was awful, I was not feeling very well and had a bleed in my
bed. I was made to change this myself whilst in a lot of pain. I was in this ward for 3 days. I was very
pleased when I was allowed to go home.
Control, primiparous
Subtheme: continuity of care
There were several brief comments from both women who had a hysterectomy and control women
suggesting that continuity of care could be improved. One woman expressed thoughts about treatment by
different doctors:
The care I had was amazing in ICU and HDU. However, some of the treatment was chaotic – different
doctors had different opinions on treatment. Luckily my midwife monitored me obsessively.
Case, multiparous
Subtheme: setting/environment
The experience of intrapartum or postpartum care of both groups of women was affected by features of
the setting/environment:
I was moved to the critical care ward on the delivery suite where I was allowed to stay for 5 days until
discharge, avoiding a busy ward.
Case, primiparous
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After the birth I was put in the ward for mums whose baby’s were in [the special care baby unit] –
not a great place to be as the only one with a baby in the room especially as some of the mums had
very sick babies and I had not long lost a child.
Control, multiparous
Theme: long-term impact of birth experience
Several women included remarks about the extent to which their birth experience had affected them
and/or their families. There were women from both groups whose birth experience does not seem to have
caused adverse impacts:
I did not become a midwife because of my birth experience but I do not know if I would be a midwife
today if that had not happened.
Case, multiparous
Although long and difficult, my labour resulted in a beautiful healthy baby and did not adversely
affect me.
Control, multiparous
I didn’t want to talk to anyone at the [hospital] about my birth because at the time I just wanted to
put the whole experience behind me and I had a beautiful baby girl which we had longed for. Looking
back now I realise how lucky we were because things could have been a whole lot worse.
Control, multiparous
However, several of the women who had a hysterectomy commented on the long-lasting detrimental
impacts of their birth experience on their own physical and/or mental health and some also spoke of the
adverse effects on other family members:
It was a miracle we were both alive. As my surgeon said though I lost 10 years of my life. I spent
15 hours in theatre and a year to recover. Still physically and mentally affected by it. It had a great
impact on my life and always will. I’m not the same person any more.
Case, multiparous
After the shock of losing my womb I felt very down and not like a complete woman any more.
I would give anything to still have my womb and be having periods and then naturally gone into the
menopause. Instead I went into the menopause at the age of 42. I feel old before my time and it still
gets me down. My libido has all but vanished and this has put a strain on my marriage to a degree.
Case, multiparous
Mum had to give up work to look after me. I was bed bound for 6 weeks. I still had pain today.
Case, multiparous
One woman who had a hysterectomy reflected on how she would have liked to have had more children,
while another commented that she had gone on to adopt a child to complete her family:
It is a shame the condition was not picked up earlier as I would have liked to have had more children.
Case, multiparous
We adopted a second son to complete our family.
Case, primiparous
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Although able to have more children, one of the control women, who experienced a perineal tear and an
emergency caesarean delivery, reflected that she needed months of physiotherapy, experienced nightmares
about the experience and was unable to contemplate having more children for years after:
I was left with a 7 1/2 inch scar and extremely painful scar tissue (internally) which needed months of
physiotherapy. I was unable to even think about having another baby for years and had continuous
nightmares about my whole experience.
Control, multiparous
There were other control women who commented how their birth experience affected their approach to
future pregnancies:
My experience made me request a home birth for my second child.
Control, multiparous
After my experience with the birth of my son in [hospital] it made me very upset and put me off
having another baby at that hospital.
Control, primiparous
Conclusions and implications for policy and practice
All the conclusions about the results of this study must be tempered by the extremely low response, which
was due to a combination of factors including difficulty in obtaining permissions to undertake the study,
which was undoubtedly severely damaging and effectively renders this and similar studies unfeasible;
reliance on third parties (reporting clinicians) to post questionnaires and the length of time since the index
birth (averaging 8 years). Nevertheless, there were some indications of long-term morbidities following the
initial hysterectomy. Women who had a peripartum hysterectomy to control haemorrhage were more likely
than women who gave birth but did not have a hysterectomy to experience pain, depression, difficulties/
pain during intercourse, severe tiredness/fatigue, ‘flash-backs’ to the labour or birth, menopausal
symptoms and difficulties concentrating in the first year after their birth. They were also more likely to
experience ‘flash-backs’ to the labour or birth and menopausal symptoms 7–8 years after the index birth.
In addition, they were more likely to have difficulties bonding with their baby (or babies, if multiple) born
in the index pregnancy and less likely to exclusively breastfeed this baby, at least in the first 6 weeks
after birth.
We did not observe any significant differences in the sociodemographic, social or previous health
characteristics of women who had and had not had a hysterectomy that could have accounted for the
differences found in women’s health, infant bonding and breastfeeding rates between these groups of
women. However, as expected, the women who had a hysterectomy were more likely during the index
pregnancy, labour or birth to have experienced other problems, to have had a caesarean delivery, to have
delivered prematurely and their baby (or babies, if multiple) was more likely to have been admitted to a
neonatal unit, which could offer alternative explanations for some of the observed associations.
The study clearly has a number of limitations. The response was low, with small numbers of women
completing the questionnaire, limiting the power of the study to detect real differences as statistically
significant. Furthermore, there is a possibility of response bias, with the women who had a hysterectomy
that responded to the questionnaire being more likely than the women who had a hysterectomy but did
not respond to be of white ethnicity and more likely to have a lower BMI at the time of the index
pregnancy. There was also evidence that the control women who responded to the questionnaire were
more likely than the controls who did not respond to be of white ethnicity and at the time of the
index pregnancy were more likely to be ≥ 35 years of age, more likely to have a higher socioeconomic
status, more likely to have experienced major maternal morbidity and less likely to have smoked during
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pregnancy. Another limitation of our study is that our findings are based on self-report, which could have
introduced bias based on women’s comprehension of questions, on their desire to respond appropriately
and the degree to which they were able to accurately recall information.
Nonetheless, the qualitative analysis of the questionnaire responses highlighted a number of examples of
good practice with regard to maternity care and examples of when care could have been improved, falling
within the following themes: the clinical care and competence of staff; the communication skills of and
information provided by staff; the listening skills/respect shown by staff; the supportiveness/helpfulness of
staff; the length of postnatal stay in hospital; staffing levels; continuity of care; and the setting/
environment. In common with the theme identified in the qualitative study reported in Chapter 2, a
number of women identified a perceived need for counselling services. It is striking that many of these
themes were also observed in the responses of the women who did not have a hysterectomy. In view of
the clear messages for services identified in this chapter and Chapter 2, the qualitative study results were
used as the basis for an investigation of experience-led commissioning (ELC) for maternity care. This is
described in the following chapter.
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Chapter 10 Taking forward women’s and their
partners’ experiences: an investigation of
experience-led commissioning for maternity care
Background
Experience-led commissioning is a commissioning process that provides a way of using patient experience
as an integral part of clinical commissioning in the NHS. The aim of ELC is to put the experience of people,
families and frontline teams at the centre of clinical commissioning by using ‘robust patient experience
insights and co-design’ (Georgina Craig, designer of ELC methodology, personal communication) in a
systematic way. ELC is relevant to the current movement within the NHS towards a more user-centred
service, for which any modernisation of the NHS involves putting patients ‘at the centre of everything the
NHS does’,208 by giving them more choice and control. A recent UK Government White Paper stated that
this change will be achieved using the principle ‘no decisions about me without me’ and that services will
be designed around users, rather than expecting users to fit into services.209
The ELC combines a number of person-centred approaches (e.g. social marketing, social movement theory,
Planning Alternative Tomorrows with Hope exercise, The Esther Project)210 and draws on the principles and
practice of Experience Based Co-Design.211–213 ELC brings Experience Based Co-Design principles and other
person-centred approaches into commissioning and combines them with the use of the highest level of
user qualitative evidence. In order to develop an ELC strategy, the relevant qualitative data are combined
with local views and ‘traditional’ commissioning data sets (e.g. public health and service use) to better
understand local need and experience. At the local level, qualitative data for ELC are gathered from a
sample of local participants (including service users, frontline medical staff, GP commissioners and service
providers). In addition to collecting local stories and to aid implementation of the ELC strategy, local
co-design events also bring stakeholders together to respond to the insights and design solutions that
build on local assets. This helps build a sense of ownership and commitment to the commissioning
strategy, as well as momentum and energy for change.
It is clear from the outputs of the qualitative work conducted as part of this programme that benefit to
patients will best be realised through changes to commissioned services. However, it is not clear how these
data can be best used to inform commissioning processes. The aim of this workstream was to investigate
the use of the ELC model for commissioning maternity services, informed by the qualitative data on
women’s experiences of severe maternal morbidity, and compare this with a service commissioned through
a standard process not informed by these data.
Research questions
l What are participants’ views of the different commissioning processes?
l How do commissioned models of maternity care differ with and without the ELC approach?
l What are the costs of commissioning using the ELC model and how do they compare to standard
commissioning costs?
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Methods
Selection of intervention and comparison Clinical Commissioning Groups
To recruit a Clinical Commissioning Group (CCG) to apply ELC to maternity services commissioning,
expressions of interest were sought from CCGs who were actively planning to recommission maternity
services. We sought CCGs that were representative of the diversity of the UK population. CCGs who had
previously applied ELC were excluded. Two CCGs, located in mixed urban/rural areas with a diverse
multiethnic population expressed interest and these were randomly allocated as intervention and
comparison groups. After allocation, the intervention CCG decided that it no longer wished to undertake
the ELC process. We were unable at this stage to identify another CCG actively recommissioning maternity
services and, therefore, the allocations were reversed and the intervention CCG became the comparison
CCG and vice versa. Once the ELC intervention CCG had agreed to do the work, other local CCGs decided
to work with them but with the ELC intervention CCG leading.
Evaluation
The evaluation focused on three aspects of the ELC project in particular: the development of a
commissioning strategy for maternity services using ELC; the implementation of the ELC strategy for
maternity services (including barriers and facilitators to implementation); and the cost implications of
applying ELC for maternity services commissioning.
The evaluation followed a predominantly qualitative, comparative case study design. Here, we triangulated
multiple sources of data including interviews with key stakeholders who were involved in the ELC for
maternity services project (and a comparison group – a CCG cluster that did not use ELC for their
maternity service commissioning). We undertook observations of events and included a documentary
analysis. The cost implications analysis examined the costs associated with the development of a
commissioning strategy, including staff/stakeholder’s time and resources, for both the ELC and
comparison groups.
The aims of the evaluation were to:
l investigate how ELC operates in a CCG for a health area where it has not been used previously
(maternity services)
l collect comparison group data (a CCG cluster that did not use ELC for their maternity service
commissioning) in order to compare the commissioning processes and strategies between groups to
establish what facilitated ELC might offer maternity services
l document any therapeutic potential for mothers (and partners/family) who have had difficult
experiences during maternity, as an outcome of their involvement in the ELC process
l establish how the ELC programme works in maternity services
l examine the cost implications of ELC for maternity services.
Sampling
The ELC interview participants were recruited predominantly from ELC events, but also via the ELC
facilitators, both using convenience sampling. To examine the development stage of the ELC strategy,
19 key stakeholders involved in the ELC for maternity services project were invited to participate and
agreed to be interviewed. Mothers, GP commissioners, health professionals, service providers, patient
representatives, representatives from the Strategic Clinical Network and NHS England, and those delivering
ELC were all recruited into the evaluation. All participants who were invited to participate in an interview
agreed, with exception of one professional who did not respond to the e-mail invitation.
The ELC interview participants for the phase of the research that examined the implementation of the ELC
strategy were recruited predominantly through researcher contacts developed from the first set of
interviews and observations of ELC events, but also through the ELC staff and facilitators and members of
the lead CCG. Ten key stakeholders (GP commissioners, health professionals, service providers, contracts
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team and those delivering ELC) who had been involved in the implementation of the ELC strategy were
invited and agreed to be interviewed. Service users were not included in the sample as, at the time of the
interviews, they had not been involved in the implementation.
We compared the ELC intervention group with the comparison group to shed light on the differences in
commissioning processes, strategies and implementation to establish what ELC might offer maternity
services (including a comparison of cost data). For the comparison group, a focus group (n= 4) and
individual telephone interviews (n= 3) were conducted with staff who had been involved in maternity
services commissioning for their CCG (including commissioners, clinical staff and staff involved
in contracting).
Data collection
Interviews were conducted using a semistructured approach. For the strategy development phase of the
research, ELC participants were interviewed by a member of the evaluation team at ELC events (n= 4), by
telephone (n= 9) or by face-to-face interview elsewhere (in their home, at their workplace and at the
University of Westminster, according to participant preference) (n= 6). The interview schedule aimed to
elicit participant views and experiences of ELC. For the strategy implementation part of the research,
interviews were conducted 5–6 months after the ELC strategy had been developed. Interviews were
conducted by telephone (n= 8) or face to face in the workplace (n= 2). The interview schedule aimed to
ascertain what (if any) steps towards implementing ELC recommendations had been made and barriers
and facilitators to making these changes.
Research observations were conducted at 9 out of 13 of the ELC events and at other meetings including at
three meetings in which the ELC team discussed their findings with the medical community and at two
implementation planning meetings. The researcher kept a fieldwork journal with observations of ELC
events and notes of key points from ELC e-mails and conversations. For the first two ELC events, journal
entries were unstructured in order to gain a feel for the kind of information gathered. Once the data were
reviewed, it was decided that it would be best to use a system for recording subsequent events to improve
the rigour of observations. This system ensured all the relevant phenomena of interest were covered by the
observations at each event. An amended version of the checklist structure recommended by Merriam214
was used. This checklist was modified based on observations of the first two ELC events to increase
its relevance.
Representatives from the comparison group CCGs were interviewed using a focus group lasting
approximately 2 hours and telephone interviews lasting between 30 and 48 minutes. The focus group/
interviews were conducted using a semistructured approach. Questions aimed to establish the approach
they had used to commissioning (including the extent of user and health professionals’ involvement),
perceived advantages and disadvantages of this approach and ease of implementation of the strategy. In
addition, in order to gain opinions of ELC resources, focus group participants were shown the ‘trigger film’
used at ELC events (see Box 4) and asked their opinions on the film.
The ELC documents and information were provided for the analysis by the ELC team and the lead CCG.
Comparison group documents and information were provided by the CCG and from publicly
available information.
Data analysis
Interviews and the focus group were typed up verbatim by a professional transcriber. The data were then
analysed using thematic analysis.215 The first researcher (AC) immersed herself in the data to develop an
initial list of themes/codes, which was then debated with a second researcher (DR) to arrive at a final
coding list. Data were inputted and explored in the qualitative data analysis software environment, NVivo
10. Typical quotations are used to illustrate findings. The role of the person making the quotation (e.g.
user, GP) is not stated in order to preserve participant anonymity. Comparison group experiences of
commissioning are used to supplement, enhance, clarify and contrast findings from the ELC intervention
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group. As the two groups were at different stages in commissioning it created difficulties in drawing out
firmer conclusions from the comparison. Data from researcher observations of ELC events are used in
particular to set the evaluation findings in context, to support, explain, critique and expand on the
interview data and to highlight information that was not recorded in the interviews. For the ELC strategy
implementation phase of the research, data from the follow-up interviews were used, but also
supplemented with some reflections on moving forward from the initial set of interviews.
The documentary analysis examined the commissioning documents from the intervention and comparison
groups for differences in their scope, focus, content and patient-centredness. To complement this paper
analysis, key commissioning documents were analysed in NVivo 10, in which word frequency searches
were conducted to generate word clouds. Other documents available to the research team were used as
background information for the report and to set the evaluation findings in context.
Cost implication analysis
The cost implication analysis of ELC for maternity services set out to estimate the full cost of developing
and implementing ELC, and to assess these costs set against the outcomes achieved as a result of the
introduction of ELC. The estimates aimed to determine the marginal costs and costs relative to outcomes.
At the time of reporting, only limited data for outcomes achieved were available. Therefore, this interim
economic analysis looked at the development phase of the ELC strategy only and does not include an
evaluation of the costs associated with implementation and the total costs incurred relative to outcomes.
Data for the cost analysis were collected through discussions with key stakeholders from the ELC
facilitators and comparison group. They provided data on the specific costs involved and other resource
input (e.g. staff/stakeholder time). In addition, the interviews with the ELC group (see Methods, Evaluation)
collected information on the amount of time stakeholders had invested in the development of the ELC
strategy to input into the cost estimates.
The ELC development activities took place between December 2013 and May 2014. Salary costs for NHS
staff were estimated from publicly available sources: the Annual Personal Social Services Research Unit Unit
Costs of Health and Social Care 2013,134 and the NHS Jobs website (www.jobs.nhs.uk).216 An opportunity
cost approach was taken to cost the time of service users. The national hourly minimum wage was
assigned to their participation in stakeholder events. The majority of service users were on maternity leave
and, as such, a stricter estimate of the cost of their time would depend on knowledge as to their
employment role, whether they were employed full- or part-time and the terms of their maternity leave. It
was not feasible within the scope of the present study to capture all of this information, so the national
minimum wage, while likely an underestimate, was used. Costs were assessed at 2014 levels (using
estimated inflation indices where necessary). Costs are reported as observed for the period of the
development activities and are not extrapolated to annual costs.
Results
The intervention and comparison groups
Table 36 provides a comparison of the main characteristics of the ELC intervention and comparison groups.
Although there are similarities, there are also important differences between the two groups. For example,
the comparison group has longer-standing roles and more developed relationships than the intervention
group. In addition, the groups were at different stages in their commissioning cycles. Note that although
the national qualitative work undertaken to inform ELC collected experiences of women who experienced
severe maternity morbidity, additional local data collected meant that a commissioning strategy for all
maternity services was developed. The overall strategic commissioning aims are therefore comparable.
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Participants’ views of the commissioning process
The experience-led commissioning process
Recruitment
The first step in developing the maternity services commissioning strategy was recruitment of key
stakeholders by the lead CCG and the ELC team to ELC events and activities. This included mothers who
had recently experienced an unexpected maternity event around the birth of their child and had used the
local hospital, their families and relevant frontline health professionals. Many mothers were eager to be
involved once they had heard about the project and some were even concerned that it was not publicised
more widely to women through health professionals’ channels:
I was so delighted when I saw that poster, I jumped at the opportunity.
Public participant
I don’t think everyone knows about the initiative, so I think perhaps an improvement would be to let
more people know so that more people could feed back on it . . . maybe a leaflet or a card with your
discharge papers.
Public participant
The lead CCG was tasked with engaging with key professionals, commissioners and managers who would
be responsible for decision making in the CCG, and developing and implementing the ELC-based strategy.
This task proved to be complex and time-consuming:
TABLE 36 Comparison of characteristics of the ELC intervention and comparison groups
Intervention group Comparison group
Lead CCG working with three other local CCGs to develop
a commissioning strategy for unexpected experiences of
maternity care
Cluster of three local CCGs working together to develop a
commissioning strategy for all maternity services
Work was conducted by the ELC support team, working
with CCG GP commissioners and lead CCG women’s
clinical lead
Work was conducted by CCG Children and Maternity
Services commissioners who have clinical background in
maternity/children’s services
Relationships between commissioners and providers were
comparatively less well developed
CCG commissioners had well-developed and long-standing
relationships with, and systems for working with,
commissioning partners and providers (e.g. primary and
secondary care management)
Adopted an entirely novel approach (ELC) to develop a new
commissioning strategy
Updated and refreshed their existing maternity strategy,
using national and local quantitative data and guidelines
Discussed prioritising and valuing user engagement in
developing their commissioning strategy
Discussed prioritising and valuing user engagement in
developing their commissioning strategy
User engagement: women and families were asked to share
their experiences of birth and using maternity services, as
part of the strategy development. This process began with a
blank sheet of paper rather than a list of pre-defined
questions. Women and families codesign the strategy with
frontline health professionals
User engagement: women and families were asked to
share their opinions of maternity services, and ongoing
feedback (e.g. friends and family test) was reviewed as part
of strategy development. In addition, women and families
were asked to comment on the strategy once it had been
developed. They were given specific options to choose
from/asked about specific pathways
Frontline health professionals were asked about their
experiences of delivering maternity services as part of the
strategy development. Frontline health professionals
codesigned the strategy with women and families
Frontline health professionals’ managers were specifically
consulted during strategy development
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We have the relationships with the communities, and that, you can’t replace that. So it does take time.
It does take your time to get, build those relationships, guide and navigate this to the place where we
know we need to get to. Talk to the seniors, talk to the grassroots, get everybody aligned to a place.
CCG participant
Participant engagement
It was generally agreed by participants that ELC achieved meaningful engagement, particularly with
mothers. Engagement was thought to be helped when ELC events avoided medical terminology and
acronyms, did not require expert/medical knowledge for women to participate, welcomed babies, were run
at accessible locations (where mothers were, e.g. community locations) and times, encouraged ‘friendly’
atmospheres, and organised participant discussions in small groups:
I think it [ELC] also helps us focus [on] our marginalised groups as well and those groups that are often
under heard and it encourages us to actually get out to those groups and not necessarily expect them
to come to us, but us actually go to them.
CCG participant
I was a bit worried about coming, that it would all be grownups and I wouldn’t feel confident to
speak up, but it was really relaxed, really enjoyable and set up in such a way, having the table
facilitators, having a person at each table to do the writing and to keep everyone together, made it
easier to speak up knowing that people weren’t going to be looking at you . . . A little bit worried that
it might be full of professional speak and talking about, so the fact that it was sort of all done in
layman’s terms made it very accessible.
Public participant
Meaningful engagement allowed local needs to be emphasised. Commissioners, for example, said that
they had not previously realised that some areas for improvement identified by ELC were a problem, such
as the negative experiences women were having on the postnatal ward. These insights were described as
‘eye opening’:
I was quite surprised at some things that women had told the ELC team were actually happening, and
I didn’t know the postnatal ward had gone to such shambles, that women felt that.
CCG participant
The trigger film
Trigger films (Box 4) were shown at the beginning of a number of events to focus ELC participants on
women’s lived experiences so as to facilitate patient-centred discussions, and these trigger films were
popular. Participants felt able to emotionally connect with the narratives and described them as
well-constructed, real, human, powerful, touching and emotional.
It’s the fact that not only did they, these mothers experience what you’re experiencing, they actually
said it in words that you understand so, and also you could sense what they were feeling in the film as
well, so it was very well done. It touched me.
Public participant
BOX 4 The trigger film
The trigger film is central to the ELC process; it shows a series of short video clips of real patients talking about
their actual experiences of unexpected maternity events. It was developed for the ELC project from the data
gathered as part of the qualitative research project described in Chapter 2.
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Trigger films affected people in a number of ways:
l Distinguished ELC events from work-based meetings, workshops and conferences by giving them a
different, more affecting dimension.
l Helped to focus people’s minds on why they were at the event.
l Evoked a range of emotions.
l Helped to illustrate how devastating it can be for women when childbirth goes wrong.
l Put a human face to the work.
l Increased understanding of what was important to women around birth.
Data from the comparison group suggested that trigger films need to be viewed in the right context and
are of limited use without the facilitation that accompanies them as part of the ELC programme,
supporting previous findings.217 There was less of an emotional connection among clinicians in the
comparison group and more concerns about the films emerged in this group. There were no such
concerns for the ELC intervention group. Comparison group participants felt that:
l Films highlighted issues of which they were mainly already aware.
l They needed to know the whole story (e.g. what had gone wrong), not just snippets of information.
l Emotional responses were limited among those with clinical background as they are
frequently ‘desensitised’.
l Films may be useful for commissioners who do not have a clinical background.
l It may be more useful for providers to look at their own local patient experience data (e.g. from friends
and family, complaints, incidents, family survey).
l The focus was too specific (e.g. it’s about emergencies rather than all maternity care).
l It may be useful to structure the film – antenatal, birth, postnatal – as this is now how things are
structured with the new national maternity tariff.
l The approach is negative and potentially frightening for women who had not had children.
Nevertheless, the researcher observed that the films did trigger discussions among these comparison group
members, suggesting that expert facilitation here could result in new and useful perspectives too.
For mothers who had more recently been through a difficult experience related to the birth of their child,
the films were particularly emotive and the importance of good facilitation in managing emotions
was highlighted.
It was a bit uncomfortable being upset [at an ELC event], but then it was quite, in a way, I didn’t mind
so much because at least then people know that there’s a human face to all the work they’re doing.
Public participant
The one event for which the trigger film had less impact (although women were still able to connect
emotionally, see Engaging with ethnic minorities) was at the event attended by Somali women and other
women from non-white ethnic backgrounds. Concerns were raised that the women in the film were of
white ethnicity, yet there were people from various ethnic backgrounds in the room and indeed in the
local area. In response to these concerns, more clips of women from ethnic minority backgrounds were
included in subsequent films.
The majority of them was not even the same colour as me, but yet I felt what they were feeling.
Public participant
As I was watching it I actually thought, goodness me, we’ve got a room full of Asian and black
women and there was no black faces on the video.
CCG participant
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Speaking and discussion at events
Participants felt that barriers between women and health-care professionals (and also between different
health professionals) had been broken down to some degree at ELC codesign events. Good facilitation, staff
not wearing their uniforms and the way events were set up (e.g. lay friendly discussions) all contributed.
So that whole process weaves people together and it weaves people together in a way that seems to
unite people and get people away from the, their entrenched camps, the baggage they came with.
CCG participant
Many participants said that the events allowed them to think differently and creatively about how to improve
maternity services. Nevertheless, one participant commented that she had found some other attendees
somewhat rigid in their approach to change, being stuck in mindsets about what was possible/practical to
achieve for maternity services. However, ELC (and the facilitation in particular) was thought to provide a safe
enough environment that participants could challenge and question any perceived lack of flexibility.
Opportunities to challenge, I think that’s been healthy.
CCG participant
You can’t say, oh we can’t do that. There’s always ways, possibly, or being more creative and being
able to think out of the box and think, well, this isn’t good. Or, we could get better at doing it and
really bringing minds together to be able to do that . . . There were a few people on the table that
were a little bit more black and white and possibly couldn’t see change or something, and I was, I felt
a little bit more I would be a bit, a lot more flexible.
CCG participant
Some participants felt that key issues in their minds had not been reflected in any of the projects/areas for
change proposed out of the ELC process. Nevertheless, individuals were still able to take what they
had learned and apply it to their own practice, even if it was not included in the final summary of
commissioning insights.
If there’s serious physical problems they [women/families] want to know and they want to know
straightaway. They don’t want people to beat around the bush . . . that’s a great piece of information
for me. Is that brought into any of the projects that have been proposed? Not really.
CCG participant
There are things that we know that we don’t do that we should do, but I don’t think they’ve been
shown in this report.
CCG participant
Engaging with ethnic minorities
The ELC intervention group is in an ethnically diverse area; therefore, it was particularly important that ELC
engage with ethnic minorities, a group who are often thought to be difficult to access. One ELC event had
high attendance comprising entirely members of ethnic minorities, particularly from the local Somali
community. The success of the attendance at this event was due to local voluntary groups, which took
time to assist with recruitment. Although some concerns were raised about a lack of interpreters and
relative difficulties of tasks for women who may be illiterate in their own language, women assisted one
another to be heard. In turn, this engagement with diversity also served to increase general awareness of
the specific cultural issues in the local community.
I actually put it in my own time because I thought it was, the community needed to be heard . . .
So that responsibility made me go out and spend that extra time to actually get them and come in
and have their say.
Public participant
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Some people said we didn’t have enough interpreters and we should have had a few more of the
non-English speakers in different languages, etc. But I think that was just one odd person who raised
that. But overall, as a third party who was just watching it and helping as required, I thought it
actually went quite well. Because I thought even the Somali population . . . Were quite vocal and said
what they wanted to say.
CCG participant
Even if English was your first language, it needs some literacy acumen to be able to process the
question and then answer it, true to its form if you see what I mean?
Public participant
The woman’s experience
Women participating in ELC events and activities reported the most positive experiences of all participants.
Many felt listened to and understood when talking about their maternity experiences (in a one-to-one
interview or a group situation) and described the experience as ‘therapeutic’ and ‘cathartic’. In addition,
they valued being part of a process that was doing something to change and improve things for other
mums in the future.
I think that was, that was quite good as well actually, because there were other mums there and
actually talking to them about, other people having similar experiences, or not even similar, just having
difficult experiences, the same as I had a difficult experience and listening to the videos they had at
the beginning and things I thought it was really brung home, so it was quite a good group
therapy really.
Public participant
It’s nice to know that you’re being heard and it seems to be a . . . bit more than just I’m a patient
representative on some kind of panel . . . It was just therapeutic to have been able to participate in
something that’s hopefully going to lead to improvement, and it’s a more positive way of venting
some of the anger and the upset that you feel towards the hospital.
Public participant
Reactions to feedback
The ELC identifies areas for improvement from a patient perspective and patient-centred findings were fed
back to staff and also discussed at events. The majority of staff welcomed the feedback and perspectives
on maternity services.
They [women/families] can tell us how it is on the end of the care that we deliver to them and some
of that information has been tremendously helpful.
CCG participant
However, hearing problems and issues with the service professionals deliver can sometimes be challenging.
When perceived as criticism, it can be demoralising for staff. Many of the lay attendees at events were
conscious of how difficult it might be for staff. They valued the fact that staff had attended events and
were prepared to listen to what was being said.
They [staff] were very open to hearing and clearly, clearly really enthusiastic about making things
better and wanting to make change, which was brilliant. But they did get a little bit defensive, which
is totally natural. And I just think it’s really important that their senior management team make them
feel really supported through the whole process, because otherwise it could get quite demoralising.
CCG participant
DOI: 10.3310/pgfar04090 PROGRAMME GRANTS FOR APPLIED RESEARCH 2016 VOL. 4 NO. 9
© Queen’s Printer and Controller of HMSO 2016. This work was produced by Knight et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
139
Barriers and facilitators to developing the strategy
Participants discussed the key issues that had helped and hindered the development of the ELC strategy.
Commitment Many commissioners, health professionals and patient representatives interviewed were
clearly committed to user engagement and understanding the women’s experiences (this was reflected in
the ELC and comparisons groups’ narratives). This enthusiasm contributed to participants giving their time
and energy to working with ELC to successfully develop a commissioning strategy, which for some meant
working in their own time to get work done.
You can’t begin to commission a service if you don’t understand where the user’s coming from, it’s
ridiculous, and commissioners that haven’t visited the units that they commission, I think that’s poor.
CCG participant
That’s in my own time, because I might be doing work in the evenings or, because there’s no other
time to do things.
CCG participant
While this evaluation detected considerable commitment among commissioners to patient engagement
and the ELC process, impressions were important too. Actions like commissioners leaving ELC events early
could be seized upon by participants as demonstrating indifference.
I think the thing that I found a little disappointing, I had, I felt very positive about the meeting because
I knew that the CCGs were going to be here and I knew that, you know, high level staff were going
to be, the decision makers, the money people, were all going to be here, and the fact that they all left
before lunch, it’s a little bit, were they really just paying lip service?
Public participant
Structure of experience-led commissioning Although commissioners were passionate about patient
engagement and user narratives, they admitted that in the past they had found it difficult to know how to
involve patients in commissioning processes. ELC was noted as providing a structure for gaining and using
robust patient experience data in commissioning.
So the formal process of engaging with people so they will tell you their stories in ways they find
acceptable, and that they can see that this is being professionally handled, that it is being valued, and
that is going to influence the people who decide where services are placed.
CCG participant
I think that’s one of the biggest challenges, many of us that have a professional background believe
in the power of narrative and what it can do, it’s actually that translation of narrative into robust
commissioning processes that we haven’t quite actually buttoned down yet.
CCG participant
Challenges in engaging patients early on in the development of a commissioning strategy were also reported
by the comparison group, who described a less focused approach to user engagement. However, they found
this hard to manage and struggled to contend with the range of conflicting views without a specific process
in place to do so. They found that users with strong personalities tended to dominate discussions, creating a
perceived bias in the agenda. In addition, it was common for people to have personal agendas or come with
apparent personal issues that had not been properly processed and which could use up valuable discussion
time. With such complex dynamics, large groups were thought to easily become ‘unstable’ and ‘unfocused’
and, thus, had a tendency to go off track. Comparison group commissioners felt that users did not know
what was wanted from them and so they became more challenging to engage. Finally, without the ELC
facilitation process, users frequently seemed to have trouble articulating what they really wanted to happen.
These kinds of issues led to concerns around representativeness and intractable challenges, thus discouraging
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more open-ended approaches. Therefore, the comparison group found it more effective to engage users by
asking more specific questions, providing limited options for comments and asking what women thought of
the commissioning strategy once it had been largely developed.
It sometimes, we’ve had groups where we’ve gone out and you’ve almost asked questions on those
lines, what’s important about this? And actually you get, if there’s five people you get five, very
different conflicting views. And maybe one of the people is slightly more confident than the rest and
will almost over-ride and actually you have to manage that situation very, in a particular manner to
prevent that from happening. But sometimes also that people may be bringing personal baggage into
it that actually hasn’t been dealt with, so it’s about managing those situations and that can be quite
difficult if it’s a large group as well and it can unstable.
Comparison CCG participant
Or you can get very little out of it, because you have, they don’t know what you want from them.
Whereas if you give them scenarios or questions or options they can comment on them and then it
tends to break the ice and they’re able to then contribute better.
Comparison CCG participant
Commissioners’ perceptions and experiences
There was a sense of satisfaction, and even pride, within the lead CCG that they had undertaken a process
that was novel and innovative that could improve women’s and families’ experiences.
It was just water to someone who’d walked 40 miles across the desert. It was just so refreshing,
necessary, vital in some ways, that we could see how right it was [hearing patient narratives].
CCG participant
I think, by [the end], we probably were a unique CCG and at least halfway achieving that, the voice of
the patient shaping the services, which I don’t think many CCGs could be so proud to have been able
to do. Because it’s a difficult thing to do.
CCG participant
However, using this novel approach also raised some questions and concerns for commissioners, such as
the potential for ELC to require additional resources (time and costs); the impact of collecting negative
feedback from ELC on their services; and the challenge of how to set commissioning outcomes for patient
experience in a target driven organisation like the NHS. In addition, there were some concerns among
commissioners regarding the role of women’s/families’ expectations in the ELC process. Some
commissioners were concerned that women may develop unrealistic hopes and expectations compared
with what the CCG was able to provide following ELC. Similarly, there were fears that women might be
disappointed if identified changes were not in fact implemented.
It’s about not meeting their expectations so, for me as a patient, it’s far worse if . . . I’ve told them and
they haven’t done anything about it. So I think it’s that reality check, that there are some things that
we can fix, and there are some things that we can’t.
CCG participant
In contrast, during the ELC activities, women were particularly mindful of the budget restraints the NHS as a
whole was under and commissioners from the comparison group also reported similar understanding among
the patients they engaged with. ELC work found that there were similarities between what women and
health professionals wanted for maternity services. One stakeholder believed that involving patients in the
commissioning process actually gave them a better understanding and respect for NHS resource restraints.
I think the more that we can actually engage people in those discussions, the more understanding that
we’ll actually have within the public about wise use of services as well as we go forward.
Public participant
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Is experience-led commissioning different from the usual way of commissioning?
Most commissioners interviewed said ELC was entirely different from the way that commissioning was
usually done, it was much more ‘innovative’ and ‘transformed’ the commissioning process. All
commissioners had previous experiences of patient engagement within commissioning. One admitted that
this had often just been informing patients once decisions had been made, or understanding patient
experiences only through clinicians’ perspectives. Others had some experience of trying to involve patients
earlier in the commissioning process. However, this was always in a much more limited way than ELC:
It was really the difference between cuneiform on a stone and reading Charles Dickens’ Great
Expectations. It was that much of an advance.
CCG participant
The usual way of commissioning would be, we’d look at data, as in hard data, outcomes, we would
not have probably even talked to any patients, but very, we’d only talk to patients probably at the end
of the process of what we’ve designed. If we’re lucky we may talk to them, talk to the patient voice in
any of this, through the clinical world. So the clinicians would bring to the table the experiences from
their lens, what their patients that they’ve treated have gone through. Which is very different.
CCG participant
Nevertheless, two other interviewees had been involved in more meaningful patient engagement work.
With the NHS push for more patient involvement in services, to one newer commissioner, ELC was felt to
be the natural and obvious way to commission. However, it was agreed that ELC did take the level of
patient involvement even further than they had done previously.
I’m quite a newbie to the commissioning and I was lucky that my first piece of work that I did was
based from the NHS Institute’s model . . . go and ask them what they think. So I’ve kind of, to me
there doesn’t seem to be a different way, or another way.
CCG participant
I’ve done lots of improvement work before, lots of patient involvement and engagement work, but
this seems to take it on to the next level.
CCG participant
Others highlighted that the range of key stakeholders that ELC drew together was very unique in
commissioning, which promoted greater equality between commissioners, frontline health professionals
and patients. It also improved communication and relationship building between key stakeholders, which
was particularly beneficial for the relationship between the CCG and providers. The comparison group also
highlighted the importance of good communication in developing and implementing an effective
commissioning strategy. All comparison group participants pointed to long-running, well-established and
successful relationships with their partners, and agreed that effective communication and engagement
between the range of parties involved in commissioning was one of the key elements to their effectiveness.
Generally there’s a very good relationship between the managers of the CCG and the [hospital], a very
good relationship and understanding between the clinicians from the two areas. So we don’t tend, it’s
not a shouty shouty type thing, it’s a very much an organisation, a very sensible, a very mature types
of meetings we have where it’s very challenging in that we do challenge them to quite a degree, but
it’s all done very professionally and because of that it’s very effective and very effective systems in
place in terms of how it’s run.
Comparison CCG participant
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Differences in commissioning documents
The ‘human’ and patient-centred elements of the ELC work, which was emphasised by the trigger films, also
extended through the ELC documents. The documentary analysis found that ELC documents contained more
‘humanistic’ language, in contrast to comparison group documents, which were more technical in nature.
For example, word clouds showed that high-frequency words that appeared in ELC documents included
emotion, recovery, families, team and help. High-frequency words that appeared more in comparison group
documents included review, clinic, provide, manage and ensure (Figures 7 and 8).
The documentary analysis supported the finding that ELC took a more patient-centred approach but, more
than this, included a deeper examination of patient experience, thus providing more detailed information
than commissioners had expected.
‘Patient centredness’: recommendations outlined in documentation appeared to be more patient-centred
in ELC (as opposed to comparison group) documents. In ELC documents, recommendations for change
followed a lineage back to patient experiences. For example, recommendations to invest in joint training to
‘enable frontline teams to respond to (and to deeply understand) cultural differences, impact of non-verbal
communication, and how to self-care and keep well’ linked to specific concerns raised by patients
described earlier in the document. By contrast, a comparison group document did not evidence the view
of patients when the reviewers concluded: ‘Both antenatal clinics were bright, welcoming and appeared
very well organised with adequate facilities for specialist investigation and counselling’.
Language in documents: commissioning documents are written for commissioners, managers and staff to
use, although commissioning documents are often publicly available. The attention to detail, context and
use of lay language by ELC meant that ELC documents were likely to be easier for members of the public
interested in commissioning to understand.
FIGURE 7 Word cloud for ELC intervention group.
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The approach: the documentary analysis highlighted differences between the approaches to
commissioning between the two groups. The comparison group had taken a broad approach to examining
the adequacy of structures, procedures, policies and pathways, and the functioning of different units in
order to understand what areas are working and where improvements might be needed. A general outline
is given, including statements on the safety of units, identifying which areas were working well and where
no recommendations for change were required. On the other hand, ELC took a more ‘micro’ and
less-broad approach, investigating patient and staff views directly about improvements needed and
exploring problems and solutions in detail. Pathways were only examined if a salient problem had been
highlighted. For example, both CCGs were ‘stretched’ by their birth rates and capacity; the comparison
group looked at this issue by examining staffing levels, whereas ELC focused on investigating how being
stretched impacted on staff ability to care for patients.
Level of detail: while comparison group documents tended to contain overarching statements of intent
and targets, ELC documents focused more on specific processes, including a breakdown of the key issues
involved and recommendations for improvement. The recommendations from the ELC approach are listed
in Box 5. For example, in terms of improving patient information, the comparison group documents
described targets (e.g. ‘to increase access to pre-conceptual care and health promotion to ensure best
pregnancy outcome’). On the other hand, ELC documents noted that ‘clinician(s) may be overestimating
women’s understanding of the consequences of diabetes’ and recommended that women who have had
gestational diabetes and understand the consequences may be the best placed people to explain the
impact to newly diagnosed mothers. However, the documentary analysis also found similarities between
the two sets of documents in terms of the kinds of recommendations, targets and outcomes the CCGs
wanted to see for maternity services. For example, both sets of documents highlight the importance of
providing patients with continuity of care/a joined-up approach, flexibility and support particularly for
vulnerable groups including ethnic minorities, as well as training for staff and improving care pathways/
multiagency working.
FIGURE 8 Word cloud for comparison group.
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Does experience-led commissioning change commissioning intentions?
One question that has been asked of ELC is what effect does ELC have on commissioning intentions?
That is, what do commissioners think they want to change and how does ELC alter these commissioning
intentions, if at all? Commissioners found this a difficult question to consider. It was already known that
maternity services for the intervention group were in need of improvement, but clear commissioning
intentions about how to do this were not necessarily available. One commissioner admitted that without
the ELC project, they may only have gone as far as to ‘tweak’ the current commissioning contract. They
felt that using ELC had provided the CCG with more scope for reconsidering maternity services than they
would otherwise had. Using ELC had meant that they looked at the area in a more substantial way, as well
as attracting additional funding for implementing one of the changes identified:
I don’t think we’d have made any change. Personally, I think we’d have gone in, we’re in the middle
of negotiating a contract, OK, I think we’d have gone in and tweaked a little bit of the contract.
Our clinical lead would not have been as involved as she has been, which meant that [the lead CCG]
would not have had the input that they have had into the contract. And secondly we would, because
you know on the back of the maternity work we applied for the [grant], now that has got, attracted
funding into [local hospital].
CCG participant
BOX 5 Summary of main changes suggested by the ELC maternity service commissioning strategy
To support women and families
l Introduce story-based discharge planning.
l Develop new and improved ways within existing service provision to connect women and community
midwives and health visitors.
l Create a nourishing, homely relaxing postnatal environment (postnatal ward).
l Build on named midwife; create buddies (frontline maternity professional for every woman, including
everyone from consultants down and GPs).
l Improve emotional recovery (identifying PTSD).
To support frontline teams
l Look at administrative burden on frontline maternity teams.
l Improve staff well-being.
l Support (hospital) to work on (organisational) cultural change.
l Invest in joint training, education, learning and reflection for staff.
l Build new capacity around emotional recovery among community midwives and health visitors
(bereavement midwifery training).
l Support the development of a volunteer strategy at [hospital] to deliver some of these initiatives
(e.g. story-based discharge).
l Build relationships between community midwives and health visitors.
l Review health visitor and community midwifery alignment with GP practices.
l Align story based discharge with existing improvement and streamlining work around postnatal discharge.
Commissioning process
l Join up commissioning.
l Link up the [grant funding].
l Link up with [lead CCG] 5-year strategic plan.
l Set and measure new outcomes (contracting).
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Another commissioner felt that ELC had raised some issues that he/she was already aware needed improving
(e.g. direct access to ultrasound slots for GPs) and other issues that commissioners were less aware of
(e.g. negative experiences on the postnatal ward and the need to increase communication between health
visitors and midwives), resulting in some changes to commissioning intentions as a result of ELC. In addition,
ELC had not picked up some clinical issues (e.g. reduction in caesarean section rates), but these were likely to
be addressed through other targets such as the Commissioning for Quality and Innovation for the Trust.
These findings suggest that ELC did have some effect on commissioning intentions. This is in contrast to
the comparison group who said that their patient engagement work had only tweaked or confirmed their
commissioning strategy.
But a lot of what we did it didn’t change it reinforced, it was the smaller things that it was really
helpful . . . But it was the little tweaky things rather than the big.
Comparison CCG participant
Cost implications
Background and limitations
It is important to view the cost findings in this report within the limitations of the evaluation. As outlined in
Table 36, the ELC intervention group had undertaken a significant piece of work to develop a new
commissioning strategy for maternity services, and the comparison group had updated and refreshed their
existing strategy (this was subsequent to conducting a more significant piece of maternity work in earlier
years). Research has found that commissioning activities often do not fit into neat commissioning cycles,
meaning that finding a matching comparison group is a challenge.218 Therefore, we have drawn limited
conclusions in comparing the costs of these two different approaches.
Costs related to commissioning strategy development using experience-led
commissioning
The estimation of the cost of development pulls together data from various sources. For the ELC strategy
this included development of trigger films, activities undertaken by the ELC team to develop the strategy,
and time invested by stakeholders associated with the CCG to facilitate the development of the ELC
strategy (including meeting/activity attendance, networking).
The cost of researcher time to develop the trigger film and two films, not including the costs of the
underpinning qualitative work, totalled £13,265.
Activities undertaken by the ELC support team to develop the strategy included desk work on programme
development; gathering commissioning insights and facilitating codesign events; analysis of data;
producing outputs; handover coaching for CCG to facilitate strategy implementation; and facilitator travel
expenses. The costs of these activities totalled £56,900. A detailed breakdown of these costs is shown in
Table 37. These costs would be lower (approximately £10,000 lower) if this approach were repeated with
other CCGs for maternity services as some learning will have taken place.
The cost for the time invested by stakeholder event participants was approximately £6800. This does not
include time stakeholders spent at events that would have taken place regardless, such as continuing
professional development events.
A significant cost of the development of the ELC strategy was attributed to networking within the CCG.
A few stakeholders in managerial roles reported spending between 75 and 210 hours over the 6-month
period in networking and communications. The estimated cost of these activities is considerable,
approximately £26,900.
Within the limitations of this analysis, it was estimated that the total costs associated with developing the
ELC strategy in maternity services in the ELC intervention group was > £103,000.
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Costs related to commissioning strategy development for the comparison group
The comparison group found it challenging to provide extensive commissioning cost information
retrospectively. The cost of stakeholder contributions to the development of a maternity commissioning
strategy in the comparison group was estimated at < £6000. This includes time spent over a 3-month
period by clinical leads/heads, managers, commissioners, communication and engagement lead, Chief
Executive Officer and user, local authority and public health representatives. Additionally, the cost of
venues for networking and communications necessary for the development of their strategy was estimated
at £5000. As expected, given the differences in the commissioning work undertaken, this is significantly
less than that observed for the ELC group, but it should be noted that these costs are estimates only.
Conclusions and implications for service commissioning
This study clearly shows that the experiences of women who have had severe morbidity in pregnancy can
usefully be used as the basis for an ELC approach for maternity services. Although mothers frequently
found the process therapeutic, some of the participants found listening to women’s experiences traumatic,
emphasising the importance of good facilitation that not only anticipated but was able to manage strong
emotions. The initial trigger film was generally effective in the ELC process, although not sufficiently
TABLE 37 Breakdown of costs for intervention group activities undertaken by the ELC team
Activity Cost estimate (£)a
Programme development and prototyping
Desk work on programme development 7500
ELC programme prototyping
Codesign one (current experience mapping) 3750
Codesign two (desired experience mapping) 3750
Codesign three (PATH) 4500
Codesign four (improvement contract co-design) 4500
Discovery interviews front-line caregivers, people, families (n= 10) 3750
Transcription of interviews (600 minutes) 1500
Analysis of interviews to identify commissioning improvement challenges 8500
Triangulation and aggregation of all data to produce for CCG:
l Health needs assessment (ELC qualitative data set)
l Draft ELC improvement challenges
l Draft ELC strategy
l Draft ELC Management Action Plan
l 360-degree appraisal and review of key commissioning process learning
(for internal CCG use)
l Draft contract framework with outcome measures
11,250
Handover coaching for CCG implementation lead to ensure strategy moves swiftly
into implementation (gratuity)
0
Project management/contribution overhead 10% 4500
Expenses (17 facilitator days at £200 each – includes travel and overnight) 3400
Total cost 56,900
PATH, Planning Alternative Tomorrows with Hope.
a These figures exclude value-added tax.
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ethnically diverse, and the balance of the film had to be adjusted during the ELC process. Regardless, the
film provided an important way to represent the experiences of women who had severe complications and
facilitated patient-focused discussions.
Participant views of the ELC process were largely positive, with the caveat that the CCG that was originally
randomised to the ELC process subsequently declined to take part, which may infer less-positive views,
and there was a clear perception that ELC led to greater engagement from both health professionals as
well as users and a bridging of understanding between the two groups. The participants felt that the
ELC process did lead to differences in the outcomes of the commissioning process compared with a
standard commissioning approach and the documentary analysis supported this finding. The language of
the commissioning strategy produced by the intervention group was more humanistic and less technical
than that from the comparison group, and ELC recommendations were clearly linked back to patient
experiences. The commissioning strategy from the comparison group tended to be more general, whereas
that from the intervention group focused on a smaller number of specific areas in detail. However, there
were also numerous similarities in the recommendations, targets and outcomes both CCGs included in
their resulting strategies. Both strategies highlighted continuity of care, support for vulnerable groups,
training for staff and improving multiagency working.
The costs of the ELC process were significantly greater than the costs of the standard process. At this
stage, we cannot assess how these additional costs translate to change in services. Although there are
differences in the resultant commissioning strategy for maternity services, implementation is still ongoing
and, thus, further evaluation will be needed to determine whether the ELC process has resulted in a
different maternity service and, in particular, whether or not the service developed is more responsive to
the needs of women with severe morbidities and whether there are additional implementation costs or
potential cost savings. It is also important to note that the costs of the process may decrease for other
CCGs using this ELC model to commission maternity services, as many of the resources and processes have
been developed and, therefore, the amount of staff time needed will be reduced. These factors will impact
on the cost–benefit assessment, and thus this economic evaluation must be considered incomplete and
interim at this stage. Further work is essential to assess the long-term outcomes of the commissioning
strategy and the associated implementation costs, and how these compare with standard commissioning.
The findings from this evaluation support the following recommendations for future commissioning work
in the NHS using ELC.
Developing a commissioning strategy using ELC:
l Additional work is required in acknowledging and helping CCGs allocate the time/resources needed to
align organisations to converting to a new way of commissioning from the outset.
l Ensure the CCG is familiar with, and confident to deliver, the ELC process and plan of activities/event
early on, so that it is clear to CCGs what needs to be done and when.
l Ensure key providers feel fully engaged in the process and explore with them early on what the process
means for them; help them relate the work to other strategic priorities.
l Explore allowing CCGs to adapt some parts of the ELC process (e.g. working with ELC insights to
develop a commissioning strategy), in order to meet the needs of different CCGs/populations
more effectively.
l Be aware that although ethnic minorities are included in the trigger films, local areas may have ethnic
diversity that is not possible to include at a national level in trigger films.
l Maintain balance of positive and negative experiences shown in trigger films, in consideration of the
effect that negative experiences may have on patients and consequent group interactions in ELC.
l Be aware that discussing negative emotional experiences for patients can be cathartic and empowering
in an appropriately managed setting, but skilled facilitation is required to manage this important process.
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Commissioning using ELC:
l Commissioners could consider using ELC if they:
¢ need a structure through which to engage with patients in a meaningful way
¢ would like to give patients more influence over commissioning strategy content and development
¢ want to build relationships and improve communication between key stakeholders within a health
economy (e.g. CCG and providers, voluntary sector, patients)
¢ require a transparent approach to commissioning decisions.
Further research/evaluation:
l Link costs of developing the ELC strategy with outcomes (e.g. changes in practice, patient experience).
l Future research could also investigate ELC outcomes numerically, looking more deeply into costs and
other outcomes and over longer periods of time to allow the study of implementation. In particular,
it is important to understand the longer-term impacts for implementation of the ELC strategy.
l Develop a set of ‘benchmark’ costs for commissioning – for both new strategies and annual strategy
refreshers – so that those seeking to innovate and test new methodologies can compare cost and
benefits of different commissioning management methods.
l The inclusion of a comparison group was useful to shed light on the commissioning processes,
strategies and implementation to establish what ELC might offer maternity services. However, the
inevitable differences between large organisations within the NHS mean that more ‘controlled’
comparisons would be difficult in this setting.
l Undertake further work in order to explore ways of making ELC more understandable to those
unfamiliar with the process.
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Chapter 11 Discussion and conclusions
Many severe maternal morbidities are classified as adverse events and may be the subject of litigationclaims.196 They can have a life-long impact on surviving women and their families. Therefore, research
is crucial both to improving safety within the NHS11 as well as outcomes for women and babies. The three
aims of this programme were to implement a national programme of study of near-miss maternal
morbidity to complement confidential enquiries into maternal deaths, to use mixed methodologies to
improve the evidence base for disease prevention and treatment, and inform commissioning of maternity
services, and to use the data to develop recommendations for best practice to prevent and manage
near-miss maternal morbidities. Our User Advisory Group provided input at all stages of the component
projects, including design, monitoring, analysis and dissemination. The series of studies clearly demonstrate
the added value of research into maternal morbidity alongside research into maternal death: for each
individual maternal death from one of these severe morbidities there were between 4 and 100 women
who had severe illness but survived. In an average-sized maternity unit, this represents 0–4 affected
women with each specific morbidity per year, emphasising the importance of collaborative research at a
national or multinational level11,219 to inform management. This also provides a clear illustration of the
difficulty of obtaining RCT evidence to guide treatment for these women. A study randomising only
100 women to two arms of a trial would require the participation of at least 100 units for 1 year or
33 units for 3 years. In this programme, we focused on using robust observational studies as a basis for
addressing our key research questions.
Key findings and implications for practice or policy
The programme had seven objectives which have been used as the basis for the summary of the key
findings below. This represents only a summary of key points; many more specific messages for
care are reported in the publications about individual conditions and these should be referred to for
further detail.54,71,72,181,220,221
The incidence of the specific morbidities most commonly leading to
maternal death in the UK
We examined the incidence of AFE, severe maternal sepsis, uterine rupture, HELLP syndrome and placenta
accreta/increta/percreta. Because the studies conducted were national cohort or case–control studies, we
were able to estimate incidence of each condition with a relatively high degree of precision. The incidences
of these conditions ranged from 2 to 47 per 100,000 maternities and these estimates are useful in order
to plan services as well as to inform the focus of labour ward skills and drills training programmes. In
addition, as we collected national data, we were able to estimate incidences in specific population
subgroups. Particular estimates that are of importance and of direct relevance to counselling and service
delivery include those associated with the risk of uterine rupture and placenta accreta/increta/percreta.
When estimated on a population basis, the incidence of uterine rupture in women who have had a
previous caesarean delivery and who are planning a vaginal delivery is 1 in 500 maternities, lower than
previous estimates.75 This allows women to assess accurately the risk of this rare, but very serious,
complication when deciding on their mode of delivery in these circumstances. Their decision-making can
also take into account differences in incidence among women in spontaneous labour versus those who
have labour induced or augmented. The incidence of uterine rupture among women with a previous
caesarean section planning vaginal delivery who labour spontaneously is 1 in 800, compared with 1 in 330
among women who are induced or augmented.181
The incidence of placenta accreta/increta/percreta can also be estimated among different subgroups of
women. Women without a placenta praevia and who have not had a previous caesarean delivery have an
estimated incidence of placenta accreta/increta/percreta of 1 in 33,000, women who had a previous
caesarean delivery but who do not have a placenta praevia have an estimated incidence of 1 in 3300, and
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women who have had one or more previous caesarean deliveries and have a placenta praevia have an
estimated incidence of placenta accreta/increta/percreta of 1 in 20.72 It is thus clear that, in particular, the
women who have had one or more previous caesarean deliveries and have a placenta praevia must be
delivered in a unit that is equipped for the possibility of a placenta accreta/increta/percreta and associated
haemorrhage, with appropriate delivery planning and the availability of a team to carry out a peripartum
hysterectomy should this be necessary.
Recommendations
l Clinicians should be aware of the frequency of these rare, but severe, complications and ensure the
facilities and training are in place to manage women with these conditions when they occur.
l Uterine rupture in women with a previous caesarean section planning vaginal delivery is less common
than previously estimated and women should be advised of this when discussing their planned mode
of delivery. The increased risk associated with induction or augmentation of labour should also
be considered.
l Women who have placenta praevia and have had a previous caesarean delivery are at high risk of
placenta accreta/increta/percreta and delivery should be managed in accordance with this risk, which
might require facilities to carry out a peripartum hysterectomy should this be necessary.
The contribution of existing risk factors to disease incidence and identifying
steps which may be taken in clinical practice to address these factors to
reduce incidence
We found several risk factors that were common to two or more severe maternal morbidities. In particular,
older maternal age and interventions associated with delivery, that is, induction of labour and operative
vaginal or caesarean delivery were commonly identified risk factors. This is of concern given current trends
among the maternity population and maternity services, with a rising average maternal age at childbirth
and rising caesarean delivery rates.14,15 Actions supporting maternity settings in which women are at lower
risk of intervention may therefore impact on the incidence of these maternal morbidities.222,223 Multiple
pregnancy and assisted reproductive techniques were also associated with particular conditions; rates of
both are clearly interrelated and higher than previously.15,224 Interestingly, in light of the findings in relation
to maternal death, maternal obesity was surprisingly not consistently associated with the incidence of
these severe maternal morbidities. Risks associated with maternal age and ethnicity are further discussed in
subsequent sections (see The outcomes of the conditions for mother and infant and any groups in which
outcomes differ and Factors that influence the risk of death and how these might be addressed to
prevent death).
The significant risks associated with prior caesarean delivery and placenta praevia are highlighted above.
In all the sources we examined, operative delivery was associated with raised odds of maternal sepsis. In
our examination of data from the Grampian region of Scotland, women with sepsis who had a caesarean
section were less likely than controls to receive antibiotics, highlighting the need for prophylaxis for every
woman having a caesarean delivery. The association we observed between operative vaginal delivery and
maternal sepsis emphasises the importance of strict aseptic technique and infection control measures in
clinical practice.
Forty per cent of women with severe sepsis had pneumonia/respiratory infection as the source of sepsis.
These results indicate that in addition to genital tract infection, respiratory infection is a major source of
severe maternal sepsis irrespective of an influenza epidemic. This is borne out in the maternal deaths
surveillance data for the UK, which also record a high proportion of deaths due to non-genital tract, and
particularly respiratory, causes of sepsis.2 Immediate implications are that in addition to precautions for
genital tract sepsis, there is clearly an urgent need to improve timely recognition of severe respiratory tract
infection in pregnant and recently pregnant women. The importance of early recognition was highlighted
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in a recent patient safety alert from NHS England225 and is illustrated in these vignettes extracted from the
most recent UK and Ireland Confidential Enquiries into Maternal Deaths and Morbidity report:2
Two hours after delivery a woman became unwell on the postnatal ward feeling faint. Her oxygen
saturation was low. She was reviewed by junior staff and found to be shocked, without evidence of
major bleeding. Her temperature was never measured and sepsis was never considered. A diagnosis of
haemorrhage was made and she was treated with fluids. She failed to improve and was taken to
theatre for treatment of presumed haemorrhage where she had a cardiac arrest and could not be
revived. At postmortem she was found to have overwhelming infection due to group A streptococcus.
Seven days after giving birth a woman became unwell at home with a fever. She was advised to
attend the maternity unit immediately. On admission she was noted to be breathless with a rapid
pulse and high temperature. She was seen quickly by the on call doctor. A diagnosis of severe
infection was made and fluid resuscitation started immediately. Intravenous antibiotics were started
within one hour of the diagnosis and she was transferred to the high dependency unit. She made a
full recovery. Early recognition, clear advice and prompt treatment led to a good outcome without any
further complications.
This first vignette also highlights another key finding with respect to risk and that is the rapid progression of
disease severity associated with group A streptococcal infection, suspicion of which represents a clear red
flag for urgent action. Rapid administration of antibiotics in cases of severe sepsis is significantly associated
with decreased mortality in the non-pregnant population226 and rapid antibiotic administration is a
cornerstone of many sepsis care bundles.124,227 These should also apply to pregnancy and be appropriately
tailored to any setting in which maternal sepsis may occur, including – in particular – freestanding midwifery
units in light of the preponderance of group A streptococcal infection among women having normal vaginal
deliveries. We also noted that women who are treated with antibiotics in the perinatal period are at
significant risk of severe sepsis and, thus, there is a need to follow women up to ensure that treatment is
effective. The different patterns of infection we observed in antenatal and postnatal women suggest that
overall greater consideration needs to be given to the source of infection and, therefore, the most
appropriate antibiotic to prescribe.
Recommendations
l Older maternal age is associated with severe maternal morbidities and women should be aware of this
if they are planning to delay childbearing.
l Caesarean section delivery is associated with severe maternal morbidity in both current and future
pregnancies. These risks, together with planned family size, need to be taken into account when
planning mode of delivery.
l Both primary and secondary care practitioners should remain aware that pregnant or recently pregnant
women with suspected infection need closer attention than women who are not pregnant.
l Antibiotic prescription does not necessarily prevent progression to severe sepsis and women should be
followed up to ensure recovery.
l The rapid progression to severe sepsis highlights the importance of early administration of high-dose
i.v. antibiotics for anyone with suspected sepsis.
l Signs of severe sepsis, particularly with confirmed or suspected group A streptococcal infection, should
be regarded as an obstetric emergency and should be routinely included in obstetric emergency
training courses.
l Consideration could be given to a change of timing of prophylactic antibiotics to administration at time
of decision for emergency caesarean section.
l Vigilant infection control at vaginal delivery should be maintained.
l Existing sepsis bundles should be used for any pregnant woman with suspected sepsis. There may be a
place for tailored bundles in settings such as freestanding midwifery units, where some elements of
standard bundles may not be immediately available.
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How the conditions are managed and any variations in management, the
impact that different management strategies or interventions have on
outcomes and costs, and recommendations for best practice to improve
outcomes for all women
Our interviews with women identified several circumstances for which variations in practice made an
important difference to their experience and outcomes of care. Women who had an antenatal diagnosis of
a condition that might be associated with early, emergency delivery (such as placenta praevia or HELLP
syndrome), valued full explanations of what might happen in order to help them prepare and cope
subsequently. For partners, frequent updates during the emergency helped them feel less isolated and
anxious; partners also appreciated repeated explanations of events. Some women found transfer to a
single room after discharge from critical care helpful to allow them to recover as well as adjust to new
motherhood. Many valued intensive care outreach/follow-up where this was provided; however, this is not
part of current maternity critical care guidance.
Specific management actions we investigated included the following.
Delayed delivery for HELLP/ELLP syndrome: we found no difference in outcomes for women in whom
delivery was delayed by a short period, up to 48 hours, to those with planned immediate delivery.54
Importantly, delay in delivery may be helpful to allow administration of steroids for fetal lung maturation.
Notably, there was a high rate of eclampsia among both women with HELLP and ELLP syndromes and,
therefore, magnesium sulphate could also be considered as prophylaxis.228 HELLP/ELLP syndromes are
covered in NICE clinical guideline 107, Hypertension in Pregnancy,229 although not in detail, and, therefore,
these findings should be used to inform future revision.
Placental removal in women with placenta accreta/increta/percreta: women with placenta accreta/increta/
percreta who had no attempt to remove any of their placenta with the aim of conserving their uterus or
prior to hysterectomy, had reduced levels of haemorrhage and reduced need for blood transfusion,
supporting recommendation of this practice.230
Mode of delivery in women with prior caesarean section: as discussed above, we noted an increased risk
of uterine rupture associated with trial of labour, but particularly if women were induced or their labour
augmented. The risk of uterine rupture also increases with the number of previous caesarean deliveries,
a short interval since the last caesarean section and labour induction and/or augmentation. These factors
should be considered when counselling and managing the labour of women with a previous caesarean
section. Current guidance231 recommends that women should be advised about the risks and benefits of
planned vaginal birth after caesarean section when considering mode of delivery in subsequent pregnancies.
Second-line therapies for PPH: the economic evaluation we conducted based on observational data from
the UKOSS study of management suggested that uterine compression sutures were the most cost-effective
second-line strategy; however, further work is required to strengthen the fundamental inputs into the
analytical model. The analytical techniques used here provide a useful model for the future of evidence
synthesis using a decision-analytic model to conduct an economic evaluation using similar observational
data in rare conditions where randomised trial evidence is lacking and never likely to be available.
We also used women’s experiences as the basis of an investigation of a new model for commissioning
maternity services in order to improve outcomes of severe maternal morbidity. Although it is too early in
the commissioning cycle to evaluate whether or not the commissioned service has made a difference to
women’s outcomes, preliminary evaluation suggests that the ELC strategy may be more patient focused
than the strategy developed using standard commissioning processes. Users, health professionals and
commissioners felt that the ELC process was positive and led to greater engagement and dialogue between
professional and users. The perspectives of each were recognised and valued. The participants felt that the
process did lead to differences in the outcomes of the commissioning process compared with a standard
commissioning approach, and examination of the documents produced suggested that patient experiences
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led directly to the recommendations produced. The commissioning strategy from the comparison group
tended to be more technical in its language, noting that there were many similarities in the recommendations,
targets and outcomes that both CCGs included in their resulting strategies. Both strategies highlighted
continuity of care, support for vulnerable groups, training for staff and improving multiagency working. The
costs of the ELC process were significantly greater than the costs of the standard process, but at this stage we
cannot assess how these additional costs translate to change in services or improved outcomes.
Recommendations
l Women who have a condition diagnosed antenatally that puts them at increased risk of an emergency
delivery/life-threatening condition should be given an explanation of what might happen. This may
need to be repeated on several occasions.
l Partners should be given frequent updates during an emergency as well as both women and their
partners receiving a subsequent full explanation of events.
l Delay in delivery of up to 48 hours may be safely undertaken in women with HELLP syndrome in whom
there is no fetal compromise and who remain clinically stable, and may assist in the delivery of
antenatal steroids when these are indicated.
l The number of previous caesarean sections and the time interval between the last delivery and
conception should be taken into account when counselling women with previous caesarean deliveries
about their mode of delivery in this pregnancy.
l Uterine compression sutures are a more cost-effective second-line therapy for PPH than interventional
radiology and guideline developers should be aware of this.
l ELC may be used as a way to commission maternity services. The commissioned strategy appears more
patient-focused and the process led to beneficial engagement of both user and health professional
groups in commissioning services. Commissioners could consider using ELC if they:
¢ need a structure through which to engage with patients in a meaningful way
¢ would like to give patients more influence over commissioning strategy content and development
¢ want to build relationships and improve communication between key stakeholders within a health
economy (e.g. CCG and providers, voluntary sector, patients)
¢ require a transparent approach to commissioning decisions.
The outcomes of the conditions for mother and infant and any groups in
which outcomes differ
We focused on three different characteristics of women that can be associated with poor maternity outcomes.
This work clearly demonstrated an increased risk of severe maternal morbidity among women from different
ethnic minority groups and women of younger and older age. We did not, however, demonstrate any
independent association with maternal socioeconomic status, after taking into account the effects of
inadequate utilisation of antenatal care and high parity. This suggests that the most important need is to
ensure that services are responsive to women of different ethnic and social groups, to ensure optimal
utilisation of care. We experienced some challenges in obtaining wide representation from ethnic minority
groups in the ELC process, but with specific events led from local community groups this was possible and this
approach may provide a route for ensuring appropriate and responsive services. Recent NICE guidance189 has
highlighted the importance of access to appropriate maternity services and this work further emphasises this.
The national cohort study of older women we undertook clearly shows that women giving birth who are
aged ≥ 48 years are at very high risk of adverse outcomes for both mother and baby. Many of these
increased risks appeared to be explained by the higher rate of multiple pregnancy or use of assisted
conception in the older women. These findings should be considered when counselling and managing
women of very advanced maternal age who are contemplating assisted reproduction. There may be a place
for considering selective fetal reduction in women of very advanced age pregnant with multiple pregnancies.
Organisations making recommendations regarding assisted conception including egg donation in older
mothers, as well as single embryo transfer, should take these findings into account.
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We investigated factors associated with poor outcome in women with AFE and showed that women who died
or had permanent neurological injury were more likely to have a greater severity of disease at presentation,
with rapidly progressive coagulopathy. Women who died or had permanent neurological disability were more
likely to have had a hysterectomy and less likely to receive specific blood products. Consideration needs to be
given to whether or not earlier treatments, including correction of coagulopathy, can reverse the cascade of
deterioration that seems to be present with AFE and so improve survival in the most serious cases.
With regard to sepsis, we did note that there are major significant disparities in socioeconomic status and the
risk of severe sepsis. The reasons behind this are unclear but highlight the importance of making women and
their families fully aware of the symptoms and signs of sepsis associated with pregnancy (Box 6).
Recommendations
l Maternity services need to be responsive to women of different ethnic and social groups, to ensure
optimal utilisation of care.
l ELC may provide a route to fully engaging different social and ethnic groups in the commissioning of
appropriate maternity services.
l Older women are at considerably higher risk of pregnancy complications and this should be considered
when counselling and managing women of very advanced maternal age, particularly in the context of
assisted reproduction.
l There may be a place for considering early fetal reduction in women of very advanced age with
multiple pregnancies.
l Recommendations regarding assisted conception including egg donation in older mothers, as well as
single embryo transfer, should take into account the high risks of adverse pregnancy outcomes in older
women with multiple pregnancies and who have undergone assisted reproduction.
l Earlier treatments, including correction of coagulopathy, may reverse the cascade of deterioration that
seems to be present with AFE and so improve survival in the most serious cases.
l Women and their families should be fully aware of the symptoms and signs of sepsis associated
with pregnancy.
BOX 6 Signs and symptoms of sepsis
Sepsis can develop very quickly. Pregnant women or new mothers can appear relatively well and yet become
seriously ill very quickly. Women and their families need to be aware of early warning signs. If you develop any
of these symptoms you or your family should seek medical advice, or go to a maternity unit, quickly. If you
think you or your partner has sepsis, getting rapid treatment with antibiotics may be life-saving.
THINK SEPSIS: SIGNS & SYMPTOMS TO WATCH OUT FOR:
l High temperature (over 38.3 °C).
l Chills and shivering.
l Fast heartbeat.
l Fast breathing, breathlessness.
l Headache.
l Extreme sleepiness.
Extract reproduced from Hinton on behalf of the MBRRACE-UK lay summary writing group.232
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Factors that influence the risk of death and how these might be addressed
to prevent death
We found six factors to be associated with maternal death from direct pregnancy complications after
adjustment: inadequate use of antenatal care; substance misuse; medical comorbidities; hypertensive
disorders of pregnancy; previous pregnancy problems; and Indian ethnicity. Together, these contributed to
70% of the increased population attributable risk. Specific medical comorbidities, including asthma,
autoimmune diseases, inflammatory/atopic disorders, mental health problems, essential hypertension,
haematological disorders, musculoskeletal disorders and infections, were found to be associated with a
higher risk of dying from the conditions included in this study. Medical comorbidities contributed 49% of
the increased risk of fatality in the study population.
Maternal medical and mental health comorbidities have also been highlighted in the recent Confidential
Enquiries into Maternal Death;2 nearly three-quarters of women who die during or shortly after pregnancy
have medical comorbidities.2 Additionally, although deaths from direct causes are significantly decreasing,
there has been no decrease in indirect (medical) maternal deaths.2 These studies together highlight the
importance of identifying and appropriately managing maternal comorbidities. Although factors such as
pre-existing medical conditions cannot be altered, their adverse consequences can potentially be mitigated
through extra vigilance and proactive management. Although further research is required to investigate
how best to provide pre-pregnancy counselling as well as multidisciplinary maternity care for these
women, one of the most important implications is that women with medical comorbidities should be
identified and fully assessed for their risks in pregnancy, and that health professionals should be aware of
the associated risk of severe morbidity.
Uptake of antenatal care was found to be poorer among women with medical comorbidities in our study
population, which could increase the adverse effects associated with these conditions. In our combined analysis
after adjusting for medical comorbidities,233 the previously observed association of older maternal age and
obesity with increased odds of dying160 was no longer evident, suggesting that this association may be mediated
through medical comorbidities. Obesity nevertheless appeared to be a risk factor for sepsis mortality100 and ICU
admission;122 however, it was evident from the missing data in the intensive care study that BMI was often not
routinely recorded. Recording BMI and being aware of associated risks of obesity remains important.73,123
Recommendations
l Health professionals should be aware of the associated risk of dying from severe obstetric morbidity in
women with medical comorbidities.
l Women with medical comorbidities should be identified and fully assessed for their risks in pregnancy.
l Inadequate uptake of antenatal care, substance misuse, hypertensive disorders of pregnancy, previous
pregnancy problems and minority ethnicity are also associated with maternal death from direct
pregnancy complications. The adverse consequences of these conditions could potentially be minimised
through access to appropriate services, extra vigilance and proactive multidisciplinary management.
Whether or not an external confidential enquiry or local review approach can
be used to investigate and improve the quality of care for affected women
We found that substantial variation exists in the local review of severe maternal morbidities, in terms of the
definition and scope of incidents that trigger a review, the guidelines for conducting a review and the
outputs and conclusions of reviews. External review (confidential enquiry) is, in contrast, carried out
nationally using a standard approach.2 Maternal sepsis cases, despite being of current major concern, are
not reviewed in one-third of maternity units,234 and neither does the RCOG guidance recommend that they
are reviewed.191 Given that it was clear that local guidelines take a major steer from RCOG guidance, there
is a case for adding maternal sepsis to the RCOG checklist of cases for review. It is also important that such
trigger checklists are responsive at both a local and national level to emerging conditions of public health
and/or patient safety concern. Processes should exist for ongoing review and revision of the incident review
trigger list to respond to such concerns.
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Stakeholder participation in local development of guidelines for serious incident investigation in maternity
services could be widened. Some guidelines had been circulated to staff to obtain their views, but service
users were rarely consulted. It was unclear in over one-quarter of guidelines whether changes in practice in
response to review recommendations were audited or monitored. Such auditing is important to ensure
recommended changes are being implemented and driving change.168 This was reflected in the local
reviews we examined as fewer than 1 in 10 of the local reviews we examined advocated auditing the
changes to care that were recommended.
Local and external reviews of the care of women who have had severe morbidities in pregnancy clearly
add different perspectives. Both local and external review processes identified important messages to
improve future care, although the number of specific messages identified was greater in the external
reviews. One-fifth of local reviews identified specific local service- or situation-specific factors which had an
impact on women’s care and, importantly, these lessons cannot be identified through external reviews
alone. There was little evidence of multidisciplinary review at a local level, which may account for the
greater number and scope of messages identified by the external review processes. It was also apparent
that local review groups had a role to institute individual disciplinary procedures, when required, and this
may detract from identifying generalised and system-level messages to improve clinical care.
However, the external review process is labour intensive, requires administrative support and costs an
average of £2100 per case. We were not able to capture costs for the local review processes. Although the
costs appear high, if lessons are learned and implemented in practice preventing future serious morbidity,
the benefits would be potentially reaped in terms of future litigation costs prevented.
Recommendations
l Maternal sepsis should be added to both RCOG and local trigger checklists of cases, which should
stimulate a local review.
l Trigger checklists need to be responsive at both a local and national level to emerging conditions of
public health and/or patient safety concern. Processes should exist for ongoing review and revision of
the incident review trigger list to respond to such concerns.
l Stakeholder participation in local development of guidelines for serious incident investigation in
maternity services should be widened.
l The implementation of recommendations from local reviews of the care of women with severe
maternal morbidity should be audited to ensure that change has led to the desired improvement
in outcomes.
l Local reviews should be multidisciplinary including, as a minimum, obstetricians, midwives and
anaesthetists, together with other professional groups such as physicians, GPs and health visitors,
as appropriate.
l At a local level, individual disciplinary procedures/recommendations should be separated from the
incident review processes.
The longer-term impacts of near-miss maternal morbidity for women, their
babies and families
All the women and their partners we interviewed had some long-term adverse consequences of their
near-miss event.46 For some, these did not have a major impact on the quality of their life and relationships
going forward, for others their pregnancy or delivery experience continued to have a major impact often
years after the event. Women often had no follow-up from hospital obstetric or midwifery staff. Primary
care teams should routinely be made aware if a woman has a severe maternal morbidity so they can offer
the support these women may need, both in coming to terms with the near miss and understanding what
long-term impact this might have on their health and ability to have more children. In addition, primary
care teams should be aware that these new mothers may be isolated from their peers and, therefore,
support networks may be required. GPs should be alert for mental health problems developing and
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mindful of the impact that the near-miss experience can have on the whole family (including partner and
other children) and be prepared to offer advice about future pregnancies.
All the partners/fathers we spoke to had been deeply affected by their partner’s life-threatening
experiences. For some it had a profound impact on their long-term mental health. Long-term mental
health problems in partners/fathers after a near-miss experience may have a big impact financially,
practically and emotionally, and families may need additional support in this event. They often felt that
counselling could have been beneficial, if it had been offered; however, clinicians should take into account
that partners/fathers who experience mental health symptoms do not necessarily seek help.
Unfortunately, the challenges we had at several stages of the study, including obtaining NHS management
approval to conduct the study, contributed to an extremely low response rate in our study of the long-term
outcomes of women who had a peripartum hysterectomy. Nevertheless, the study suggested that women
who had a peripartum hysterectomy to control haemorrhage were more likely than women who give birth
but do not have a hysterectomy to experience pain, depression, difficulties/pain during intercourse, severe
tiredness/fatigue, ‘flash-backs’ to the labour or birth, menopausal symptoms and difficulties concentrating
in the first year after their birth; findings which were echoed in the interview study. They were also more
likely to experience ‘flash-backs’ to the labour or birth and menopausal symptoms 7–8 years after the
index birth. The qualitative analysis of the questionnaire responses highlighted a number of examples of
good practice with regard to maternity care and examples for which care could have been improved.
As in the interview study, a number of women identified a perceived need for counselling services.
Recommendations
l When a woman has had a severe maternal morbidity, community midwives as well as her GP should
be made aware of this when she is discharged from hospital.
l Follow-up appointments with hospital obstetric and/or midwifery staff are helpful for women with
severe maternal morbidities. However, women reported that they felt they needed these at varying
times after the event; flexibility beyond the standard timing of 6 weeks post delivery would be helpful.
l There should be a clear pathway for access to counselling services for women with severe
maternal morbidities.
l GPs should remain alert to the possibility of ongoing mental health problems in women who have had
a severe pregnancy complication, as well as being aware that the experience may impact on the mental
health of the woman’s partner.
Implications for future research
Pre-pregnancy
l A key finding of this programme is the fact that maternal medical conditions are a significant risk for
both morbidity and mortality, not only from indirect (medical), but also from direct (obstetric)
morbidities. Pre-pregnancy assessment and advice could address many factors associated with
morbidity, including optimising health and drug regimes in preparation for pregnancy. However, it is
unclear how, and by whom, pre-pregnancy care is best delivered to access women with the wide
spectrum of medical disorders that are associated with morbidity, while taking into account that up to
40% of pregnancies are unplanned. The outcomes, in terms of benefits for mothers and their babies,
of pre-pregnancy counselling are not well established. Obtaining this evidence will be important for
establishing appropriate services.
l Allied to this, further research is needed to fully identify the pathways through which minority ethnicity
is associated with severe maternal morbidity. This may include pre-pregnancy educational, cultural and
social factors that provide a focus for further research into possible pathways of prevention of severe
maternal morbidity.
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During pregnancy
l Research into these rare conditions can be difficult owing to issues of study power even with national
collaborations such as UKOSS. Further studies, for example to investigate the role of early correction of
coagulopathy in the prevention of mortality and severe morbidity from AFE, will require multinational
collaborative studies, such as through the International Network of Obstetric Survey Systems (INOSS).219
l International comparative studies may be valuable to further investigate the impact of different
management strategies. At the time this research was conducted, few comparable international studies
existed because data collection was ongoing in many INOSS participating countries, the notable
exception being the study completed from the Netherlands.198 Comparison of the results of these
studies with those recently published using similar methodology, such as those from the Nordic
countries,235,236 may provide further information to guide optimal management.
l Obstetric interventions, such as induction of labour and caesarean delivery, are associated with a
number of severe morbidities and research to investigate methods to reduce intervention rates without
increasing other adverse outcomes is important as a route to prevention of near-miss morbidity.
l Further investigation is needed to establish the role of prophylactic antibiotics for the prevention of
infection following operative vaginal delivery.
l Some women found intensive care outreach services helpful and further studies are needed as to how
this can be optimally provided to the maternity population to improve outcomes. There may also be a
role for further investigation of the delivery of critical care to the maternity population. Although the
critical care that women received appeared to be good, women did report difficulties in seeing and
feeding their babies, and consideration should be given to their need to be a mother as well as a
patient as part of their recovery from critical obstetric illness.
l Economic evaluation of interventions in maternity care is as important as it is in other disciplines. This
programme demonstrated that robust observational data can be used to conduct a cost–utility analysis
and further studies of interventions for severe maternal morbidities could include similar approaches to
ensure that both costs and outcomes are considered.
l Future research should assess the efficacy of rapid antigen diagnostic tests for group A Streptococcus
in obstetrics.
Following pregnancy
l There has been little research on the long-term impact of traumatic birth and how best to help women.
There is inconclusive evidence on the impact of debriefing programmes237 and this needs to be
robustly evaluated.
l Many of the women we interviewed reported symptoms associated with PTSD, which was also the
case among women who had a peripartum hysterectomy. However, some women who had not had a
severe pregnancy complication also reported similar symptoms. Further investigation of the role that
severe pregnancy complications play as precipitating factors for PTSD is needed, alongside investigation
of possible therapies to prevent traumatic flashbacks238 in both women who have, and those who have
not, had severe pregnancy complications. Similar research is also needed for partners.
Serious incident reviews
l Evidence-based, standard, national guidance on conducting local reviews of the care of women with
severe maternal morbidity may be helpful to reduce variation in quality and outcomes of local reviews,
and this should be evaluated in a prospective study.
l Further evaluation is needed to establish whether or not there is added value to including an external
perspective to local reviews once high-quality multidisciplinary local review processes are
fully implemented.
l The balance of cost/complexity versus benefit of local versus external reviews of the care of women
with severe pregnancy morbidity needs to be fully established in a prospective study including audit of
change in practice and outcomes.
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Services
l The cost–benefit of ELC needs to be fully evaluated, linking the costs of developing the commissioning
strategy with outcomes such as changes in services and patient experience. The longer-term impacts of
implementation of the ELC strategy need to be fully understood.
l Costs of ELC may be reduced when the technique is used in other CCGs, as materials/processes
developed in this study can be reused and do not need to be redeveloped. This requires
further investigation.
l Further research could explore ways of making ELC more understandable to those unfamiliar with
the process.
Conclusions
Implementation of the findings of this research could prevent both future severe pregnancy complications
as well as improving the outcome of pregnancy for women who have one of these severe morbidities.
These ‘near-miss’ events represent only a small proportion of the women with complications, but
improving care for women with the severest complications also benefits women with less-severe disease
and, thus, the programme findings may have wider impacts. One of the clearest findings relates to the
population of women with other medical and mental health problems in pregnancy and their risk of
severe morbidity. Going forward, further research is needed into the means of preventing pregnancy
complications as well as improving the outcomes of pregnancy complications in this group. With current
trends in maternal age at childbirth as well as population trends in factors such as obesity, this group is
likely to become more numerous. However, with the wide range of comorbidities experienced, detailed
and nuanced research into models of pre-pregnancy, pregnancy and postnatal care and the impact on
outcomes for women and their infants is clearly needed.
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